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The Rtf1 subunit of the Paf1 complex is required for specific conserved transcription-coupled 
histone modifications, including histone H2B lysine 123 monoubiquitylation. In Saccharomyces 
cerevisiae, deletion of RTF1 is lethal in the absence of Rkr1, a ubiquitin-protein ligase involved 
in the destruction of nonstop proteins, which arise from mRNAs lacking stop codons or 
translational read-through into the poly(A) tail. To understand the combined requirement for 
H2B ubiquitylation and protein quality control in yeast, I performed a transposon-based 
mutagenesis screen to identify suppressors of rtf1Δ rkr1Δ lethality. I found that mutations in the 
genes encoding RNA Polymerase III subunit Rpc17, sister chromatid cohesion protein Chl1, or 
the protein chaperone Hsp104 could rescue viability. Of these genes, the role of Hsp104 in yeast 
is best understood. Hsp104 plays a role in prion propagation, including the maintenance of 
[PSI+], which contributes to the synthesis of nonstop proteins. I demonstrate that rtf1Δ and rkr1Δ 
are synthetically lethal only in the presence of [PSI+]. The deletion, inactivation, and 
overexpression of HSP104 or the overexpression of prion-encoding genes URE2 and LSM4 clear 
[PSI+] and rescue rtf1Δ rkr1Δ lethality. In addition, the presence of [PSI+] decreases the fitness 
of rkr1Δ strains. I investigated whether the loss of RTF1 exacerbates an overload in nonstop 
proteins in rkr1Δ [PSI+] strains but, using reporter plasmids, found that rtf1Δ decreases nonstop 
protein levels, indicating that excess nonstop proteins may not be the cause of synthetic lethality. 
INVESTIGATING THE COMBINED BURDEN OF TRANSCRIPTION AND 
QUALITY CONTROL ERRORS IN YEAST  
  Kristin Marie Klucevsek, Ph.D 
University of Pittsburgh, 2012 
 
 v 
Although the mechanism of suppression is not yet clear, mutations in CHL1 suppress this rtf1Δ-
specific defect by increasing nonstop protein levels. In addition, I have performed experiments to 
identify substrates and interacting partners for Rkr1 and these results have further indicated a 
role of Rkr1 in protein quality control. My data suggest that the loss of Rtf1-dependent histone 
modifications increases a burden on quality control in rkr1Δ [PSI+] cells. Importantly, my 
research indicates an essential connection between these conserved processes of transcription 
and quality control.  
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1.0  INTRODUCTION 
My dissertation research investigates the combined necessity of the transcription factor Rtf1 and 
the quality control ubiquitin ligase, Rkr1. Rtf1 is a member of the Paf1 complex, which is 
necessary for proper gene expression and formation of RNA Polymerase II transcripts through 
several of its functions, such as its role in histone modifications and the recruitment of 3’-end 
processing machinery. Rkr1 was originally identified as a protein required for cell viability in the 
absence of RTF1, and has since been shown to be involved in the quality control of nonstop 
proteins. I have discovered that strains lacking RKR1 are further burdened by the presence of the 
prion [PSI+] and the absence of Rtf1-mediated histone modifications. Because my thesis research 
is based primarily on investigating the interactions between these components, this introduction 
chapter will focus on the functions of the Paf1 complex in transcription, the role of Rkr1 as a 
ubiquitin ligase, and the identification and consequences of prions in yeast.  
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1.1 TRANSCRIPTION  
Transcription by RNA Polymerase II (RNA Pol II) occurs primarily in three stages: initiation, 
elongation, and termination. As RNA Pol II proceeds through an open reading frame, it 
encounters obstacles in the form of chromatin structure. In this section, I will discuss how RNA 
Pol II overcomes these obstacles and proceeds through the transcription cycle.  
1.1.1 Transcription occurs within the context of chromatin 
The cell employs several mechanisms to navigate through a repressive chromatin environment. 
These mechanisms include nucleosome remodeling, the exchange of canonical histones for 
histone variants, and histone modifications. I will briefly describe these mechanisms, with 
particular detail paid to the mechanisms influenced by the Paf1 complex (further described in 
section 1.2).  
1.1.1.1 Chromatin structure 
The repeating unit of chromatin structure is nucleosomes. Nucleosomes are an octamer of two 
each of four histone proteins (H2A, H2B, H3, and H4), around which are wound approximately 
147 bp of DNA. The linker histone H1 further condenses chromatin between nucleosomes. 
Nucleosomes aid in packaging negatively-charged DNA into chromatin by making DNA 
contacts with positively-charged histone residues, thereby allowing a large genome to fit into a 
small nuclear space. Histones are assembled on DNA by histone chaperones, which deposit an 
H3-H4 tetramer followed by two H2A-H2B dimers to form the higher-order structure (reviewed 
in (POLO and ALMOUZNI 2006)).  The nucleosomal core forms a globular structure that, together 
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with flexible N-terminal histone tails, serve as sites of binding and modification for proteins that 
protect or alter this chromatin structure (reviewed in (RANDO and CHANG 2009)). Because 
nucleosomes also serve as an obstacle to DNA-related processes, histones are dynamically 
removed, replaced, and modified to allow access to the machinery needed for replication, repair, 
recombination, and transcription (See the following sections in 1.1.1 for more details). 
Several nucleosome positions in the genome are precisely placed, such as the -1 and +1 
nucleosome flanking the promoter, while nucleosomes are generally more loosely positioned as 
they progress through the open reading frame. The rigid polydA/dT rich sequences of promoters 
help maintain this region nucleosome-free (NFR) in vivo and in vitro (KAPLAN et al. 2009; LEE 
et al. 2007; YUAN et al. 2005). Nucleosome-depleted regions have also been identified at the 3’ 
ends of some genes. These NFRs could be due to the presence of anti-sense transcripts at these 
loci or sites of termination-factor binding, but also to areas of gene-looping, where the 5’ and 3’ 
ends of genes interact to keep the transcription cycle active (MAVRICH et al. 2008). 
Histone genes are essential and extremely conserved. In yeast, two copies of each core 
histone gene exist: H2A (HTA1 and HTA2), H2B (HTB1 and HTB2), H3 (HHT1 and HHT2) and 
H4 (HHF1 and HHF2). Genes for H2A/H2B and H3/H4 are paired at divergent loci. Several 
other copies of histone genes exist in higher eukaryotes. These genes are under cell cycle control 
and are most highly transcribed during S-phase. Histone gene transcript levels are also highly 
regulated by degradation and 3’-end processing (reviewed in (MARZLUFF et al. 2008)). In 
humans, histone gene transcripts contain a stem-loop structure at their 3’ ends instead of the 
canonical poly(A) tail of other mRNAs, which is most likely important to the export and 
degradation of these transcripts in a cell-cycle specific manner (reviewed in (MARZLUFF 2005)). 
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Yeast histone-encoding mRNAs are polyadenylated, but differentially than other mRNAs, which 
may help in their regulation (BEGGS et al. 2012).   
1.1.1.2 Nucleosome remodeling factors and histone chaperones 
Nucleosomes must be remodeled or exchanged in order to allow RNA Pol II access to DNA 
during transcription, as well as other processes. Using ATP-hydrolysis, nucleosome remodeling 
complexes translocate nucleosomes by breaking DNA-histone contacts. Several classes of 
nucleosome remodeling factors exist, including the SWI-SNF, ISWI, CHD, and INO80/SWR 
classes. Distinctions within these families of chromatin remodelers lies within or outside their 
ATPase domain which results in their differential ability to slide, eject, space, or assemble 
nucleosomes (reviewed in (CLAPIER and CAIRNS 2009)). The chromatin remodeler Chd1 is an 
example of a chromatin remodeling enzyme that physically associates with elongation factors 
such as Rtf1 of the Paf1 complex during active transcription and is required for full nucleosome 
occupancy at actively transcribed genes (LEE et al. 2012; SIMIC et al. 2003). In addition, histone 
modifications can alter the affinity of chromatin remodelers for their substrates.  Such is the case 
for H4 acetylation, which can decrease the activity of Chd1 but increase the activity of RSC 
(FERREIRA et al. 2007). RSC is a type of SWI-SNF family remodeler which is required for RNA 
Pol II elongation at stress-activated genes and contains bromodomains that can recognize 
acetylated lysines (KASTEN et al. 2004). 
Histone chaperones remove and replace histones within nucleosomes to make way for 
elongating RNA Pol II in an ATP-independent manner. For example, FACT (facilitates 
chromatin transcription), a complex consisting of Spt16 and Pob3, helps open chromatin 
structure by displacing H2A/H2B dimers (BELOTSERKOVSKAYA et al. 2003). The chaperone Spt6 
is required for restoring H3/H4 dimers, a process required to occlude RNA Pol II from 
 5 
recognizing cryptic initiation start sites (BORTVIN and WINSTON 1996; KAPLAN et al. 2003). 
Histone chaperones usually bind directly to histones to aid in remodeling or exchange. By 
binding to positively-charged histones, chaperones are able to block interactions with unwanted 
proteins or negatively-charged DNA so that chromatin rearrangement can occur, often with the 
help of ATP-dependent chromatin remodelers (reviewed in (HONDELE and LADURNER 2011)). It 
is therefore likely that both histone chaperones and ATP-dependent chromatin remodelers work 
together with RNA Pol II to remove and reassemble nucleosomes across open reading frames. 
For example, full activity of the RSC complex in vitro is only achieved with the aid of histone 
chaperones such as Nap1 (LORCH et al. 2006).  
1.1.1.3 Histone variants 
The exchange of the canonical histones H2A, H2B, H3, or H4 for histone variants allows 
chromatin to be specialized for a particular process. By containing different sequences than the 
original histones, variants may be differentially modified post-translationally and recruit 
different factors to chromatin. Many histone variants have been identified across species, some 
being cell-type specific, and the number of variants for each histone increases with higher 
eukaryotes. For example, five variants have been identified for H3, including H3.3 in Drosophila 
and mammals and CenH3 which is conserved from yeast through humans (reviewed in 
(BOYARCHUK et al. 2011)).  While H3.3 and CenH3 are both associated with marking 
centromeres, CenH3 has also been correlated with high levels of histone turnover in yeast as well 
as DNA breaks in humans (LEFRANCOIS et al. 2009; ZEITLIN et al. 2009).  
One of the most important histone variants in transcription is the H2A variant Htz1 
(yeast), also known as H2A.Z in humans. H2A.Z has been mapped to centromeres, telomeres, 
promoters, and gene bodies. As it relates to transcription, it is most often associated with the 
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nucleosomes flanking the nucleosome-free region of the promoter, where it may help in poising 
a promoter for activation (RAISNER et al. 2005; ZHANG et al. 2005a).  Structural analysis of 
H2A.Z suggests that incorporating this variant may destabilize the nucleosome, due to effects of 
its C-terminal region, which is highly divergent from canonical H2A (FAN et al. 2002; SUTO et 
al. 2000). The H2A.Z C-terminal  region most likely aids in recruiting specific factors to 
chromatin that are not recruited in the presence of H2A-containing nucleosomes, either by 
serving as a binding site for new factors or by opening the nucleosome to facilitate access to 
DNA and promote transcription. H2AZ is incorporated into nucleosomes through the ATP-
dependent SWR1 complex, which binds to H2AZ and exchanges it for H2A within nucleosomes 
(KROGAN et al. 2003a; MIZUGUCHI et al. 2004). This complex is also aided by the histone 
chaperone Chz1 (LUK et al. 2007).  
1.1.1.4 Histone modifications 
Histones are subject to an array of post-translational modifications that mark them for both 
transcription-dependent and independent processes and help define the chromatin landscape into 
sections such as active transcription, silenced genes, telomeres, centromeres, and sites of DNA 
damage. Several types of modifications exist on different residues of each histone, most on the 
exposed N-terminal lysine-rich histone tails. These modifications define the “histone code,” 
which allows the binding of specific factors to these marks (reviewed in (LEE et al. 2010)). In 
this section, select pathways of histone ubiquitylation, methylation, and acetylation as they relate 
to transcription will be further discussed.  
 Histone acetylation, often at multiple lysine residues, correlates with active transcription 
across open reading frames, most likely aiding to recruit RNA Pol II (DURANT and PUGH 2006; 
POKHOLOK et al. 2005). This dynamic mark is thought to loosen contacts between DNA and 
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histones by neutralizing the lysine charge, thereby making it more accessible to transcriptional 
regulators, although the modification may also serve as a binding site for proteins (reviewed in 
(VERDONE et al. 2005)). Histone acetyltransferase (HATs) and histone deacetylase complexes 
(HDACs) are responsible for placing and removing this mark, respectively. There are several 
identified eukaryotic HATs, categorized into families such as Gcn5-related, MYST, and 
p300/CBP (reviewed in (VERDONE et al. 2005)). Gcn5, a subunit of the SAGA and ADA 
complexes, is one well characterized HAT which is required for the correct expression of many 
genes. It can acetylate both histone H3 and H2B and non-histone co-activator substrates to 
influence gene regulation (GRANT et al. 1997; HOLSTEGE et al. 1998; IMOBERDORF et al. 2006). 
Although there are many other HATs, Gcn5 and Esa1, which acetylates H4 and H2A, are 
responsible for the majority of genome-wide histone acetylation in yeast (DURANT and PUGH 
2006).   
There are several co-dependencies of histone acetylation and methylation, which are 
prime illustrations of “histone cross-talk,” where one modification influences another. One 
example involves acetylation and H3 K36 methylation, which is catalyzed by the 
methyltransferase Set2 at the 3’ ends of genes (DROUIN et al. 2010; GOVIND et al. 2010; KIZER et 
al. 2005; KROGAN et al. 2003b).  The HDAC Rpd3s complex is recruited to open-reading frames 
as a result of H3 K36 di-methylation in order to deacetylate nucleosomes. This coordination of 
events helps prevent cryptic initiation at hidden promoters within genes due to high levels of 
activating acetylation (CARROZZA et al. 2005; KEOGH et al. 2005; LI et al. 2007b).  
Histone H2B is monoubiquitylated on K123 in yeast and K120 in humans by the 
ubiquitin conjugase and ubiquitin ligase pair Rad6 and Bre1 (HWANG et al. 2003; KIM et al. 
2005; ROBZYK et al. 2000; WOOD et al. 2003a). This modification is associated with active 
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transcription on many genes and disrupts higher-order chromatin compaction in vitro, but has 
also been associated with a repressive function on open reading frames, indicating a dual role for 
this mark (CRISUCCI and ARNDT 2011a; FIERZ et al. 2011; MUTIU et al. 2007; XIAO et al. 2005).  
H2B K123 monoubiquitylation is a prerequisite for two independent and conserved downstream 
histone modifications on H3, K4 methylation by Set1 (of the complex COMPASS) and K79 
methylation by Dot 1 on active open reading frames  (DOVER et al. 2002; POKHOLOK et al. 2005; 
ROGUEV et al. 2001; SUN and ALLIS 2002; VAN LEEUWEN et al. 2002).   
Methylation can exist on lysines in a mono, di or tri- state, which may help recruit 
specific binding factors. Different levels of this histone methylation modification may simply be 
due to levels of methyltransferase recruitment or to the recruitment of histone demethylases to 
reverse this mark. For example, H3 K4 tri-methylation is found on active genes while di-
methylation can be found across the genome (BERNSTEIN et al. 2002; SANTOS-ROSA et al. 2002).  
Set1 is recruited to transcribed loci by Ser-5 phosphorylation on the RNA Pol II CTD (further 
described in section 1.1.2.1) and therefore H3 K4 tri-methylation is enriched at promoters of 
active genes. H3 K4 di-methylation is enriched within the open reading frame (NG et al. 2003b; 
POKHOLOK et al. 2005). While H3 K4 tri-methylation recruits the histone acetyltransferase 
complex NuA3, di-methylation specifically recruits the histone deacetylase complex Set3 (KIM 
and BURATOWSKI 2009; TAVERNA et al. 2006). H2B K123 deubiquitylation by the enzymes 
Upb8 and Ubp10 reverses H2B K123 ubiquitylation and controls its levels in a locus-specific 
fashion. Ubp8 targets H2B K123 ubiquitylation at the 5’ ends of genes where H3 K4 tri-
methylation is highest, and Ubp10 targets H2B K123 ubiquitylation associated with H3 K79 
methylation within gene bodies (SCHULZE et al. 2011).  
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Histone modifications are regulated by several factors. An important pathway for several 
of the modifications discussed in this section is through the Paf1 complex (Paf1c). This pathway 
begins with the cyclin-dependent kinase and regulatory partner Bur1-Bur2, which is recruited to 
chromatin with the aid of Ser5 phosphorylation of the RNA Pol II CTD (QIU et al. 2009). 
Bur1/Bur2 phosphorylates the C-terminal domain of the elongation factor Spt5, an event that is 
required for Spt4-Spt5-mediated recruitment of the Paf1c (LIU et al. 2009; ZHOU et al. 2009). 
Accordingly, the loss of Bur1-Bur2 also causes a decrease in Paf1c recruitment to chromatin 
(LARIBEE et al. 2005). Paf1c, as well as the upstream factors, are required for H2B K123 
ubiquitylation and H3 K4 and K79 methylation  (Figure 1) (NG et al. 2003a; TOMSON et al. 
2011; WARNER et al. 2007; WOOD et al. 2003b; ZHOU et al. 2009).  Interestingly, Bur1 is also 
required independently for efficient H2B ubiquitylation through its phosphorylation of Rad6 
(WOOD et al. 2005).  Further, purified yeast Bre1 physically interacts with Paf1 in vitro, 
suggesting a physical link between this pathway and H2B ubiquitylation in vivo (KIM and 
ROEDER 2009). In another related pathway, both Bur1-Bur2 and Paf1c are required for full levels 
of H3 K36 tri-methylation and recruitment of Set2 to active genes (Figure 1) (CHU et al. 2007; 
KROGAN et al. 2003b).   
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Figure 1: Regulation of histone H2B ubiquitylation and H3 methylation 
Histone H2B ubiquitylation by Rad6/Bre1 is a pre-requisite for H3 K4 and H3 K79 methylation by the 
methyltransferases Set1 and Dot1, respectively (DOVER et al. 2002; POKHOLOK et al. 2005; ROGUEV et al. 2001; 
SUN and ALLIS 2002; VAN LEEUWEN et al. 2002). These marks are regulated by a pathway involving Bur1/2 
recruitment to active genes and phosphorylation of Spt5. The Spt4/5 complex in turn recruits the Paf1 complex, 
which is required for these modifications (NG et al. 2003a; TOMSON et al. 2011; WARNER et al. 2007; WOOD et al. 
2003b; ZHOU et al. 2009). As a separate event, H3 K36 tri-methylation by Set2 also requires a functional Bur1/2-
Paf1 complex pathway (CHU et al. 2007; KROGAN et al. 2003b).  
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1.1.2 Transcription is a highly regulated process 
RNA Polymerase II (RNA Pol II) is a 12 subunit complex that transcribes genes into messenger 
RNAs, as well as some other noncoding RNAs. RNA Pol II transcription initiates at promoters 
with the aid of general transcription factors, and proceeds through the DNA template during 
elongation until exiting during the termination stage. At this point, RNA Pol II is recycled to 
reenter the transcription cycle. In this section, I will discuss the stages of transcription by RNA 
Pol II and their regulation.  
1.1.2.1 RNA Polymerase II C-terminal domain phosphorylation 
The carboxyl-terminal domain (CTD) of the largest RNA Pol II subunit, Rpb1, contains a 
sequence of repeated heptapeptides (Y1S2P3T4S5P6S7) whose post-translational modifications are 
essential to transcription regulation (reviewed in (BURATOWSKI 2009)). There are 26 
heptapeptide repeats in yeast and 52 in humans. Although several residues are modified in the 
CTD, CTD serine phosphorylation is particularly well-studied in correlation with the stage of 
transcription across the open reading frame. These phosphorylation states allow the dynamic 
recruitment of different transcription and processing factors dependent on the CTD code 
(reviewed in (BURATOWSKI 2009)). An unphosphorylated CTD recruits initiation factors, for 
example, while a differently phosphorylated CTD within the open reading frame helps move 
RNA Pol II through stages of transcription from initiation to elongation to termination and 3’end 
processing (reviewed in (EGLOFF and MURPHY 2008)).  
Ser5 of the CTD is phosphorylated mainly by the cyclin-dependent kinase Cdk7/Kin28 
(human/yeast), and aids in recruitment of factors to cap the 5’ end of the newly transcribed RNA 
(CHO et al. 1997; RODRIGUEZ et al. 2000; SCHROEDER et al. 2000). Ser5-P levels decrease as 
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RNA Pol II moves towards the 3’ ends of genes, where Ser2-P levels are highest (CHO et al. 
2001; KIM et al. 2010a). Ser2 is phosphorylated largely by P-TEFb (Cdk9)/Ctk1 (human/yeast), 
but also by other kinases such as Bur1 (LIU et al. 2009; PATTURAJAN et al. 1999; PETERLIN and 
PRICE 2006). This modification helps RNA Pol II transition from transcription elongation to 
termination and 3’ end formation at the end of open reading frames (reviewed in (BURATOWSKI 
2009)). Both Ser5-P and Ser2-P are regulated by dephosphorylation by the phosphatases Ssu72, 
Rtr1 and Fcp1 in yeast,  as RNA Pol II moves through the transcription cycle (CHO et al. 2001; 
KRISHNAMURTHY et al. 2004; MOSLEY et al. 2009).  Although this pattern holds true for most 
genes, the levels of Ser2-P are overall  decreased on shorter, non-coding RNA genes, which 
could explain differences in termination pathways at these loci (TIETJEN et al. 2010). In addition 
to Ser2 and Ser5 phosphorylation, Ser7 has recently been shown to be phosphorylated 
throughout open reading frames by the kinases Cdk7 and Cdk9, where it highly overlaps with 
Ser5-P (GLOVER-CUTTER et al. 2009; KIM et al. 2010a; ST AMOUR et al. 2012). Ser7-P has been 
implicated in helping recruit P-TEFb for Ser2 phosphorylation, and can also be 
dephosphorylated by Ssu72 (BATAILLE et al. 2012; CZUDNOCHOWSKI et al. 2012).  
1.1.2.2 Transcription Initiation 
The pre-initiation complex (PIC), consisting of RNA Pol II and the general transcription factors, 
assembles at promoters to begin transcription. The promoter region can be TATA box 
containing, or TATA-less, and usually contains a nucleosome-free region flanked on either side 
by a well-positioned nucleosome (KAPLAN et al. 2009; LEE et al. 2007; YUAN et al. 2005).  The 
general transcription factors TATA-binding protein (TBP) of TFIID, TFIIA, and TFIIB find and 
bind the promoter and recruit TFIIF and RNA Pol II, followed by TFIIE and TFIIH to begin 
transcription by separating the DNA strands and scanning for the transcription start site 
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(reviewed in (HAHN and YOUNG 2011)). Co-activators such as Mediator, SAGA, and NuA4 help 
control which genes are recognized and bound by the PIC.  Factors required for efficient 
transcription initiation require proper CTD phosphorylation. For example, the general 
transcription factor TBP and co-activator Mediator complex are both recruited to 
unphosphorylated CTD to start the transcription cycle, and are released upon Ser5 
phosphorylation (MAX et al. 2007; USHEVA et al. 1992).  
1.1.2.3 Transcription Elongation 
As RNA Pol II proceeds through the open reading frame and Ser5 becomes phosphorylated, a 
new set of factors is recruited to properly synthesize the nascent RNA. This transition involves 
histone modifying enzymes, histone variants, histone chaperones, and chromatin remodeling 
enzymes, which help RNA Pol II navigate a repressive chromatin structure by loosening histone-
DNA contacts and disassembling nucleosomes (See section 1.1.1 of this Introduction for a more 
detailed review of these processes). RNA splicing and processing factors are also recruited 
during transcription elongation through association with the CTD (reviewed in (SELTH et al. 
2010)).  Ser5-P is required for recruitment of the 5’ end capping machinery and the Set1 H3 K4 
methyltransferase through Paf1c (reviewed in (EGLOFF and MURPHY 2008)). As Ser2 is 
phosphorylated, histone modifying enzymes such as the H3 K36 methyltransferase Set2 
associate with the CTD, also with the help of Paf1c (KIZER et al. 2005; KROGAN et al. 2003b). 
Several mechanisms are employed by these factors to facilitate RNA Pol II transcription. For 
example, H2A/H2B dimers, more frequently than H3/H4, can be displaced and exchanged to 
make way for elongating RNA Pol II, but RNA Pol II is able to transverse nucleosomes without 
displacement in vitro, indicating that this might not be necessary at all genes (reviewed in 
(SELTH et al. 2010)) (THIRIET and HAYES 2005).  
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1.1.2.4 Transcription Termination and RNA 3’-end processing 
As elongating RNA Pol II reaches the end of the DNA template, it recruits several factors to 
terminate transcription and process the nascent mRNA. This step is crucial in completing gene 
expression, as improper 3’-end processing can result in errors in exporting or translating the 
transcript, as well as target the transcript for premature quality control and degradation (reviewed 
in (MANDEL et al. 2008)).  
Transcription termination at RNA Pol II –transcribed genes can occur via two pathways 
(reviewed in (KUEHNER et al. 2011)). The first involves recognitions and cleavage of the nascent 
mRNA, followed by polyadenylation. Transcripts extend beyond the translational stop codon in a 
region called the 3’ untranslated region (or UTR), which can be anywhere from 50 to thousands 
of nucleotide base pairs in length (reviewed in (PROUDFOOT 2011)). Within this region exists a 
cleavage and polyadenylation signal, often the conserved sequence AAUAAA, which is required 
for 3’end polyadenylation of nascent transcripts by a poly(A) polymerase, such as Pap1 in yeast 
(reviewed in (ZHAO et al. 1999)) (WICKENS and STEPHENSON 1984). This signal and others are 
recognized by the cleavage and polyadenylation specificity factor (CPSF) and cleavage 
stimulatory factor (CstF) in mammals, factors which are conserved in higher eukaryotes 
(reviewed in (PROUDFOOT 2011). In addition, one transcript can contain multiple, alternate 
polyadenylation sites, which can aid in regulating transcript levels through the formation of 
different 3’ UTRs (reviewed in (PROUDFOOT 2011)). Transcription is  required for proper RNA 
3’ end processing, as the RNA Pol II CTD recruits the cleavage and polyadenylation factors and 
this event is necessary for the release of RNA Pol II from newly transcribed mRNA (reviewed in 
(KUEHNER et al. 2011)). The cleavage and polyadenylation factor Pcf11, for example, directly 
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and preferentially interacts with Ser-2 phosphorylation on the CTD to promote transcription 
termination (LICATALOSI et al. 2002; MEINHART and CRAMER 2004) 
The second method of transcription termination for RNA Pol II transcripts exists mainly 
for noncoding, nonpolyadenylated RNAs such as snRNAs and snoRNAs (reviewed in (KUEHNER 
et al. 2011)). This process requires the Sen1 DNA helicase and the RNA binding proteins Nrd1 
and Nab3 in yeast, as well as the nuclear exosome (TRAMP) in order to cleave and trim the 3’ 
end (STEINMETZ et al. 2001; STEINMETZ et al. 2006). Interestingly, the non-polyadenylation 
factor Nrd1 also interacts with Ser5-P and Ser7-P CTD to process specific transcripts, indicating 
the importance of RNA Pol II in coordinating this termination activity (MEINHART and CRAMER 
2004; TIETJEN et al. 2010; VASILJEVA et al. 2008). In general, it has been hypothesized that the 
shorter ncRNA genes have a different distribution of CTD phosphorylation, consisting mostly of 
Ser5-P and Ser7-P, which helps distinguish which transcription termination pathway to employ 
(reviewed in (KUEHNER et al. 2011)) (GUDIPATI et al. 2008). 
1.2 THE PAF1 COMPLEX MODULATES SEVERAL EVENTS IN 
TRANSCRIPTION 
The Paf1 complex (Paf1c) physically associates with elongating RNA Pol II to facilitate 
transcription. In this section, I will describe the known functions of the Paf1 complex, including 
its roles in transcription elongation, histone modifications, and 3’-end formation of nascent 
transcripts (Figure 2).   
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1.2.1 Paf1c is an elongation complex 
There are several factors that aid in the proper transcription of a chromatin template. Several 
studies support the role of Paf1c as one such factor that is specifically required for proper 
transcription by elongating RNA Pol II. This complex is conserved from yeast through humans, 
though with slightly different members. In Saccharomyces cerevisiae, Paf1c consists of the five 
proteins Paf1, Ctr9, Leo1, Cdc73, and Rtf1 (KROGAN et al. 2002; MUELLER and JAEHNING 2002; 
SHI et al. 1997; SQUAZZO et al. 2002). In humans, the Paf1 complex can exist as hCtr9, hLeo1, 
hCdc73, hPaf1, and hSki8, sometimes with hRtf1 depending on purification strategies (KIM et al. 
2010b; ROZENBLATT-ROSEN et al. 2005; ZHU et al. 2005) 
  Genetic studies showed that the loss of RTF1 was synthetically lethal with several 
mutations in genes connected to transcription elongation-related processes, such as the mediator 
subunit SRB5, CTD kinase CTK1, CTD phosphatase FCP1, and FACT chromatin remodeling 
subunit POB3 mutations (COSTA and ARNDT 2000).  Further data supporting Paf1c in 
transcription elongation include physical interactions between Paf1c and the elongation factors 
Spt4-Spt5 and the Spt16-Pob3/FACT complex, as well as phenotypes associated with 
transcription elongation defects, such as sensitivity to 6-azauracil (SQUAZZO et al. 2002). In 
humans, RNA Pol II and the transcription elongation factor SII/TFIIS have also been shown to 
physically and directly interact with Paf1c to enhance transcription elongation (KIM et al. 
2010b).  In vitro, reconstituted or purified hPaf1c can stimulate and enhance transcription of a 
DNA template in a dosage dependent manner (KIM et al. 2010b). Depletion of Paf1c subunits 
also causes a decrease in transcription elongation both in vivo and in vitro (RONDON et al. 2004; 
TOUS et al. 2011). Additionally, the loss of Paf1c members causes delayed histone removal in 
the GAL1 coding region upon induction, and a decrease in nucleosomal occupancy across the 
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SER3 promoter, indicating a role for Paf1 in proper nucleosome levels (MARTON and DESIDERIO 
2008; PRUNESKI et al. 2011).   
1.2.2 Paf1c physically associates with RNA Pol II on actively transcribed genes 
The namesake of the Paf1 complex was coined for Polymerase associated factor, as it purifies 
with RNA Polymerase II (WADE et al. 1996). It physically interacts with RNA Pol II in all of its 
phosphorylated forms (ROZENBLATT-ROSEN et al. 2005).  Paf1c is distributed across all active 
open reading frames with transcribing RNA Pol II from the transcription start site to the poly(A) 
site, but loss of Paf1c does not change Poll II distribution (KIM et al. 2004; MUELLER et al. 
2004). Subunits of the Paf1c bind RNA in vitro and in vivo, which may also play a role in aiding 
to localize the complex to actively transcribed genes (DERMODY and BURATOWSKI 2010). A 
reduction or mutation in Rtf1 or Cdc73 causes loss of Paf1c from chromatin, suggesting their 
role in tethering the complex to elongating RNA Pol II (AMRICH et al. 2012; MUELLER et al. 
2004; WARNER et al. 2007). In coordination with this, loss of PAF1 causes more severe growth 
defects and phenotypes. However, loss of PAF1 also results in a decrease in both Rtf1 and Cdc73 
levels, which could explain the defects of paf1Δ strains in both reduction of chromatin 
association in addition to its own phenotypes (BETZ et al. 2002; MUELLER et al. 2004).   
Although Paf1c physically associates with RNA Pol II on all actively transcribed genes, 
the loss of its members only affect a subset of genes and these effects can be both positive or 
negative (CRISUCCI and ARNDT 2011a; MAYER et al. 2010; SHI et al. 1996). In addition, genome-
wide studies comparing loss of PAF1 or CTR9 show that they have overlapping but not identical 
effects on transcript abundance (PENHEITER et al. 2005).  
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1.2.3 An effect of Paf1c on CTD phosphorylation 
Loss of Paf1c subunits disrupts RNA Pol II phosphorylation of its heptapeptide sequence. For 
example, studies have shown that the loss of PAF1, CTR9, or CDC73 causes a decrease in total 
Ser2-P levels on the CTD (NORDICK et al. 2008b), while others have correlated this CTD 
phosphorylation defect with a global length of poly(A) tails (MUELLER et al. 2004). Loss of 
Paf1c subunits also causes a decrease in recruitment of factors that require CTD phosphorylation, 
such as the cleavage and polyadenylation factor Cft1 (NORDICK et al. 2008b). Because proper 
CTD phosphorylation serves as a platform for recruitment of multiple factors, it is likely that 
changes in CTD phosphorylation or interacting proteins are likely the cause of many phenotypes 
seen in the absence of PAF1.  
1.2.4 Histone modifications 
One of the best described roles of the Paf1c members is their requirement for specific and 
conserved histone modifications. These histone modifications have been shown to be important 
for a variety of processes, indicating their importance in transcription.  
1.2.4.1 H2B monoubiquitylation 
The Paf1c is required for monoubiquitylation of H2B in eukaryotes, a function mainly attributed 
to the subunit Rtf1 (NG et al. 2003a; TOMSON et al. 2011; WARNER et al. 2007; WOOD et al. 
2003b). Rtf1 regulates this modification through an unknown mechanism requiring the ubiquitin 
conjugating enzyme Rad6 and the ubiquitin protein ligase Bre1 (HWANG et al. 2003). Without 
Rtf1, both yeast and human chromatin also lack the downstream methylation of H3 on K4 and 
 19 
K79 by the methyltransferases Set1 and Dot1, respectively (DOVER et al. 2002; NG et al. 2003a; 
SUN and ALLIS 2002; WOOD et al. 2003b). 
1.2.4.2 H3 K36 tri-methylation and histone acetylation 
Specific members of Paf1c (Paf1, Ctr9, and Cdc73) and the upstream Bur1-Bur2 cyclin-
dependent protein kinase, are required for proper histone H3 K36 tri-methylation by the 
methyltransferase Set2, as well as the proper recruitment of Set2 to active genes (CHU et al. 
2007; KROGAN et al. 2003b).  This defect was shown by western analysis of global H3 K36 
methylation, as well as chromatin immunoprecipitation at specific genes, which indicated a 
decrease in H3 K36 tri-methylation. This reduction was greater at the 5’ end than the 3’ ends of 
active genes. The same study found a concurrent increase in histone acetylation at the 5’ends of 
some genes and varying effects on histone acetylation at the 3’ ends. However, this increase in 
histone acetylation at the 5’ end was not dependent on the decrease in methylation (CHU et al. 
2007) .  
1.2.5 Role of Paf1c in RNA 3’-end formation 
The correct 3’-end formation of RNAs is important to creating stable, functional RNAs that can 
be properly exported and translated. The Paf1 complex is involved in regulating several aspects 
of transcription termination and polyadenylation. Errors in this process may lead to changes in 
transcript levels and targeting by quality control pathways.  
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1.2.5.1 Cleavage and polyadenylation 
Both yeast and human Paf1c are required for the correct maturation of RNA Pol II transcripts 
(MUELLER et al. 2004; NAGAIKE et al. 2011; NORDICK et al. 2008a; PENHEITER et al. 2005; 
SHELDON et al. 2005). This complex is required for proper mRNA cleavage, polyadenylation, 
and export to the cytoplasm of transcripts produced from a reporter construct in human cells 
(NAGAIKE et al. 2011). The human ortholog of Cdc73 is also required for proper cleavage and 
formation of the 3’ ends of histone mRNAs, resulting in their stabilization (FARBER et al. 2010). 
Processed human histone mRNAs are normally not polyadenylated, which aids in regulating the 
levels of these transcripts (HARRIS et al. 1991; STAUBER and SCHUMPERLI 1988). hCdc73 also 
physically associates with the 3’ cleavage and polyadenylation specificity factor CPSF and the 
cleavage stimulation factor CstF, confirming an important role for this factor in coordinating 3’-
end formation (ROZENBLATT-ROSEN et al. 2009).  
In yeast, loss of Paf1c members results in decreased poly(A) tail length and alternative 
poly(A) site usage (MUELLER et al. 2004; STRAWN et al. 2009). This may be due to a decrease in 
the recruitment of 3’-end processing factors, as the cleavage and polyadenylation factor Cft1 
requires Rtf1 and Cdc73 for proper association with Ser5-P of the CTD. In addition, Ctr9 also 
physically interacts with Cft1 (NORDICK et al. 2008b).  Paf1c is also important in preventing 
premature transcription termination by Sen1/Nab3/Nrd1 at the open reading frame FKS2 in 
response to cell stress (KIM and LEVIN 2011). Spt5 is required for recruitment of both the RNA 
cleavage factor CFI and Paf1c, further connecting this complex in many facets of transcription 
termination on RNA Pol II genes (MAYER et al. 2012). Interestingly, Paf1c also functions in 
termination outside of RNA Pol II transcription, as it is also required for efficient rRNA 
processing (PORTER et al. 2005; ZHANG et al. 2009). 
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1.2.5.2 snoRNA 3’-end formation 
Members of the Paf1 complex are also required for the efficient 3’-end formation of non-mRNA 
transcripts, such as non-polyadenylated small nucleolar RNAs (snoRNAs). This function is at 
least partially dependent on Paf1-mediated histone modifications such as H2B ubiquitylation 
(SHELDON et al. 2005; TOMSON et al. 2011). The proper 3’-end formation of snoRNAs requires 
the proteins Nab3 and Nrd1, the Sen1 helicase, and cleavage/polyadenylation complex factors, as 
well as the 3’ to 5’ activity of the exosome (ALLMANG et al. 1999; FATICA et al. 2000; 
MORLANDO et al. 2002; STEINMETZ et al. 2001). Regulation of snoRNA transcription 
termination by Paf1 most likely occurs through Nab3 and Nrd1, as deletion of PAF1 affects Nrd1 
recruitment to these genes (SHELDON et al. 2005).  
1.2.5.3 mRNA quality control of Paf1-regulated transcripts 
Improperly processed transcripts resulting from loss of Paf1c, such as those described above, can 
be substrates for mRNA quality control pathways (PENHEITER et al. 2005) and (reviewed in 
(CRISUCCI and ARNDT 2011b; JAEHNING 2010)). For example, loss of PAF1 causes altered usage 
of poly(A) sites on the genes SDA1 and MAK21. The resulting extended transcripts are 
recognized as substrates by the nonsense-mediated decay machinery and are targeted for 
degradation (PENHEITER et al. 2005). Therefore, changes in transcripts in paf1Δ cells may be due 
not only to decreased transcription, but also to errors in 3’-end processing that lead to the 
destruction of aberrant mRNAs. Likewise, changes in 3’-end processing may not affect transcript 
levels, but instead affect their ability to be exported or translated. This is the case for the yeast 
nonsense allele ade1-14, which requires a functional Paf1c for proper levels of protein. The 
ade1-14 transcript levels are unchanged in mutant strains. Instead, it seems that these Paf1c 
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mutant strains use a different poly(A) site, which results in decreased export or translational 
expression of the transcript (STRAWN et al. 2009). 
 In human cells, hPaf1 has been isolated with the additional subunit hSki8, which is a 
member of the SKI complex necessary for proper mRNA degradation (ZHU et al. 2005). In yeast, 
this complex also contains Ski2 and Ski3 and is cytoplasmic, but in humans this complex is both 
cytoplasmic and nuclear, where it interacts with the exosome to promote 3’ to 5’ mRNA decay 
(BROWN et al. 2000; ZHU et al. 2005). The nuclear exosome associates along transcriptionally 
active open reading frames in Drosophila, suggesting that like Paf1c, it also plays a role in 
transcription elongation (ANDRULIS et al. 2002). Knockdown of hSki8 results in decreased levels 
of other Paf1c members and several associated histone modifications, similar to the loss of 
hPaf1c (ZHU et al. 2005). The finding that human Paf1c stably associates with a member of an 
mRNA decay complex implies that mRNA surveillance occurs co-transcriptionally, and further 
suggests a Paf1c role in targeting mRNA quality control and decay of aberrant transcripts.  
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Figure 2: The roles of the Paf1 complex 
The Paf1 complex plays several roles in transcription through its physical association with elongating RNA Pol II on 
all actively transcribed open reading frames and its ability to bind RNA (Complex as shown is representation, and 
does not necessarily reflect physical associations between members). These conserved functions include maintaining 
proper CTD phosphorylation, histone modifications such as H2B K123 ubiquitylation and H3 methylation, as well 
as 3’ end formation of nascent transcripts (reviewed in (CRISUCCI and ARNDT 2011b; JAEHNING 2010)). 
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1.2.6 Roles of Paf1c outside RNA Pol II transcription 
The Paf1c has been connected to other processes in addition to proper transcription elongation, 
histone modification, and mRNA formation. These functions may be due indirectly to its 
association with RNA Pol II, but also to other unidentified roles.  For example, mutations in 
Paf1c members are synthetically lethal with a mutation in the cell cycle regulator genes SWI4 
and SWI6, and affect the expression of many cell cycle associated genes (Costa and Arndt 
unpublished data, (BETZ et al. 2002; PORTER et al. 2002)). Paf1c is also required for DNA 
damage repair in a Rad26-dependent pathway as well as in global genomic repair through H2B 
K123 ubiquitylation. The same study also showed that, in cooperation with the elongation factors 
Spt4 and Spt5 in yeast, Paf1c suppresses a Rad26-independent transcription-coupled repair 
pathway (TATUM et al. 2011). Outside its physical connection to RNA Pol II, Paf1c is also 
required for efficient RNA Pol I transcription and associates with rDNA without affecting Pol I 
occupancy (ZHANG et al. 2009).  
Recently, the Paf1 complex has also been associated with chromosome segregation. The 
methyltransferase for H3 K4me, Set1, has also been shown to methylate the kinetochore protein 
Dam1. Dam1 is also phosphorylated by the Aurora kinase Ipl1, and both Dam1 phosphorylation 
and methylation are important for its function in chromosome segregation (ZHANG et al. 2005b). 
Further investigation into Set1 regulation of this process uncovered the necessity for the Paf1 
complex and Rad6-Bre1, as well as H2B K123 ubiquitylation, for Set1-mediated Dam1 
methylation, connecting the Paf1 complex to mitosis and suggesting that histone cross-talk can 
occur outside the context of chromatin (LATHAM et al. 2011).  
In higher eukaryotes, both Leo1 and Cdc73 have been implicated in Wnt signaling, which 
can affect both cell fate and cancer (MOSIMANN et al. 2006). hCdc73 overexpression leads to an 
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increase in the expression of Wnt target genes through mediating Wnt translocation into the 
nucleus. In addition, Drosophila Cdc73 and Leo1 directly bind the Wnt signaling regulator β-
catenin (MOSIMANN et al. 2006).  
1.2.7 Connections of Paf1c to disease 
Due to the many functions of the Paf1 complex, mutations or overexpression of the genes 
encoding these subunits can have a myriad of effects on human disease. hPaf1 is overexpressed 
in pancreatic cancer cells, and the overexpression of hPaf1 can transform nononcogenic cells, 
suggesting this protein is an oncogene (MONIAUX et al. 2006). hCdc73, also known as 
parafibromin, is often mutated in hyperparathyroidism-jaw tumors (CARPTEN et al. 2002).The 
overexpression of the gene encoding parafibromin, HRPT2, has also been associated with liver, 
pancreatic, and breast cancers (CHANG et al. 2005; PARADA et al. 1998; STANGE et al. 2006)  
In addition, human Paf1C-mediated histone modifications have been associated with 
disease. Mistakes in these histone modifications can lead to erroneous transcription and result in 
cancer. For example, reduced H2B ubiquitylation results in decreased expression of the p53 
tumor suppressor gene and increased expression of tumor-promoting genes (SHEMA et al. 2008). 
Paf1c-mediated histone modifications can also be exploited in an infection. A strain of influenza 
encodes a protein that mimics the H3 K4 methylation sequence and binds to Paf1c, thereby 
resulting in decreased gene expression, including genes required for antiviral immunity 
(MARAZZI et al. 2012).  
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1.3 RKR1 UBIQUITYLATION AND PROTEIN QUALITY CONTROL 
Rkr1 (Ring domain mutant killed by rtf1) is a ubiquitin ligase originally identified in a screen for 
factors required for viability in the absence of the transcription factor Rtf1 (BRAUN et al. 2007). 
It possesses a RING domain, which has ubiquitin ligase activity in vitro (BRAUN et al. 2007). 
Rkr1 is required for the quality control of nonstop proteins, resulting from translational read-
through into the poly(A) tail of mRNA (BENGTSON and JOAZEIRO 2010). In this section, I will 
further discuss the process of protein ubiquitylation in yeast, with particular focus on what is 
known about Rkr1. 
1.3.1 The components of ubiquitylation 
Ubiquitin is a conserved 76 amino acid protein that covalently is attached to other proteins to 
target them for processes such as apoptosis, cell cycle progression, DNA repair, and proteasome-
mediated degradation (reviewed in (WEISSMAN 2001)). The ubiquitylation pathway consists of 
three main steps. The first occurs when a ubiquitin activating enzyme (E1) activates ubiquitin, 
and the next occurs as the E1 transfers ubiquitin from its active-site cysteine to an active-site 
cysteine in a ubiquitin-conjugating enzyme (E2). The third step occurs when the E2 transfers 
ubiquitin to a lysine residue on a substrate, targeted with the aid of a ubiquitin ligase (E3) (Figure 
3) (reviewed in (DESHAIES and JOAZEIRO 2009)). Ubiquitin is usually attached to a substrate 
lysine via an isopeptide bond with its C-terminal glycine. The substrate can then targeted for its 
indicated pathway based on number and placement of ubiquitin proteins. This dynamic process is 
reversible, as deubiquitylating enzymes can remove ubiquitin from substrates (reviewed in 
(LOVE et al. 2007)).  
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1.3.1.1 Ubiquitin activating enzymes 
In yeast, only one ubiquitin activating enzyme, or E1 (Uba1) exists, and this protein is essential 
for cell viability (MCGRATH et al. 1991). Early studies with a temperature-sensitive allele of a 
mammalian E1 verified the importance of this enzyme to protein turnover (CIECHANOVER et al. 
1984; FINLEY et al. 1984). E1s  are ATP-dependent enzymes which first bind to MgATP and 
then form a high-energy thioester between its active-site cysteine and the carboxyl-terminal 
glycine of a free ubiquitin (reviewed in (FANG and WEISSMAN 2004)). An E1 can bind two 
ubiquitin molecules at one time, one at its active site and one as an adenylate intermediate that 
can be donated to the active site once it is free (HAAS and ROSE 1982). The E1 can transfer the 
activated ubiquitin to the active-site cysteine of an E2 (reviewed in (FANG and WEISSMAN 
2004)). 
1.3.1.2 Ubiquitin conjugating enzymes 
E2s contain a conserved ubiquitin-conjugating catalytic (UBC) fold which contains a cysteine 
residue that binds activated ubiquitin from the E1 (BURROUGHS et al. 2008). There are 11 
conserved ubiquitin E2s in yeast (Ubc1-8, Ubc10, Ubc11, and Ubc13), while humans have over 
30 (reviewed in (VAN WIJK and TIMMERS 2010)). Most E2s are found both in the nucleus and 
cytoplasm, although several are associated with organelles, such as the case for Ubc6/7, which 
resides on the surface of the endoplasmic reticulum (BIEDERER et al. 1997). 
1.3.1.3 Ubiquitin ligases 
E3s allow for specificity in substrate selection in the ubiquitin pathway. The predominant classes 
of E3 proteins are HECT and RING domain ubiquitin ligases, although E3s without these 
domains have been described, including the Skp1-Cul1-F box protein (SCF) ubiquitin ligases  
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and U box proteins (reviewed in (ARDLEY and ROBINSON 2005)). HECT E3s contain a 350 
amino acid-terminal domain containing a conserved cysteine that forms a thioester with ubiquitin 
(HUIBREGTSE et al. 1995). Many HECT E3s also contain an N-terminal WW domain, which 
participates in interactions with proline-rich proteins, and is most likely important in targeting 
substrates (reviewed in (WEISSMAN 2001)). The F box protein of an SCF complex recognizes the 
specific substrate to be recruited for ubiquitylation by the complex (reviewed in (ARDLEY and 
ROBINSON 2005).  RING domain (Really Interesting New Gene) ubiquitin ligases represent a 
class of proteins that number in the hundreds in yeast and humans. This RING domain is 
described as a cysteine-rich motif, with the canonical sequence Cys-X-Cys-X-Cys-X-His-X-Cys-
X-Cys-X-Cys-X (where X is a number of any amino acids), although other variations exist 
(FREEMONT et al. 1991). Two atoms of zinc are bound by the cysteine and histidine core of this 
domain, which serves as a rigid domain for protein-protein interactions (BARLOW et al. 1994). 
Not all proteins with RING domains possess ubiquitin ligase activity alone, but most RING E3s 
studied so far have been shown to have activity if not alone, then in conjunction with a second 
E3 partner. For example, the breast cancer associated ubiquitin ligases BRCA1 and BARD1 have 
little activity in vitro, yet robust activity as a heterodimer (HASHIZUME et al. 2001). NMR studies 
with BRCA1 have shown that the RING domain of this E3 is essential to its interaction with its 
E2 partner, a finding which appears will be expanded to more E2-RING E3 complexes (BRZOVIC 
et al. 2003; ZHENG et al. 2000).  
RING domain and U box E3s do not directly ubiquitylate a substrate, but rather serve as a 
platform for the E2-Ub complex to come in close proximity with the substrate by binding both 
substrate and E2 at the same time (reviewed in (ARDLEY and ROBINSON 2005). The ubiquitin is 
then transferred from the E2 to the substrate before the E2 detaches and recharges with another 
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ubiquitin. This is in contrast to HECT domain E3s, which do acquire ubiquitin from their E2 
partner to form an E3-Ub thioester as an intermediate to substrate ubiquitylation (Figure 3) 
(reviewed in (DESHAIES and JOAZEIRO 2009)).   
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Figure 3: The ubiquitylation pathway. 
In an ATP dependent step, the ubiquitin activating enzyme, E1, binds ubiquitin via a thioester bond. Next, the  
activated ubiquitin is transferred to a ubiquitin conjugase enzyme or E2. This E2 then binds a partner E3, or 
ubiquitin ligase, for ubiquitylation of a specific substrate. A HECT domain E3 accepts transfer of ubiquitin from the 
E2 before ubiquitylating the substrate directly. A RING domain E3, however, does not directly interact with 
ubiquitin, but rather mediates the transfer of ubiquitin from an E2 to the substrate (adapted from (WEISSMAN 2001)). 
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1.3.2 Interactions and outcomes of the ubiquitylation pathway 
The ubiquitylation pathway described above results in a modified substrate now targeted for a 
specific process. As new studies emerge on the interactions between the components involved in 
this pathway, they paint a picture of a very complicated network where specificity is achieved by 
a precise partnership of proteins and amino acid residues. In this section, I will describe some of 
these interactions during ubiquitylation and how they result in such a myriad of consequences.  
1.3.2.1 Interactions among ubiquitin components 
The components of the ubiquitin pathway must work in faithful succession, which relies on the 
specific order and interactions of these proteins. For example, in order to polyubiquitylate a 
substrate, an E2 must obtain a new ubiquitin molecule. The E2 would therefore shuttle between 
the E1 to bind ubiquitin and the E3 to aid in transfer of the ubiquitin to a substrate, and is unable 
to bind both E1 and E3 at the same time (ELETR et al. 2005). As may be expected for a reaction 
that is part of a multi-step pathway, the E2-E3 interaction is often not stable, and this transient 
interaction is therefore difficult to detect. To make this interaction increasingly difficult to 
predict, the known interacting residues are not conserved between E2-E3 pairs and are likely 
specific to the E2-E3 partnering involved (reviewed in (DESHAIES and JOAZEIRO 2009)).  In 
addition, ubiquitin ligases have been identified for which multiple E2 partners work in 
succession – with one E2 initiating a slow substrate ubiquitylation and a different E2 elongating 
a faster addition of a ubiquitin chain, such as the case with APC/C  in yeast (RODRIGO-BRENNI 
and MORGAN 2007). Because it is difficult to capture E2-E3 interactions, few structural studies 
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have been done. However, recent studies have illuminated potential E2-E3 partners through 
large-scale screens for interactions in human proteins using a yeast 2-hybrid assay (MARKSON et 
al. 2009; VAN WIJK et al. 2009).  
1.3.2.2 Ubiquitin lysine residues target substrates for a specific process 
A large-scale proteomics study in yeast identified over 1000 proteins ubiquitylated at any time, 
with ubiquitin chains being formed via any of its seven conserved lysines (6,11,27,29,33,48, and 
63) in yeast, indicating that there is a large diversity in polyubiquitin chains (PENG et al. 2003). 
This site specific linkage seems to be characteristic mostly of the E2 involved, and it is possible 
that a RING E3 can therefore use multiple E2s to create branched ubiquitin chains (KIM et al. 
2007). That said, one E2 can mediate different linkages depending on the E3 with which it 
interacts, such as human E2 UbCH5 mediating Lys6, 11, 48, or 63 linkages with different RING 
E3s (reviewed in (DESHAIES and JOAZEIRO 2009)). Reactions involving HECT E3s, however, 
can direct their own chain linkage with a specific ubiquitin lysine residue independent of its E2 
partner (WANG and PICKART 2005). 
 The different ubiquitin chain linkages aid in directing ubiquitylated proteins to different 
cellular processes. For example, K63 chains are indicative of a signaling process, such as DNA 
repair (SPENCE et al. 1995) and endocytosis (reviewed in (HICKE 2001)) while K48 and K11 
chains are targets to the proteasome (THROWER et al. 2000; XU et al. 2009). The finding that a 
ubiquitin can form chains via any linkage or combination of linkages, implies that the 
complexity of ubiquitin-targeting is yet to be fully understood (PENG et al. 2003; WEISSMAN et 
al. 2011).  
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1.3.2.3 Polyubiquitylation and proteasome-targeting 
Due to translation or folding mistakes, nearly 30% of all translated proteins are targeted for 
degradation immediately following synthesis in mammalian cells to allow recycling of defective 
proteins and generation of small peptides (SCHUBERT et al. 2000; WHEATLEY et al. 1982). At 
least four ubiquitins linked by their Lys48 residues are required for proteasome-targeting via the 
proteasome subunit Rpn10 and Rpn13 (CHAU et al. 1989; DEVERAUX et al. 1994; HUSNJAK et al. 
2008). The 26S proteasome has a 19S regulatory complex (composed of a six ATPase base and 
lid) at either end of a 20S core, which recognizes a multi-ubiquitin chain (reviewed in 
(KLOETZEL 2001)). Substrates targeted for proteasome-mediated degradation are deubiquitylated 
by the 19S subunit Rpn11 (VERMA et al. 2002), unfolded, and channeled into the 20S core, 
which is comprised of four stacks of α and β subunits (reviewed in (KLOETZEL 2001)). The α 
subunits form the outer rings, which accept substrates and releases products. The β subunits, 
some with catalytically active residues, form the inner rings (GROLL et al. 1997; LOWE et al. 
1995). These β subunits are responsible for degrading and recycling substrates into smaller 
peptide chains and amino acids (GROLL et al. 1997). 
1.3.2.4 Substrate monoubiquitylation 
In addition to polyubiquitylation at various lysines, substrates can be monoubiquitylated. 
Monoubiquitylation usually acts as a cellular signal, and has been connected with multiple 
processes, including transcription, endocytosis, and viral replication (reviewed in (HICKE 2001)). 
For example, monoubiquitylation of histone H2B K123 by the E2 Rad6 and E3 Bre1 in yeast is a 
well-studied and conserved mark of active transcription (HWANG et al. 2003). This H2B mono-
ubiquitylation signal is a prerequisite for downstream histone H3 methylation (DOVER et al. 
2002; SUN and ALLIS 2002).  The linker histone H1 is monoubiquitylated in Drosophila 
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embryos, another example of an important transcription-related cell signaling mark (PHAM and 
SAUER 2000). Several plasma membrane proteins, such as G-protein-coupled receptors, must 
also be monoubiquitylated in order to be internalized and degraded by the lysosome (reviewed in 
(HICKE 1999)).  
How a substrate is selectively targeted for monoubiquitylation rather than 
polyubiquitylation is unknown, but factors have been identified that give clues to different ways 
proteins can regulate this event. For example, Rad23 in yeast and humans inhibits the formation 
of multi-ubiquitin conjugates (ORTOLAN et al. 2000). Some multi-ubiquitin chains also require 
the presence of a factor termed an E4 (KOEGL et al. 1999). The presence of deubiquitylating 
enzymes in the cell also suggests the possibility that ubiquitin chains are trimmed to regulate 
their lengths  (reviewed in (HICKE 2001)).  
1.3.2.5 Identification of ubiquitylated substrates 
Hundreds of E3s exist in eukaryotes, allowing substrate targeting and specificity of the ubiquitin 
pathway. Although thousands of proteins have been found to be ubiquitylated (PENG et al. 2003), 
finding a substrate for a particular E3 is a very challenging task. Besides having a very large pool 
of both E3s and potential substrates, ubiquitylated substrates are often quickly turned over and 
the interactions between E3 and substrate are therefore transient. Systematic identification of E3 
and substrate pairings is a daunting though not impossible, undertaking;  therefore several studies 
have used more global methods of identifying substrates of E3s (reviewed in (KAISER and 
HUANG 2005)). 
Large-scale in vitro approaches have been successful in identifying E3 targets. For 
example, the APC/C E3 complex regulates substrates only during mitosis. Xenopus oocyte 
cDNAs were translated in vitro and incubated with lysate from either oocytes in interphase or 
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mitosis, and the resulting proteins after incubation were compared. Those proteins lost from 
mitotic lysate incubations were further investigated as targets of APC/C (LUSTIG et al. 1997; 
MCGARRY and KIRSCHNER 1998).  Another study involving the BRCA1/BARD1 heterodimer 
involved immunoprecipitation of the complex and incubating the resulting proteins with FLAG 
tagged ubiquitin in an in vitro ubiquitylation reaction. FLAG-tagged substrates were then 
identified by mass-spectrometry (SATO et al. 2004). In yeast, two studies have been done to 
identify substrates for the E3 Rsp5 using screens of purified potential substrates and protein 
microarrays (GUPTA et al. 2007; KUS et al. 2005). 
Ubiquitin profiling has been developed to study ubiquitin substrates in vivo. Initially, this 
technique was performed by expressing His-tagged ubiquitin in cells and performing 
immunoprecipitation against all His-ubiquitylated proteins under denaturing conditions, which 
helps prevent degradation or deubiquitylation of substrates. These substrates were identified by 
mass spectrometry to reveal a picture of all ubiquitylated proteins within yeast at a given time 
(PENG et al. 2003). Ubiquitin profiling has been used for the proteasomal ubiquitin receptor 
Rpn10  by isolating all ubiquitylated proteins from wild type cells in yeast and comparing it to 
rpn10 mutant cells (MAYOR et al. 2005). Methods such as these may prove useful in the future 
for identifying specific E3 targets.  
1.3.3 Rkr1 is a quality control ubiquitin ligase 
Rkr1 is a conserved RING domain ubiquitin ligase with genetic connections to transcription. 
Interestingly, it is also required for the quality control of nonstop proteins. In this section, I will 
describe protein quality control mechanisms and the role of Rkr1 in this process. 
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1.3.3.1 Quality control ubiquitin ligases 
With limited resources on hand, it is important that cells employ mechanisms to overcome 
stresses in quality control and are able to recycle aberrant proteins. Many proteins are 
mistranslated or become misfolded after synthesis and are unable to be refolded by the chaperone 
machinery, leaving them as targets for protein quality control by the ubiquitylation pathway 
(WHEATLEY et al. 1982). There have been several identifications of ubiquitin ligases that target 
aberrant proteins in yeast and these ligases are localized in various parts of the cell, such as the 
endoplasmic-reticulum associated E3s Hrd1 and Doa10 (reviewed in (HAMPTON 2002)), the 
nuclear E3 San1 (GARDNER et al. 2005), and the “N-end rule pathway” cytoplasmic E3 Ubr1 
(BARTEL et al. 1990).  
Quality control ubiquitin ligases are specific for their class of substrates, either relying on 
sequence characteristics of these targets or the help of chaperones to identify them. San1 
physically binds to and recognizes abnormal nuclear proteins, but not their normally folded 
counterparts. ER-associated degradation requires the help of chaperones and other proteins for 
target recognition (reviewed in (FREDRICKSON and GARDNER 2012)) (GARDNER et al. 2005; 
METZGER et al. 2008). In the N-end rule pathway, Ubr1 recognizes potential substrates via an N-
terminal sequence which includes a lysine for ubiquitylation (BARTEL et al. 1990). The role of 
Ubr1 in this process is to target short-lived proteins for turnover (reviewed in ((VARSHAVSKY 
1997)).  
In some cases, quality control ubiquitin ligases have overlapping roles. For example, a 
study was performed to find factors required for degradation of the misfolded cytoplasmic 
protein CPY‡ (HECK et al. 2010; MEDICHERLA et al. 2004), finding that both the N-end rule 
pathway E3 Ubr1 and nuclear E3 San1 were required for quality control of this protein. This 
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study revealed two parallel pathways for quality control of misfolded proteins. In the cytoplasm, 
Ubr1 targeted this substrate and other misfolded proteins with the aide of chaperones in a manner 
independent from its role in the N-end rule pathway, while San1 ubiquitylated the same 
substrates in the nucleus after a chaperone-dependent transport step (HECK et al. 2010). 
Therefore, the cell is able to employ several mechanisms to target aberrant proteins, sometimes 
in parallel approaches. With hundreds of ubiquitin ligases within a cell and thousands of proteins 
targeted for ubiquitylation, it is likely that many more quality control E3s will be identified in 
future studies.  
1.3.3.2 Rkr1 is involved in nonstop protein quality control 
Rkr1 was originally identified as a RING finger ubiquitin ligase required in the absence of the 
transcription factor, Rtf1, suggesting that these two proteins are most likely required in yeast for 
parallel processes with a common essential goal (Figure 4) (BRAUN et al. 2007). rkr1Δ strains 
also genetically interact with the loss of H2B K123 ubiquitylation, a histone modification 
modulated by Rtf1, indicating that it most likely functions specifically in parallel to this Rtf1-
mediated event. Strains lacking SPT10, which functions in histone gene expression, are also 
lethal in the absence of RKR1, further indicating a function genetically connected to transcription 
(BRAUN et al. 2007). The RING domain of Rkr1 (C4HC3 type) was shown to have ubiquitin 
ligase activity in vitro, confirming its role as an E3 (BRAUN et al. 2007). Rkr1 is conserved 
throughout higher eukaryotes, with conservation highest in the N-terminal region and C-terminal 
RING domain. The human homologue, known as RNF60 or ZNF294, is commonly mutated in 
colon cancer (IVANOV et al. 2007), while the mouse homologue, Listerin, has been implicated in 
neurodegeneration (CHU et al. 2009). In yeast, Rkr1 has also been called Ltn1 to reflect this 
homology to Listerin (BENGTSON and JOAZEIRO 2010). 
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Rkr1 is found bound to ribosomes and co-fractionates predominantly with the 60S 
subunit (BENGTSON and JOAZEIRO 2010; FLEISCHER et al. 2006). It has also been shown to 
interact with the 19S proteasome subunit, indicating it most likely functions to target proteins for 
degradation (VERMA et al. 2000). In agreement with this data, I and others have found this 
protein to be predominantly, though not exclusively, localized in the cytoplasm of yeast 
(BENGTSON and JOAZEIRO 2010).  
In a screen for mutations that caused an increase in nonstop protein levels in yeast, a 
deletion of RKR1 was identified (WILSON et al. 2007). Nonstop proteins result from translational 
read-through into the poly(A) tail, which can happen during translation of both nonstop 
transcripts (lacking a stop codon), or by translational failure to recognize normal stop codons. 
Nonstop mRNAs and nonstop proteins are both targeted for degradation (FRISCHMEYER et al. 
2002; VAN HOOF et al. 2002; WILSON et al. 2007). Loss of RKR1 resulted in an increase in 
nonstop protein levels from a reporter, but not an increase in nonstop mRNA levels (WILSON et 
al. 2007). These results were confirmed by a later study, which showed that Rkr1 was required 
for the ubiquitylation and degradation of nonstop proteins. This study also showed that Rkr1 
recognizes these nonstop substrates by the presence of a poly-lysine chain, which results from 
translational read-through of the mRNA poly(A) tail (BENGTSON and JOAZEIRO 2010). Rkr1 was 
also shown to co-immunoprecipitate with a nonstop protein reporter immediately following 
protein synthesis (BENGTSON and JOAZEIRO 2010). It was therefore proposed that Rkr1 is 
recruited to the ribosome upon translational-stalling at the poly(A) sequence in order to 
ubiquitylate the  newly synthesized nonstop protein for proteasomal degradation. Although to 
date, Rkr1 has not been shown to interact with an endogenous nonstop protein, these results 
strongly suggest that Rkr1 functions in nonstop protein quality control. Additionally, it has 
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recently been shown that the loss of RKR1 causes sensitivity to media containing geldanamycin, 
which inhibits Hsp90 chaperone activity and causes an increase in aggregated and unfolded 
proteins targeted for degradation (THEODORAKI et al. 2012). This phenotype is shared by the loss 
of other quality control ubiquitin ligases in yeast, such as Ubr1 and San1, and suggests that Rkr1 
may have broader implications for quality control (THEODORAKI et al. 2012). Understanding why 
yeast require the efficient degradation of nonstop proteins when faced with the loss of Rtf1 
transcription-related functions is the basis of my thesis research (Figure 4).  
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Figure 4: Rkr1 is required in the absence of Rtf1-mediated H2B ubiquitylation. 
Yeast can survive the loss of the transcription factor RTF1, a member of the Paf1 complex required for H2B K123 
ubiquitylation.  However, in combination, the loss of RTF1 and the ubiquitin ligase RKR1 is lethal in yeast (BRAUN 
et al. 2007). Rkr1 is required for the ubiquitylation and degradation of nonstop proteins, produced from translational 
read-through into the poly(A) tail (BENGTSON and JOAZEIRO 2010; WILSON et al. 2007). This synthetic interaction 
between RTF1 and RKR1 in yeast suggests that the two factors are required for parallel processes that result in a 
common essential role. Investigation into this interaction is the basis of my thesis research.  
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1.4 YEAST PRIONS 
Prions are infectious protein aggregates found in organisms from yeast to humans. Although 
these proteins have presumed normal functions as soluble proteins, aggregation can cause a 
disruption in normal protein function. This, in addition to the nature of having an aggregated 
protein in the cell, can cause problems in organismal function. Additionally, these protein 
aggregates can be inherited or transferred to other cells to perpetuate the prions within a 
population. Yeast as a model organism has served as an important tool for studying prion 
genesis, phenotypes, and transmission. In my thesis work, I identified the prion [PSI+] as 
required for the synthetic lethal relationship between rtf1Δ and rkr1Δ mutations in yeast.  This 
chapter will further explain the nature of prions in Saccharomyces cerevisiae.  
1.4.1 Characteristics of a prion 
Prions are insoluble infectious proteins which are able to propagate without genetic material, and 
be transferred to other cells or passed on by non-Mendelian inheritance. Prions, together with 
chaperones, are also able to recruit soluble proteins around them to further propagate the 
structure.  
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1.4.1.1 Prion domains 
Only the prion domain is required for successful transmission and seeding of the prion in other 
yeast cells (MASISON et al. 1997; MASISON and WICKNER 1995). The majority of prion domains 
in yeast are characterized by glutamine and asparagine (Q/N-rich) rich regions which form 
amyloids, filamentous aggregates of β-sheets which can also be formed in vitro (DEPACE et al. 
1998). These amyloids are proposed to be an in-register parallel β-sheet structure of polar zipper-
like structure, where identical residues touch and interact through their side chains (Figure 5A) 
(reviewed in (WICKNER et al. 2011)) (PERUTZ et al. 2002; WICKNER et al. 2010). This structure 
recruits new soluble monomers to the prion form by directing the same conformation as the other 
proteins in the filament (Figure 5B) (reviewed in (WICKNER et al. 2011). The order of amino 
acids in the prion domain are not important for original amyloid formation, and shuffling this 
domain does not affect propagation (ROSS et al. 2004). However, the prion domain sequence 
itself is important to transmission of a prion, as differences in this sequence can prevent 
transmission of a prion variant between different yeast species, a phenomena known as the 
“species barrier” (BATEMAN and WICKNER 2012). Prions have variants which affect their 
stability, phenotype, and transmission ability, and these variants may be caused by differences in 
amyloid structures caused by sequence differences or initial differences in filament formation 
(Figure 5B) (BRADLEY and LIEBMAN 2003; EDSKES et al. 2009; SCHLUMPBERGER et al. 2001).   
In yeast a bioinformatics study was performed to identify proteins with Q/N-rich domains 
and a low number of hydrophobic or charged amino acids which would hinder the formation of 
in-parallel amyloids (ALBERTI et al. 2009). This study initially identified approximately 200 S. 
cerevisiae proteins which included known yeast prion-forming proteins Sup35 and Rnq1. Several 
of the top 20 protein domains from this list were verified as having the propensity to form 
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aggregates, indicating that the characteristics of this domain are indeed important to prions 
(ALBERTI et al. 2009). Another study in yeast determined that prion domains indeed are 
characterized by a Q/N-rich region, but that there is not an exact requirement for the number of 
these residues in a region and that a Q/N-rich region did not necessarily dictate formation of a 
prion (TOOMBS et al. 2010). Outside of S. cerevisiae, prions have been characterized that do not 
contain Q/N-regions, such as [Het-S]y in the fungus Podospora anserina and the human prion 
protein PrP, indicating that the propensity to form a prion does not absolutely require these 
residues (BALGUERIE et al. 2003).  
1.4.1.2 Prion propagation by chaperones 
In yeast, molecular chaperones are required for the propagation of all prions studied to date. In 
particular, prion propagation requires a functional Hsp104 protein, as an HSP104 deletion or 
inhibition of this protein through growth of yeast on guanidine hydrochloride (GuHCl) results in 
the inability to transfer prions to daughter cells (FERREIRA et al. 2001; JUNG and MASISON 2001). 
The role of Hsp104 in yeast is to disaggregate proteins after heat shock (SANCHEZ and 
LINDQUIST 1990), an activity that requires an ATPase domain and threading of an aggregated 
substrate through the Hsp104 channel (reviewed in (HASLBERGER et al. 2010)). This same 
activity is responsible for breaking prion amyloids into smaller oligomers, which can then be 
efficiently passed onto daughter cells. Therefore, Hsp104 is required to create “seeds”  with 
infectious ends that will become the prions of the next generation and recruit additional soluble 
protein to the prion form (reviewed in (HASLBERGER et al. 2010)).  
Interestingly, overexpression of HSP104 cures cells of one identified yeast prion, [PSI+], 
but not other prions tested (CHERNOFF et al. 1995; MORIYAMA et al. 2000) (reviewed in (CROW 
and LI 2011)). In fact, overexpression of HSP104 can lead to an increase in other yeast prions 
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(KRYNDUSHKIN et al. 2011). Although the exact mechanism of this unique interaction is unclear, 
studies have shown that curing cells of [PSI+] by increased Hsp104 dosage involves a different 
mechanism than curing by deletion of HSP104, which results in an increase in prion-particle size 
that may then be too large to be transferred to a daughter cell (DERDOWSKI et al. 2010).  
Additional chaperones in yeast are required for prion propagation besides Hsp104, and 
these findings present a very complicated network of chaperones involved in this process. For 
example, the Hsp70 chaperone Ssa1 is also required for the propagation of [PSI+], and 
overexpression of SSA1 can also cure [PSI+] similar to Hsp104  (MATHUR et al. 2009; SONG et 
al. 2005). However, overexpression of Ssa1 in the presence of excess Hsp104 antagonizes [PSI+] 
clearing (NEWNAM et al. 1999). Ssa1 functions with multiple partners, including the Hsp40 co-
chaperones Ydj1 and Sis1 (reviewed in (KAMPINGA and CRAIG 2010)). Sis1 is required for the 
propagation of several yeast prions, including [URE3], [PIN+], [PSI+], and [SWI+] (HIGURASHI et 
al. 2008; HINES et al. 2011; SONDHEIMER et al. 2001), however overexpression of Sis1 is only 
known to cure the yeast prion [SWI+] (HINES et al. 2011). Similarly, deletion of YDJ1 is only 
known to cure [SWI+] (HINES et al. 2011) while increased dosage of Ydj1 can cure yeast of the 
prion [URE3] (MORIYAMA et al. 2000).These studies indicate the importance of chaperones to 
prion transmission and propagation and also reveal that a very intricate network of proteins is 
involved in this process. Much additional work is needed to understand how these chaperones 
and others work together to influence which prions are present at one time in yeast. 
1.4.1.3 Prion-prion interactions 
Prions also have a profound influence on each other, as the presence of one prion can both 
negatively and positively affect the presence of other prions. This may be due to the similar 
structure of prion domains in yeast, as well as their overlapping chaperone requirements 
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(reviewed in (DERKATCH and LIEBMAN 2007)). The most well-studied example of this 
interaction is between [PIN+] and [PSI+]. The prion [PIN+] is generally required for the de novo 
appearance of [PSI+] (DERKATCH et al. 2001; DERKATCH et al. 1997). However, weak and strong 
variants of both [PIN+] and [PSI+] have been identified, based on phenotype and aggregation, 
and these variants as well as the levels of these prions can influence whether or not they impair 
each other’s inheritance (BRADLEY and LIEBMAN 2003). This indicates the influence of [PIN+] 
on [PSI+] is not a simple event. Additionally, the presence of [PSI+] and [URE3] can enhance the 
formation of [PIN+] (DERKATCH et al. 2001), while [URE3] and [PSI+] have been shown to 
negatively affect the appearance of each other especially in the presence of [PIN+] (SCHWIMMER 
and MASISON 2002). The ways in which prions interact with each other will likely be further 
elucidated, or further complicated, as more yeast prions are being identified and studied.   
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Figure 5: Prion formation in yeast 
(A) Q/N-rich domains of prions are proposed to be organized into amyloid fibrils in an in-register parallel β-sheet 
structure, where identical residues interact through their side chains (reviewed in (WICKNER et al. 2011)) (WICKNER 
et al. 2010). (B) Prions are the insoluble form of the native protein, which aggregate to form an amyloid fibril. These 
amyloids can form de novo, and can be arranged into different prion variants which recruit the same variants of 
soluble protein. Prions are propagated by chaperones, such as Hsp104, which breaks the fibrils into small pieces 
with new infectious ends that can be passed to daughter cells (reviewed in (WICKNER et al. 2011). 
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1.4.2 Well-studied yeast prions 
With the current knowledge of typical prion domains, several studies have emerged over the 
years to identify and confirm new prions in S. cerevisiae. In addition, the continued study of 
well-known prions has led to better understanding of their resulting phenotypes in yeast. 
1.4.2.1 [PSI+] 
[PSI+] was the first identified yeast prion and is the most well-studied. It is the prion form of the 
translation termination factor Sup35, an essential protein required for proper stop codon 
recognition. Sup35, also known as translational release factor eRF3, normally functions with 
eRF1 to release nascent polypeptide chains. When a cell contains Sup35 as [PSI+], it results in 
translational read-through of both normal stop codons and nonsense (premature) stop codons, 
leading to a nonsense suppression phenotype and production of nonstop proteins (PAUSHKIN et 
al. 1996; WILSON et al. 2005). In addition, improper translation termination caused by [PSI+] 
also results in the inability to properly degrade aberrant nonstop or nonsense mRNAs which 
normally rely on this Sup35 function (WILSON et al. 2005). Therefore, the presence of this prion 
causes multiple identified nonsense suppression phenotypes, although these phenotypes can vary 
with strain background (TRUE et al. 2004). The most common assay to assess for the presence of 
[PSI+] is with an ade1-14 reporter, which contains a nonsense codon. Soluble Sup35, or a [psi-] 
strain, is able to recognize the early stop codon, producing a nonfunctional Ade1 protein and an 
Ade- phenotype. Cells containing [PSI+] lead to nonsense suppression and translational read-
through of ade1-14, producing Ade+ cells (Figure 6) (CHERNOFF et al. 1995). [PSI+] is the only 
prion known to be cured by both the overexpression and deletion of HSP104 (CHERNOFF et al. 
1995), indicating that this chaperone is needed at precise levels for [PSI+] propagation. 
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1.4.2.2 [PIN+] 
The prion [PIN+] was first identified by its role in [PSI+] propagation, and named for [PSI+] 
inducibility (DERKATCH et al. 1997). Years later, the gene RNQ1 was found to encode the prion-
forming protein (DERKATCH et al. 2001). Although many studies have been done on the prion 
potential of [PIN+] in relation to other yeast prions, to date, there is no known non-prion function 
for Rnq1. It has also been shown that [PIN+] is required to propagate polyQ aggregation in a 
yeast model of Huntington’s disease (MERIIN et al. 2002). Therefore, without other phenotypes 
to attribute to this prion, the presence of [PIN+] in yeast is generally determined by the ability of 
a cell to induce or propagate other prions. 
1.4.2.3 [URE3] 
[URE3] is another early-identified yeast prion and has also been used frequently as a model for 
understanding prion genesis and inheritance. [URE3] is the prion form of Ure2, which negatively 
regulates nitrogen metabolism genes, such as DAL5, by sequestering the transcription factor 
Gln3 to the cytoplasm (COX et al. 2000; WICKNER 1994). There are multiple methods for 
detecting [URE3], including using yeast reporters genes fused to a DAL5 promoter 
(SCHLUMPBERGER et al. 2001).  
1.4.2.4 Other identified yeast prions 
More recently identified yeast prions include [SWI+], [OCT+], [ISP+], and [MOT3+]. 
Interestingly, all of these prions are encoded by genes that normally function in a transcription-
related process. [SWI+] is the prion form of the SWI/SNF chromatin remodeling complex factor 
Swi1 (DU et al. 2008).  The corepressor Cyc8 is the soluble form of [OCT+] (PATEL et al. 2009).  
Sfp1 is a transcription factor that regulates 10% of the yeast genome, and it can form the prion 
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[ISP+] (ROGOZA et al. 2010). [MOT3+], encoded by MOT3, is the prion form of a transcriptional 
regulator originally identified as a potential prion from the screen for Q/N-rich domains 
performed by Alberti et al (ALBERTI et al. 2009).  
Additional prions have been described by phenotype in yeast, but the genes encoding the 
prions have yet to be confirmed.  Common characteristics of the well-studied prions include the 
presence of a Q/N-rich domain, the ability to form amyloid fibrils in vivo and in vitro, the ability 
to be transferred and inherited, and the dependence on chaperones for propagation. Deletion of 
the gene encoding the prion should cure cells of the prion over generations, and an increase in 
prion protein levels should increase the de novo appearance of the prion (reviewed in (CROW and 
LI 2011)). Although over 20 potential yeast proteins have been identified by their Q/N-rich 
domains (ALBERTI et al. 2009), many have yet to be confirmed as true prions with these 
characteristics. Likely, future studies on these candidates will reveal an even larger pool of 
prions that could exist in S. cerevisiae or be transferred to or within a population. 
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Figure 6: Sup35 aggregation in [PSI+] cells causes nonsense suppression 
Soluble Sup35 functions in translation termination. During translation of the ade1-14 reporter in yeast, which 
contains a premature stop codon, the nonsense codon is recognized by Sup35 and Ade1 protein is not produced, 
making the cells Ade-. However, in [PSI+] cells, aggregated Sup35 cannot efficiently recognize stop codons. This 
results in translational read-through of the ade1-14 nonsense codon and production of functional Ade1 protein, 
making the cells Ade+ (CHERNOFF et al. 1995). 
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1.4.3 Prions in humans 
Yeast have served as an excellent model system for studying prion inheritance and transmission. 
Prions have been found in multiple organisms and learning about them in yeast may prove 
beneficial in understanding their roles in human disease.  
1.4.3.1 PrP 
The only identified human prion is called PrP for “prion protein,” which can be transmitted to 
other humans through a genetic mutation causing amyloid formation or by incubation with 
infectious brain material (HSIAO et al. 1989). This one prion protein in humans can cause several 
known neuronal diseases, such as Kuru, Creutzfeldt-Jakob disease, and Gerstmann-Strӓussler-
Scheinker syndrome, most likely by forming differently structured aggregates (reviewed in 
(SOTO and CASTILLA 2004)). Although PrP does not have the same classical Q/N structure as 
prions identified in yeast, it does form similar fibrils of β-sheets in its insoluble form (PAN et al. 
1993). The discovery and identification of PrP and its encoding gene has led to the protein-only 
hypothesis, which is the basis of prion biology from yeast to humans – that only a misfolded 
protein is needed to infect other organisms, not any genetic material. To date, however, 
infectious PrP has not been made in vitro that can cause disease in vivo. Studies in yeast have 
been more successful at this approach with the prion [PSI+], as well with understanding how 
prions are propagated and transferred (reviewed in (HOFMANN et al. 2012; SOTO and CASTILLA 
2004)), revealing the utility of studying yeast prions. In addition, [PSI+] can be propagated in 
neuroblastoma cells,  suggesting that eukaryotic pathways of prion propagation may be 
somewhat conserved and better understood by studying their mechanisms in model systems such 
as yeast (KRAMMER et al. 2009). 
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1.4.3.2 Amyloids in disease 
There are several other human diseases, many of which are well-known and well-studied, that 
display phenotypes associated with amyloid aggregates. However, because these aggregates have 
not been shown to be infectious, they are not termed as prion diseases. For example, 
Huntington’s disease is characterized by aggregates of a polyglutamine-rich protein, similar to 
yeast prions, which is able to propagate in a similar fashion (REN et al. 2009)). Another common 
example is the Aβ (Beta-amyloid) peptide, which is implicated in both genetic and spontaneous 
forms of Alzheimer’s disease (reviewed in (HARDY and SELKOE 2002)). Interestingly, this 
peptide can also be toxic in yeast (TREUSCH et al. 2011). A screen was then performed to find 
genetic factors that modulated Aβ  toxicity, and identified multiple human homologues in 
endocytic trafficking, several of which are known human risk factors for Alzheimer’s (TREUSCH 
et al. 2011). Therefore, while these aggregates are not known to be infectious like human or 
yeast prions, the parallels they share with these proteins illuminate the need to further study the 
commonalities among them. 
1.4.4 ARE PRIONS ADVANTAGEOUS? 
Although prions in humans have been described as disease-causing, the yeast prion community is 
caught in a high degree of controversy over whether or not they are disadvantageous in yeast. 
The existence of a species barrier, which can prevent transmission of a prion to an outside strain 
of yeast, as well as the inability to detect many prion variants in the wild, have led some to 
conclude that yeast prions are a disease (BATEMAN and WICKNER 2012; NAKAYASHIKI et al. 
2005). In addition, several [PSI+] variants are lethal, indicating that their presence is merely 
tolerated in weaker [PSI+] varieties due to the their mild phenotypes (MCGLINCHEY et al. 2011). 
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Many unfavorable phenotypes have been associated with specific prions, which may also imply a 
negative impact on growth (TYEDMERS et al. 2008). However, prions allow yeast to respond to 
environmental changes (TYEDMERS et al. 2008). This “survival advantage” might be especially 
relevant with phenotypes related to [PSI+]-mediated nonsense suppression which could have its 
advantages to evolution too (TRUE et al. 2004). Additionally, recent studies done in wild yeast to 
measure phenotypes of strains grown in the absence or presence of guanidine hydrochloride to 
inhibit Hsp104 function suggest that prions do broadly exist in the wild, and can confer selective 
advantages (HALFMANN et al. 2012). It is highly likely that both arguments truthfully represent 
the broader implications of prions in yeast, which may very well depend on the environment 
examined. It remains to be seen if these arguments can also be applied to higher organisms.  
 
1.5 THESIS AIMS 
In a screen for genes that were required for viability in the absence of the transcription factor 
RTF1, the ubiquitin ligase Rkr1 was uncovered. Other genes from this screen were connected to 
transcription, suggesting that Rkr1 might also be related to this function. Recent studies have 
implicated Rkr1 in the quality control of nonstop proteins, produced from translational read-
through of stop codons or from translation of nonstop mRNAs which lack a stop codon 
altogether. However, the basis of lethality between a transcription factor and this ubiquitin ligase 
is unknown. The foundation of my thesis work is to understand this genetic relationship. I sought 
to answer several questions to clarify this connection. For example, what are the substrates for 
Rkr1 and are they related to transcription? With what partners does Rkr1 interact within the cell? 
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What are the phenotypes associated with loss of RKR1 in the cell? Are there mechanisms to 
suppress rtf1Δ rkr1Δ lethality that may identify additional functions for these proteins? Using 
multiple genetic and biochemical techniques, I addressed each of these questions and others to 
better understand the role of these proteins in S. cerevisiae.  
A genetic screen to find mutations that rescued lethality of rtf1Δ rkr1Δ strains identified 
three genes that allowed viability in this context. I found that mutations in the genes encoding the 
heat shock protein, Hsp104, the sister chromatid cohesion protein Chl1, as well as in the RNA 
Polymerase III subunit Rpc17, suppress rtf1Δ rkr1Δ lethality. Further investigations into these 
results showed that by loss of HSP104, cells are alleviated of the prion [PSI+], which causes 
increases in nonstop protein and aberrant mRNAs. This and other studies indicated the need for 
Rtf1 and Rkr1 in the face of [PSI+]-mediated stress. The basis for obtaining CHL1 and RPC17 
suppressor mutations is currently unknown; however, these genes have interesting functions in 
chromatid cohesion and translation. These results allow speculation and planning for exciting 
and previously unexplored connections between these factors and transcription, chromosome 
segregation, and translation.  
 I have performed several experiments and used a variety of approaches to identify 
substrates or interacting partners for Rkr1. While the results did not uncover any novel 
interactions, I will discuss in this thesis how my results provide evidence for the quality control 
role for Rkr1. Additionally, I have uncovered an important phenotype for rkr1Δ cells, sensitivity 
to cycloheximide, which I have used to identify potential interacting partners for Rkr1, as well as 
important histone residues and proteins that share this phenotype and likely parallel Rkr1 
function.  
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 Collectively, my thesis research has provided additional understanding of Rkr1 as a 
quality control factor that is sensitive to the presence of the prion [PSI+] and changes in 
transcription-related processes. These results suggest that the additional stress caused by loss of 
Rtf1-mediated H2B ubiquitylation is lethal because this function is required to buffer cells 
against protein and/or mRNA quality control problems in yeast.  
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2.0  TRANSPOSON MUTAGENESIS TO IDENTIFY SUPPRESSORS OF 
SYNTHETIC LETHALITY IN YEAST LACKING RTF1 AND RKR1  
2.1 INTRODUCTION 
Eukaryotic transcription is a highly regulated process which occurs within the controlled and 
regulated context of chromatin. During transcription, various factors modify chromatin in 
coordination with elongating RNA polymerase (RNA Pol II) in order to successfully transcribe 
the DNA template. Changes in chromatin include ATP-dependent chromatin remodeling, the 
exchange of histone variants, and histone modifications such as methylation, ubiquitylation, and 
acetylation. The Paf1 complex (Paf1c) is one set of factors that is required for the correct pattern 
of specific histone modifications (reviewed in (CRISUCCI and ARNDT 2011b; JAEHNING 2010)). 
This protein complex is conserved from yeast through higher eukaryotes and is present with 
RNA Pol II on all actively transcribed genes examined, implicating a role for Paf1c in 
transcription elongation (MAYER et al. 2010). Consistent with this, Paf1c in Saccharomyces 
cerevisiae consists of Paf1, Ctr9, Leo1, Cdc73, and Rtf1, and loss of these members causes 
genetic interactions with mutations in other transcription elongation factor genes and phenotypes 
associated with defects in elongation (COSTA and ARNDT 2000; MUELLER and JAEHNING 2002; 
SHI et al. 1997; SQUAZZO et al. 2002). 
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Of the histone modifications regulated by members of Paf1c, Rtf1 plays a prominent role 
in regulating mono-ubiquitylation of K123 on H2B (NG et al. 2003a; TOMSON et al. 2011; 
WARNER et al. 2007; WOOD et al. 2003b). Rad6 is the ubiquitin conjugating enzyme (E2) for this 
mark, while Bre1 is the ubiquitin ligase (E3) (HWANG et al. 2003). This modification is an 
example of histone crosstalk, as it is a prerequisite for methylation at K4 and K79 of H3 by the 
Set1 and Dot1 methyltransferases, respectively (DOVER et al. 2002; NG et al. 2003a; SUN and 
ALLIS 2002; WOOD et al. 2003b). These histone modifications are conserved through humans, 
where errors in these processes can lead to aberrant gene expression and tumorigenesis. For 
example, depletion of hBre1 can result in decreased expression of histone genes and the p53 
tumor suppressor (SHEMA et al. 2008). Conserved patterns of histone modifications are also 
indicative of transcriptionally active or inactive genes (MINSKY et al. 2008). 
Paf1c has several roles in addition to its requirement for specific histone modifications, 
including proper transcript 3’-end formation (MUELLER et al. 2004; NAGAIKE et al. 2011; 
NORDICK et al. 2008a; PENHEITER et al. 2005). The absence of Paf1c members in mammalian 
cells causes decreased mRNA cleavage, polyadenylation, and mRNA export to the cytoplasm of 
a VP16 RNA, as well as aberrantly processed and polyadenylated histone mRNAs (FARBER et al. 
2010; NAGAIKE et al. 2011). Human Cdc73 also physically associates with RNA 3’ cleavage 
factors CPSF and CstF (ROZENBLATT-ROSEN et al. 2009). In yeast, loss of Paf1c members 
results in decreased poly(A) tail length and alternative poly(A) site usage (MUELLER et al. 2004; 
STRAWN et al. 2009). These studies suggest that the Paf1 complex is essential for both the proper 
expression and processing of a subset of RNAs and that loss of the Paf1 complex may result in 
aberrantly formed transcripts that may not be efficiently exported or translated; therefore, these 
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species could be targeted by mRNA quality control pathways (PENHEITER et al. 2005) and 
(reviewed in (CRISUCCI and ARNDT 2011b; JAEHNING 2010)).  
RKR1, which is required for viability in the absence of the Paf1c member Rtf1, encodes a 
RING finger ubiquitin ligase required for the quality control of nonstop proteins in yeast 
(BENGTSON and JOAZEIRO 2010; BRAUN et al. 2007; WILSON et al. 2007). Nonstop proteins are 
the translational result of nonstop mRNAs, which lack stop codons, or translational read-through 
of normal stop codons. Both nonstop mRNAs and nonstop proteins are targets for quality control 
(FRISCHMEYER et al. 2002; VAN HOOF et al. 2002; WILSON et al. 2007). Further, mutations of 
RKR1 homologs in higher eukaryotes have been implicated in colon cancer and 
neurodegeneration, suggesting an important role in cell homeostasis (CHU et al. 2009; IVANOV et 
al. 2007).  Interestingly, RKR1 is also required for proper growth of strains with a histone htb1-
K123R mutation, suggesting that Rkr1 functions in a pathway parallel to the histone modification 
functions of Rtf1, particularly H2B ubiquitylation, to promote an essential cellular goal  (BRAUN 
et al. 2007). However, how this protein quality control factor genetically interacts with Rtf1 is 
not understood. 
To investigate the relationship between Rtf1 and Rkr1, I performed a transposon-
mediated mutagenesis screen to identify suppressors of rtf1Δ rkr1Δ synthetic lethality in yeast. 
Through this screen, I confirmed that mutations in genes encoding the chaperone Hsp104, sister 
chromatid cohesion protein Chl1, and RNA polymerase III subunit Rpc17 rescue lethality of 
rtf1Δ rkr1Δ strains. Further analysis of the mutation in HSP104 revealed that some RKR1 genetic 
interactions occur only in the presence of the prion [PSI+] (See Chapter 3 for these results), 
indicating that the presence of this prion negatively influenced strains lacking RKR1. In this 
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chapter, I will discuss further characterization of these three suppressor mutations and their 
effects on rtf1Δ or rkr1Δ phenotypes and genetics.  
2.2 MATERIALS AND METHODS 
2.2.1 Yeast strains and growth conditions 
KY Saccharomyces cerevisiae strains are isogenic with FY2, a GAL2+ derivative of S288C 
(WINSTON et al. 1995). Yeast deletion mutants, crosses, and transformants were created using 
standard protocols (AUSUBEL 1988; ROSE 1991). Yeast were grown on rich (YPD), synthetic 
complete (SC), synthetic minimal (SD), 5-fluoroorotic acid (5-FOA) or sporulation media as 
specified and prepared as previously described (ROSE 1991). 6AU plates were made by adding 6-
azauracil to SC-URA media to a final concentration of 50 µg/ml.  
2.2.2 Yeast dilution assays 
Unless otherwise noted, dilution analysis was performed as follows. Specified strains were 
grown to saturation at 30oC in rich or selective media, washed with sterile water, and diluted into 
1x108 cell/ml stocks from which 10-fold serial dilutions were made.  Two microliters of cell 
suspension were plated on appropriate control and selective media plates and were incubated at 
30oC for the specified number of days (2 to 7).   
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2.2.3 Plasmids 
The his3 nonstop plasmid, pAV240 (LEU2), and protein A nonstop plasmid, pAV184 (URA3), 
were gifts from Dr. Ambro van Hoof (WILSON et al. 2007). The sup35NM-GFP (URA3 or 
LEU2) plasmids were gifts from Dr. Susan Liebman (ZHOU et al. 2001).  The URA3-marked 
plasmid carrying RTF1, pKA69, was used to maintain rtf1Δ rkr1Δ viability (STOLINSKI et al. 
1997).  2µ RTF1 (pAP45), empty vector (pAP37), Rtf1 HMD (residues 66-152) (pAP39) or Rtf1 
HMD-E104K (pAP54) TRP1-marked plasmids were constructed by cloning the indicated gene 
under control of an ADH1 promoter and N-terminal Myc-tag. For the HMD and HMD-E104K 
constructs, the Large T antigen nuclear localization signal was included before the Myc tag (Piro 
et al, PNAS, in press). The ade1-14 allele was amplified from a strain from Dr. Susan Liebman 
and cloned using XmaI and SacI sites into pRS306 for integration into our strain background via 
a two-step integration (BRADLEY et al. 2003). 
2.2.4 Mutagenesis and confirmation of genetic suppressors 
Transposon mutagenesis to identify suppressors of rtf1Δ rkr1Δ synthetic lethality was performed 
by transforming a LEU2-marked set of integrating plasmids (described in (KUMAR et al. 2000)) 
into an rtf1Δ rkr1Δ strain (KY1663) carrying RTF1/URA3/CEN/ARS (pKA69) and selecting on 
SC-LEU medium. Transformants were replica-plated onto SC-LEU medium containing 5-FOA 
to select for colonies that had lost the RTF1/URA3 plasmid. Fifteen-thousand colonies were 
screened and fifty-five candidates were purified and analyzed further. Approximately 30,000 
transformants would be necessary to cover 98% of the yeast genome (described in (KUMAR et al. 
2000)). Stable integration of the transposon was verified by streaking strains onto YPD and 
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replica-plating onto SC-LEU medium containing 5-FOA. Thirty-nine candidates passed this test 
and were taken from 5-FOA plates for further analysis. These strains, rtf1Δ rkr1Δ TnSup::LEU2, 
were then used in backcrosses with an rtf1Δ (KMKY139) strain containing pKA69, as a 
functional copy of RTF1 is required for sporulation (data not shown). Tetrad analysis of these 
crosses confirmed that only one Tn was present per candidate by 2:2 sorting of LEU2. This cross 
also confirmed that every rtf1Δ rkr1Δ Leu- spore was 5-FOAs while every rtf1Δ rkr1Δ Leu+ spore 
was 5-FOAR, verifying linkage of the Tn to suppression of lethality. Fifteen rkr1Δ TnSup::LEU2 
strains exhibited 2:2 sorting of the transposon, and the transposon was linked to suppression of 
lethality. These fifteen candidates were taken through a second backcross with an rtf1Δ strain 
(KY619) to verify that the transposon rescued rtf1Δ rkr1Δ lethality independently of pKA69 and 
5-FOA. In this case, we expected suppression of lethality only in rtf1Δ rkr1Δ TnSup::LEU2 
strains. Three Tn mutants passed these genetic criteria, and the Tn insertion was recovered as 
previously described by rescuing the insertion in yeast with linearized pRSQ2-URA3 and the 
plasmid insert was sequenced with an M13 oligo (BURNS et al. 1994). The Tn candidate 
designated 5-5 had a Tn insertion located 70 base pairs (bp) 3’ to the stop codon of RPC17. The 
second candidate, 13-5, mapped within HSP104, 68 bp from the end of the open reading frame. 
The third, 13-7, contained a Tn insertion 43 bp into the open reading frame of CHL1. Mutations 
in all three genes were verified to suppress rtf1Δ rkr1Δ lethality by creating clean KanMX 
replacements of CHL1 or HSP104, or by the use of the rpc17-DAmP allele (Open Biosystems) 
and performing tetrad analysis of a triply heterozygous diploid (rtf1/RTF1 rkr1Δ/RKR1 
sup/SUP).  
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2.2.5 Live-cell imaging 
Strains were transformed with a Sup35NM-GFP (ZHOU et al. 2001) plasmid to test for the 
presence of [PSI+] and patched onto selective media containing 100 µM CuSO4. Plates were 
protected from light and incubated at 30oC for several days to ensure actively growing cells 
before live cell imaging. Imaging was performed on wet mounts using a Leica TCS SP5 
Confocal Microscope (Leica Microsystems, Buffalo Grove, IL). Observations were made of at 
least three transformants per strain and hundreds of cells per transformant. Representative 
images are shown for Sup35NM-GFP fluorescence. 
2.2.6 Western analysis 
For Protein A nonstop western analysis, strains transformed with pAV184 (WILSON et al. 2007) 
were grown at 30oC in SC-Ura liquid medium containing 2% galactose to an OD600 of 0.7 to 0.9. 
Cells were normalized to 10.8 OD600 units. For histone methylation levels, strains were grown in 
YPD to 2.66 OD600 units. Extracts were made using glass bead lysis in 20% trichloroacetic acid 
as previously described (COX et al. 1997; ZHENG et al. 2010). An equal amount of each extract 
(5 µl) was run on a 15% SDS polyacrylamide gel and transferred to nitrocellulose membrane for 
western analysis using standard methods. Briefly, the membrane was probed with Peroxidase-
Anti-Peroxidase (1:2000 dilution; Sigma) to assay levels of Protein A and anti-G6PDH antibody 
(1:50,000; Sigma) as a loading control for the Protein A blots. For the histone methylation levels, 
membranes were probed with anti-H3 K4 me2 (1:2,000, Millipore) or anti-H3 (1:50,000 Custom 
made by GenScript). Immunoreactivity was measured using chemiluminescence (Perkin-Elmer) 
and a 440 CF digital imaging station (Kodak).  
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2.3 RESULTS 
2.3.1 rtf1Δ rkr1Δ synthetic lethality is rescued by restoring Rtf1-dependent histone 
modifications 
Patrick Costa and Mary Braun previously identified RKR1 in a screen for mutations that cause 
synthetic lethality in the absence of RTF1 and showed that mutations in several genes required 
for H2B ubiquitylation, including HTB1, RAD6, and BRE1, cause synthetic growth defects in 
combination with rkr1∆ (BRAUN et al. 2007).  These results suggested that the H2B 
ubiquitylation function of Rtf1 is required for normal cell growth in the absence of Rkr1.  To test 
this idea further, I asked whether a 90-amino acid histone modification domain (HMD)-
containing fragment of Rtf1 could complement an rtf1∆ mutation and restore viability to an 
rkr1∆ rtf1∆ double mutant.  Anthony Piro recently demonstrated that this Rtf1 HMD fragment, 
which includes amino acids 62-152 of Rtf1, is sufficient for promoting H2B ubiquitylation and 
downstream methylation of H3 in the absence of all other parts of the Rtf1 protein (Piro et al, 
PNAS, In press).  Using a plasmid shuffle assay, I found that expression of either full-length 
Rtf1 or the isolated HMD fragment rescued lethality of an rtf1Δ rkr1Δ strain (Figure 7). In 
contrast, a mutant version of the HMD, HMD-E104K, which is defective in promoting Rtf1-
dependent histone modifications (Piro et al. PNAS, In Press) (TOMSON et al. 2011) did not 
rescue rtf1Δ rkr1Δ synthetic lethality, even though it is expressed at similar levels as the wild-
type HMD.  Together with our previous genetic data, these results strongly suggest that, with 
respect to RTF1, a primary cause of the synthetic lethality between rtf1∆ and rkr1∆ is the 
absence of H2B K123 ubiquitylation and its downstream effects. 
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Figure 7: Restoration of histone modifications rescues rtf1Δ rkr1Δ synthetic lethality 
2µ TRP1-marked plasmids expressing the indicated form of RTF1 or empty vector were transformed into an rtf1Δ 
rkr1Δ [RTF1/URA3] strain (KY2205) and dilution analysis was performed on SC-W or SC-W 5-FOA. Plates were 
incubated at 30oC for 3 days.  
 
 
 
 
2.3.2 Identification and verification of Tn mutations that suppress rtf1Δ rkr1Δ synthetic 
lethality  
To further investigate the basis of lethality in strains deficient in H2B ubiquitylation through loss 
of Rtf1 and the ubiquitin ligase Rkr1, I used a transposon-based (Tn) mutagenesis strategy to 
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find suppressors of the rtf1Δ rkr1Δ synthetic lethal interaction (KUMAR et al. 2000). A library of 
plasmids containing yeast genomic DNA and LEU2-marked transposon insertions was 
transformed into an rtf1∆ rkr1∆ strain, which carried a URA3-marked RTF1 plasmid for 
viability. Approximately 15,000 transformants were screened for loss of the URA3-marked RTF1 
plasmid on medium containing 5-FOA. Following phenotypic confirmation, candidates were 
crossed to an rtf1Δ strain containing an URA3-marked RTF1 plasmid to verify 2:2 sorting of the 
LEU2-marked transposon, indicating only one insertion site, as well as linkage of the 5-FOA 
resistance to the LEU2 marker in rtf1∆ rkr1∆ colonies. Fifteen strains met these requirements, 
and rkr1Δ Tnsup::LEU2 strains from those crosses were backcrossed to an rtf1Δ strain to verify 
that the Tn insertion rescued lethality of the rtf1∆ rkr1∆ double mutants in the absence of a 
plasmid source of RTF1. Three candidate strains met these criteria and were chosen for further 
analysis. For the other 12 candidates, spontaneous rtf1∆ rkr1∆ spores arose during this 
backcross, and therefore were not further analyzed at this time due to suspicion of other 
suppressors in the cross. (This is further discussed in the conclusions of this thesis.)  
The transposon insertions were recovered and sequenced in the three final candidates by 
plasmid rescue (BURNS et al. 1994), revealing transposon insertions in the 3’ coding region of 
HSP104, the 5’ coding region of CHL1, and the 3’-UTR of RPC17. HSP104 encodes a heat 
shock protein involved in the maintenance and propagation of aggregated and misfolded 
proteins, including yeast prions (reviewed in (GRIMMINGER-MARQUARDT and LASHUEL 2010)).  
Chl1 is a putative DNA helicase required for sister chromatid cohesion, as well as proper 
transcriptional silencing of the HMR loci, and DNA damage repair (DAS and SINHA 2005; LAHA 
et al. 2006; XU et al. 2007).  Rpc17 is an essential and specific subunit of RNA polymerase III 
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(Pol III) that physically interacts with TFIIIB70, Rpc11, and Rpc31, likely indicating a role for 
this protein in transcription initiation of Pol III transcribed genes (FERRI et al. 2000).  
To confirm that mutations in the three suppressor genes rescued rtf1∆ rkr1∆ synthetic 
lethality, the HSP104 and CHL1 genes were deleted and replaced by a KanMX cassette and the 
resulting strains were crossed to a rkr1Δ strain. For RPC17, which encodes an essential gene, an 
rpc17-DAmP allele with a mutation also within the 3’UTR was obtained (Open Biosystems) and 
crossed to a rkr1Δ strain. The DAmP (Decreased Abundance by mRNA Perturbation) mutation 
contains a KanMX cassette inserted immediately following the open reading frame and  likely 
causes decreased RPC17 transcript levels (not verified) (BRESLOW et al. 2008). Double mutants 
from these three crosses were then mated with an rtf1Δ strain. The diploids, which are 
heterozygous for three genes (RTF1, RKR1, and HSP104, CHL1, or RPC17), were subjected to 
tetrad analysis. As expected, double mutant spores lacking RTF1 and RKR1 were inviable or 
very slow growing in the crosses with a rpc17-DAmP or a chl1Δ mutation. Mutations in RPC17 
or CHL1 suppressed this lethality in all cases (Figure 8). Surprisingly, spores lacking RTF1 and 
RKR1 were alive and healthy in crosses where the diploid was heterozygous for HSP104 (This 
result is further examined in Chapter 3). Confirming the identification of HSP104 in our 
suppressor screen, hsp104Δ rtf1Δ rkr1Δ triple mutants were also alive (Figure 8).  
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Figure 8: Mutations in HSP104, CHL1, and RPC17 rescue rtf1Δ rkr1Δ synthetic lethality 
Shown are tetrad dissections of crosses between rkr1Δ rpc17-DAmP, rkr1Δ chl1Δ, or rkr1Δ hsp104Δ strains and an 
rtf1Δ strain (KY958). Dissections were done on YPD and incubated at 30oC for 3 days. All spores have been 
assigned to ensure proper sorting of the tetrad. For simplicity, double rtf1Δ rkr1Δ mutants are highlighted by boxes 
while triple mutants are highlighted by circles. 
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2.3.3 Mutations in HSP104, CHL1, and RPC17 and suppression of rtf1Δ or rkr1Δ 
phenotypes 
To better understand the mechanism of suppression, I tested which phenotypes of rtf1Δ or rkr1Δ 
cells were rescued by these suppressor mutations. These results would indicate whether 
mutations in HSP104, CHL1, or RPC17 were alleviating the loss of RTF1 or RKR1 and therefore 
help to elucidate the role of the factor in suppression of rtf1Δ rkr1Δ lethality.  
2.3.3.1 Suppression of rkr1Δ genetic interactions 
In addition to synthetic lethality with rtf1Δ and H2B K123R mutations, loss of RKR1 is also 
synthetically lethal with loss of SPT10, which is required for proper histone gene expression 
(BRAUN et al. 2007; DOLLARD et al. 1994). Therefore, to investigate if mutations in CHL1, 
HSP104, or RPC17 could also rescue this genetic interaction, I performed tetrad analysis of a 
rkr1Δ/RKR1 spt10Δ/SPT10 sup/SUP (HSP104, RPC17, or CHL1) strain and found that only 
deletion of hsp104Δ could rescue rtf1Δ spt10Δ synthetic lethality (Table 1). This result indicated 
that loss of HSP104 likely rescued a rkr1Δ-specific defect.  
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Table 1:  Effect of suppressors on rtf1Δ or rkr1Δ genetic interactions 
 
 
 
 
2.3.3.2 Suppression of rtf1Δ genetic interactions 
Loss of rtf1Δ causes sickness or lethality in combination with several mutations, including 
swi4Δ, htz1Δ, arg82Δ, and spt4Δ (Costa and Arndt, unpublished results and (COSTA and ARNDT 
2000; PORTER et al. 2002)). To investigate if any of these genetic interactions with rtf1Δ were 
rescued by loss of CHL1, HSP104, or RPC17, I performed tetrad analysis of diploids 
heterozygous for three genes. Interestingly, I did not observe suppression of the rtf1Δ genetic 
interactions in these crosses (Table 1), other than a very slight increase in growth of htz1Δ rtf1Δ 
hsp104Δ triple mutants compared to htz1Δ rtf1Δ double mutants or arg82Δ rtf1Δ hsp104Δ strains 
compared to arg82Δ rtf1Δ double mutants (Table 1). However, this was rather weak suppression 
of the htz1Δ rtf1Δ and arg82Δ rtf1Δ growth defects. Also, these strains frequently picked up 
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suppressor mutations that enhanced growth (personal observation, data not shown), which made 
further analysis difficult. As will be further discussed in Chapter 3, the loss of HSP104 clears 
cells of [PSI+] and alleviates a stress on cells lacking RKR1, which is involved in controlling 
levels of nonstop proteins. Interestingly, both ARG82-related processes and HTZ1 have also been 
shown to play a role in nonstop quality control (WILSON et al. 2007). Therefore a small part, but 
not all, of the genetic interaction between rtf1Δ and these genes may be due to the nonstop 
quality control pathway.  
2.3.3.3 Suppression of rtf1Δ growth phenotypes 
Loss of RTF1 causes phenotypes usually associated with defects in transcription. These include a 
suppressor of Ty (Spt-) phenotype using a his4-912δ allele of HIS4, which contains a Ty δ (long 
terminal repeat) element upstream of the TATA box. The δ insertion within the promoter of 
HIS4 interrupts wild type growth on medium lacking histidine. Strains with an Spt- phenotype, 
such as rtf1Δ strains, are able to grow on medium lacking histidine by suppressing this promoter 
defect and altering start-site selection (ROEDER and FINK 1982; STOLINSKI et al. 1997). In 
addition, rtf1Δ strains are sensitive to the base analog 6-azauracil (6AU), which causes a 
reduction in intracellular nucleotide pools and subsequent polymerase stalling, requiring 
functional elongation factors for continued transcription (EXINGER and LACROUTE 1992; 
SQUAZZO et al. 2002). Therefore, strains with defects in transcription elongation are sensitive to 
medium containing this compound.  To investigate if loss of CHL1, HSP104, or RPC17 was able 
to suppress these rtf1Δ defects in transcription, I assessed the growth of rtf1Δ sup double mutants 
on medium lacking histidine or containing 6AU. Although no double mutant suppressed an rtf1Δ 
Spt- phenotype, deletion of HSP104 or mutation in RPC17 slightly rescued an rtf1Δ 6AU 
sensitivity phenotype (Figure 9). These results suggest that loss of HSP104 or RPC17 may 
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partially suppress rtf1Δ-dependent defects in transcription. Notably, rpc17-DAmP strains exhibit 
slower growth than wild type strains (apparent on earlier days, data not shown), suggesting that 
suppression of an rtf1Δ defect in transcription suppression may be greater than what can be 
appreciated by this assay.  
 Rtf1 is required for the regulation of H2B K123 ubiquitylation and downstream 
methylation on H3 K4 and H3 K79 by Set2 and Dot1, respectively (NG et al. 2003a; TOMSON et 
al. 2011; WARNER et al. 2007; WOOD et al. 2003b). To assess if the identified suppressor 
mutations were able to restore Rtf1-dependent histone modifications, I performed a western 
analysis of H3 K4 di-methylation levels in double mutant strains. However, none of these strains 
had detectable levels of this mark (Figure 10). These data suggest that defects in Rtf1-dependent 
histone modifications were not suppressed in these strains and this was not the reason for 
restoring viability to rtf1Δ rkr1Δ double mutants.  
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Figure 9: Effects of suppressor mutations on rtf1Δ spt- or 6AUS phenotypes 
Wild type (KY1008), rtf1Δ (KY2161), chl1Δ (KY2163), chl1Δ rtf1Δ (KY2162), hsp104Δ (KY2165),  hsp104Δ rtf1Δ 
(KY2164), rpc17-DAmP (OKA249), rtf1Δ rpc17-DAmP (OKA248) and strains were used for dilution growth assays 
on SC-U, SC-U+6AU, SD Complete or SD-H and incubated at 30oC for 2 to 4 days.  
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Figure 10: Mutation of HSP104, CHL1, or RPC17 does not rescue an rtf1Δ defect in H3 K4 di-
methylation 
Wild type (KY1019), rtf1Δ (KY2161), chl1Δ (KY2162), chl1Δ rtf1Δ (KY2162), hsp104Δ (KY2165), hsp104Δ rtf1Δ 
(KY 2164), rpc17-DAmP (OKA249), rpc17-DAmP rtf1Δ (OKA248), and set1Δ strains were grown to log phase in 
YPD. Extracts were made using TCA and an equal amount of extract was loaded onto two separate 15% SDS 
POLYACRYLAMIDE gels. The gels were transferred to nitrocellulose and probed with anti-H3 K4me2 or anti-H3 
as a loading control.  
 
 
 
2.3.4 Genetic interactions of rtf1Δ and rkr1Δ mutations with defects in mRNA 
degradation pathway components 
Loss of RKR1 causes an increase in nonstop protein levels (BENGTSON and JOAZEIRO 2010; 
WILSON et al. 2007). Rtf1 is a member of the Paf1c, which is required for proper mRNA 
formation (reviewed in (CRISUCCI and ARNDT 2011b; JAEHNING 2010)). Therefore, loss of RTF1 
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may increase levels of aberrant mRNA. I hypothesized that combined defects in protein and 
mRNA quality control from the loss of RKR1 and RTF1, respectively, may be lethal to yeast.  To 
test this hypothesis, I obtained strains with mutations in genes with known roles in mRNA 
quality control (SKI7, SKI3, XRN1, UPF1, UPF3, TRF4, and RRP6). If loss of RTF1 increases 
levels of abnormal RNA, then deletion of genes encoding mRNA quality control pathway 
members, which are known to increase aberrant transcripts, may also be synthetically lethal with 
RKR1. These genes represent several mRNA quality control pathways, including the nuclear and 
cytoplasmic exosome, nonsense-mediated decay, and nonstop mRNA degradation (reviewed in 
(FASKEN and CORBETT 2005)).  
I performed a tetrad analysis of heterozygous double mutant diploids mutated in RKR1 
and one of the above quality control genes. Interestingly, I only found that the deletion of XRN1 
causes extreme sickness or lethality in combination with rkr1Δ (data not shown). This original 
cross was performed using an xrn1Δ strain from the yeast deletion collection, and so I verified 
this genetic interaction by creating an XRN1 deletion in our strain background and repeating this 
tetrad analysis (Figure 11).  XRN1 encodes a cytoplasmic 5’ 3’ exonuclease which decaps and 
degrades aberrant transcripts, including those targeted for nonsense mediated decay (reviewed in 
(FASKEN and CORBETT 2005)). Although these data do not prove that loss of RTF1 increases 
substrates for Xrn1-mediated decay, it does suggest that strains lacking RKR1 are indeed 
sensitive to defects in mRNA quality control and increases in aberrant transcripts such as 
nonsense mRNAs or improperly processed mRNAs. The connection between these two 
pathways remains an avenue to be further investigated.  
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Figure 11: Loss of RKR1 genetically interacts with loss of mRNA degradation factor XRN1 
A rkr1Δ/RKR1 heterozygous diploid (SHY13 crossed by KY1030) was transformed with a PCR product to delete 
the XRN1 gene and replace it with a KanMX cassette. Shown is tetrad analysis of one resulting diploid dissected 
onto YPD and incubated 3 days at 30oC. 
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2.3.5 Further analysis into suppression of rtf1Δ rkr1Δ strains by an rpc17 or chl1 
mutation 
I will show in Chapter 3 that deletion of HSP104 rescues rtf1Δ rkr1Δ synthetic lethality by 
clearing cells of the prion [PSI+]. The presence of [PSI+], an aggregated form of the translation 
termination factor Sup35 required to efficiently recognize stop codons, causes an increase in 
nonsense suppression and increased aberrant mRNAs and proteins (TRUE et al. 2004; WILSON et 
al. 2005). Clearing cells of [PSI+] by mutation of HSP104 relieves these cells of an additional 
burden quality control pathway. Therefore, in these unpublished investigations, I also analyzed 
the effects of rpc17 and chl1 suppressor mutations on these [PSI+]-related phenotypes. RPC17 
encodes a member of the RNA Pol III machinery, which transcribes non-messenger RNAs such 
as tRNAs and 5S rRNA, while CHL1 encodes a putative DNA helicase implicated in sister 
chromatid cohesion and transcriptional silencing (DAS and SINHA 2005; FERRI et al. 2000; LAHA 
et al. 2006; XU et al. 2007).  
2.3.5.1 [PSI+] phenotype 
The suppressor mutations that rescue rtf1Δ rkr1Δ synthetic lethality represent three proteins 
associated with very different cellular functions. Of Chl1, Rpc17, and Hsp104, Hsp104 is the 
best studied. Loss of Hsp104 or mutation of its ATPase domain disrupts the ability of yeast cells 
to propagate prions, particularly [PSI+], an aggregate of the translation termination factor Sup35 
(CHERNOFF et al. 1995; MACKAY et al. 2008). To assay if the transposon insertion in HSP104 
identified in my suppressor screen cleared cells of [PSI+] in our strain background, I transformed 
this strain and the original strain used in my transposon mutagenesis screen with a GFP-tagged 
prion domain of Sup35. In [PSI+] strains, cells exhibit puncta representative of Sup35-GFP 
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aggregates. The fluorescence is diffuse in cells cleared of [PSI+] (ZHOU et al. 2001).  
Transformants were analyzed using live-cell imaging with a confocal microscope. Indeed, the 
transposon insertion in HSP104 cleared cells of [PSI+] from our strain background (Figure 12; 
Further elaborated in Chapter 3). However, the same analysis on the transposon mutations within 
CHL1 or RPC17 showed that these strains still contained [PSI+], suggesting that suppression by 
the CHL1 or RPC17 mutations is likely occurring through a different mechanism.  
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Figure 12: Tn mutations within HSP104, but not CHL1 or RPC17, clear cells of [PSI+] 
The strain originally used for transposon-mediated mutagenesis, an rtf1Δ rkr1Δ strain (KY1663) carrying a URA3-
marked RTF1 plasmid, was also transformed with a LEU2-marked pCUP1-SUP35NM-GFP plasmid. The 
transposon-mutant strains recovered from this screen, hsp104Tn::LEU2, chl1Tn::LEU2, and rpc17Tn::LEU2 were 
transformed with a URA3-marked pCUP1-SUP35NM- GFP plasmid. Strains were patched onto SC-Leu or SC-Ura 
plates containing 100 µM CuSO4 and incubated in the dark at 30oC before life-cell imaging use a confocal 
microscope. 
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2.3.5.2 Assays to measure nonstop protein levels 
Inactivation of HSP104 rescues lethality between rkr1Δ and rtf1Δ by curing cells of [PSI+].  
Most likely, this alleviates cells of accumulated nonstop proteins, which could be targets for 
Rkr1-dependent quality control. However, it is unclear how CHL1 and RPC17 mutations rescue 
this synthetic lethality since mutations in these genes do not cure cells of [PSI+]. 
I hypothesized that loss of RTF1 caused an increase in aberrant transcripts lacking a stop 
codon, and a consequent increase in nonstop protein. This, in conjunction with the increase in 
nonstop proteins from loss of RKR1 and the presence of [PSI+], lead to synthetic lethality in 
yeast. To address this question, I used two nonstop protein reporter plasmids. The first contained 
the HIS3 gene without a stop codon. Wild type cells carrying the reporter efficiently degrade the 
his3 nonstop transcript and protein and cannot grow on media lacking histidine, while cells 
lacking RKR1 are unable to degrade the His3 nonstop protein and therefore grow in these 
conditions (WILSON et al. 2007). The second nonstop reporter contained a Protein A gene also 
lacking a stop codon, and the levels of the resulting protein were assayed by western analysis 
(WILSON et al. 2007). Using these reporters, I found that while loss of RKR1 increases levels of 
nonstop reporter proteins, there is a surprising decrease in nonstop protein levels in rtf1Δ cells 
(Figure 13; See also Chapter 3) (WILSON et al. 2007). 
 Although this result could not simply explain synthetic lethality between rtf1Δ and 
rkr1Δ, the decrease in nonstop proteins in rtf1Δ cells was still an intriguing finding. This 
indicated that RTF1 is necessary for the correct levels, processing, mRNA export/stability, or 
translation of these transcripts/proteins and provided me an additional phenotype with which to 
further explore the role of my genetic suppressors. Therefore, to identify if mutations in RPC17 
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or CHL1 could suppress this rtf1Δ defect, I assayed the levels of nonstop proteins in these 
strains.  
rpc17-DAmP strains have a slow-growth phenotype, making dilution analyses difficult to 
interpret. Therefore, I used western analysis to examine the levels of protein A nonstop levels. 
Although I confirmed that loss of RKR1 increased nonstop levels and loss of RTF1 has the 
opposite effect, I did not observe an effect of rpc17-DAmP on total protein A (Figure 13). 
 I next focused on a potential role in nonstop protein synthesis or stability for CHL1. 
Using both the his3 and Protein A nonstop reporters, I found that deletion of CHL1 in a rkr1Δ 
resulted in increased nonstop protein levels compared to a rkr1Δ strain alone (Figure 14A). 
Furthermore, the deletion of RTF1 suppressed the high nonstop protein levels of chl1∆ rkr1∆ 
cells back to wild type levels (Figure 14B).   
2.3.5.3 Nonsense suppression 
The above results suggest a role for Rtf1 in controlling nonstop protein levels. The Paf1c has 
also been implicated in altering levels of nonsense transcripts, including decreasing protein 
levels from an ade1-14 allele containing a premature stop codon (STRAWN et al. 2009). To 
investigate if a chl1∆ mutation could suppress an rtf1∆ defect in aberrant transcripts other than 
nonstop, I performed a dilution analysis on medium lacking adenine with strains containing the 
ade1-14 allele in the [PSI+] background, which allows read-through of the nonsense allele and 
production of functional Ade1 protein. As previously observed, rtf1∆ ade1-14 strains are unable 
to grow in this condition (Figure 14C) (STRAWN et al. 2009). However, I observed that a chl1∆ 
rtf1∆ strain partially suppressed this defect (Figure 14C). Further, a chl1∆ mutant exhibited 
better growth on medium lacking adenine than a wild type strain (Figure 14C).Therefore, 
consistent with the results of my genetic suppressor screen, I have shown that rtf1∆ and chl1∆ 
 81 
act in opposition to one another, by affecting the levels of nonstop and nonsense proteins 
independent of the presence of prions. 
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Figure 13: A mutation in the RPC17 3' UTR has little effect on nonstop protein levels 
WT (KY307), rtf1Δ(KY2211 ), rkr1Δ (KY2236), rpc17-DAmP rtf1Δ (KMKY178), rpc17-DAmP rkr1Δ 
(KMKY174), rpc17-DAmP (KA137), rpc17-DAmP rkr1Δ rtf1Δ (KMKY181) strains were transformed with a 
URA3-marked plasmid containing a protein A nonstop reporter and grown to early log phase in SC-U containing 2% 
galactose to induce expression of the protein A gene. TCA extracts were made and analyzed by western analysis 
using antibodies against Protein A or G6PDH as a loading control. 
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Figure 14: chl1Δ suppresses rtf1Δ effects on nonsense and nonstop protein levels 
(A) WT (KY1030), rkr1Δ (KY2236), chl1Δ (KY1899) and chl1Δ rkr1Δ (KY2210) strains were transformed with a 
LEU2-marked plasmid containing a his3 non-stop reporter. Ten-fold serial dilutions were performed on SC-Leu or 
SC-Leu-His plates and incubated at 30oC for 2 days. (B) WT (KY307), rtf1Δ (KY2211), rkr1Δ (KY2201), chl1Δ 
(KY1898) and chl1Δ rkr1Δ (KY2208), chl1Δ rtf1Δ (KY2207), chl1Δ rtf1Δ rkr1Δ (KY2206) strains were 
transformed with a URA3-marked plasmid containing a protein A nonstop reporter and grown to early log phase in 
SC-Ura containing 2% galactose to induce expression of protein A. TCA extracts were made and analyzed by 
western analysis using antibodies against Protein A or G6PDH as a loading control.  (C) WT (KY2212), rtf1Δ 
(KY2213) chl1Δ (KY2214) rtf1Δ chl1Δ (KY2215) strains carrying the ade1-14 nonsense allele were grown to 
saturation in YPD and dilution analysis performed on SD Complete and SD-Ade and incubated at 30oC for 3 or 7 
days, respectively.  
 
 84 
2.4 DISCUSSION 
In this chapter, I have investigated the genetic relationship between Rtf1, a member of the RNA 
polymerase II-associated Paf1 complex, and the ubiquitin ligase Rkr1. Rtf1 has strong 
connections to transcription, while Rkr1 has strong links to protein quality control. Although 
elimination of one of these factors alone does not affect cell viability, deletion of both of these 
factors results in synthetic lethality. Overexpression of the Rtf1-HMD, which is required for 
proper Rtf1-mediated histone modifications, rescues viability of rtf1Δ rkr1Δ strains, 
strengthening the genetic relationship between H2B ubiquitylation and loss of RKR1. To better 
understand the interaction between pathways of transcription and protein quality control, I used a 
transposon mutagenesis screen for genetic suppressors of rtf1Δ rkr1Δ synthetic lethality, and 
identified mutations in genes encoding three very different functional products (CHL1, RPC17, 
and HSP104). To understand how these genetic suppressors functioned, I investigated their 
ability to suppress different phenotypes and genetic interactions of rtf1Δ and rkr1Δ.  
 In results that will be further examined in Chapter 3, I found that deletion of HSP104 
rescued rtf1Δ rkr1Δ  synthetic lethality by clearing cells of the prion [PSI+], which is an 
aggregate of the translation termination factor Sup35 that causes increases in aberrant mRNAs 
and proteins. This includes an increase nonstop proteins, which are targets of Rkr1-mediated 
quality control (BENGTSON and JOAZEIRO 2010; DOEL et al. 1994; PAUSHKIN et al. 1996; 
WILSON et al. 2005; WILSON et al. 2008). Additionally, I show in this chapter that deletion of 
HSP104 also rescues synthetic lethality between rkr1Δ and spt10Δ, which is further evidence that 
the presence of [PSI+] negatively influences strains lacking RKR1. This suggests that the 
presence of [PSI+] and excess nonstop proteins are detrimental in the absence of RKR1.  
However, I also found that deletion of HSP104 slightly suppressed a sick phenotype of rtf1Δ 
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htz1Δ or rtf1Δ arg82Δ strains. Interestingly, mutation of HTZ1 or genes functionally connected 
to ARG82 also cause an increase in nonstop proteins, similar to RKR1 (WILSON et al. 2007). 
These data suggest that [PSI+] has a general effect on strains with increased nonstop protein 
levels.  In addition, I showed that loss of HSP104 caused a slight suppression of rtf1Δ 6AU 
sensitivity, which is a phenotype associated with defects in transcription elongations (EXINGER 
and LACROUTE 1992; SQUAZZO et al. 2002). Hsp104 is required for both protein disaggregation 
and prion propagation. It is unclear from these results which function of Hsp104 alleviates the 
rtf1Δ phenotypes and genetic interactions, but these data suggest the possibility that the presence 
of prions could also negatively affect some defects in rtf1Δ strains.  
The Paf1 complex is required to prevent aberrantly formed transcripts that are targets of 
nonsense-mediated decay  (PENHEITER et al. 2005). It has also been shown that Paf1 complex 
members are required for the expression or stability of nonsense and nonstop transcripts from 
both endogenous loci and reporter plasmids (PENHEITER et al. 2005; STRAWN et al. 2009). A 
screen for mutations that suppressed the [PSI+]-mediated nonsense suppression of an ade1-14 
allele identified a mutation in CTR9 of the Paf1 complex and suggested that mutations in CTR9 
result in transcripts that may be unstable or unable to be properly translated (STRAWN et al. 
2009).  These results are supported by my data, where I have demonstrated that the loss of Paf1 
complex member Rtf1 results in decreased protein product from two nonstop reporters and the 
ade1-14 allele (See also Chapter 3). Further, I have shown here that a mutation in CHL1 opposes 
this Rtf1-specific defect, indicating an exciting mechanism of suppression independent of [PSI+]. 
Mutations in CHL1 result in defects in sister chromatid cohesion, but also in telomeric silencing 
and rDNA recombination (DAS and SINHA 2005). My results suggest that this putative DNA 
helicase may have additional underappreciated roles in transcription. Interestingly, Rtf1-
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mediated H2B ubiquitylation is also required for Dam1 methylation at kinetochores, implicating 
this histone modification in mitosis (LATHAM et al. 2011).  Future studies will expand on the 
connections between these processes.   
As demonstrated by the above findings and others, Rtf1 is most likely required for proper 
levels and processing of specific transcripts. In fact, errors in Paf1c have been found to cause 
defects in 3’ end formation, including altered poly(A) site usage and shorter poly(A) tails  
(MUELLER et al. 2004; NORDICK et al. 2008a; PENHEITER et al. 2005). Therefore, it is reasonable 
to further hypothesize from my described results that the loss of RTF1 causes an increase in 
aberrant mRNA that is lethal in combination with other quality control problems, such as those 
that occur in the absence of RKR1 and presence of [PSI+]. To address this question, I asked if a 
disruption in mRNA quality control, which would also cause an increase in aberrant mRNAs, 
could mimic rtf1Δ rkr1Δ synthetic lethality. Of the mutations tested, I found that loss of XRN1 
caused synthetic sickness or lethality with loss of RKR1. Xrn1 is required for decapping and 
degrading multiple aberrant transcripts by its 5’  3’ exonuclease activity, including a class of 
noncoding RNAs as well as some nonsense transcripts, which possess a premature termination 
codon  (VAN DIJK et al. 2011) (reviewed in (FASKEN and CORBETT 2005)). Loss of UPF1, which 
is also responsible for nonsense transcript decay, was not lethal in combination with rkr1Δ. 
These results therefore do not suggest that it is one particular class of aberrant mRNAs that may 
cause lethality in rkr1Δ [PSI+] cells. Further genetic studies into possible mechanisms of rkr1Δ 
xrn1Δ suppression may help explain if this synthetic interaction is indeed similar to that observed 
for rtf1Δ rkr1Δ strains.  
Lastly, the role of my last suppressor mutation in RPC17 is the least clear. I found that a 
mutation in RPC17 caused a slight suppression of rtf1Δ 6AU sensitivity. The finding that an 
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rpc17 mutation could rescue rtf1Δ 6AU sensitivity suggests a connection between RNA Pol III 
transcription and RNA Pol II transcription elongation defects.  Presumably, decreased levels of 
RPC17 transcripts from an rpc17-DAmP allele impair RNA Pol III function, an effect that would 
most likely be felt at the level of translation in the cell. It is unknown if loss of RTF1 also has an 
effect on translation. However, given these findings, future experiments into this function may 
help elucidate these results and illuminate a novel connection between Rtf1 and translation.  
` 
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Table 2: S. cerevisiae strains used in Chapter 2 
Strain Genotype 
KY307 MATα his3Δ200 ura3-52 trp1Δ63 lys2Δ202 
KY958 MATα rtf1Δ101:LEU2 his3Δ200 leu2Δ1 ura3Δ0 trp1Δ63 lys2-128δ 
KY1008 MATa leu2Δ1 his4-912δ 
KY1019 MATa leu2Δ1 his4-912δ kys2-128δ 
KY1030 MATα his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY1663 MATα rtf1Δ102::ARG4 rkr1Δ::KanMX leu2Δ1 ura3-52 arg4-12 [pKA69: RTF1/URA3/C/A] 
KY1898 MATα chl1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY1899 MATa chl1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 
KY2161 MATa rtf1Δ101:LEU2 leu2Δ1/0 his4-912δ kys2-128δ 
KY2162 MATa chl1Δ::KanMX rtf1Δ101:LEU2 leu2Δ1/0 his4-912δ kys2-128δ 
KY2163 MATa chl1Δ::KanMX leu2Δ1/0 his4-912δ kys2-128δ 
KY2164 MATa hsp104Δ::KanMX rtf1Δ101:LEU2 leu2Δ1/0 his4-912δ kys2-128δ 
KY2165 MATa hsp104Δ::KanMX leu2Δ1/0 his4-912δ kys2-128δ 
KY2202 MATa rkr1Δ::HIS3 his3Δ200 leu2Δ1 ura3-52 
KY2205 MATa rtf1Δ102::ARG4 rkr1Δ::KanMX leu2Δ1 ura3-52 arg4-12 trp1Δ63 [pKA69: RTF1/URA3/C/A] 
KY2206 MATa chl1Δ::KanMX rtf1Δ101::LEU2 rkr1Δ::HIS3 his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY2207 MATa chl1Δ::KanMX rtf1Δ101::LEU2 his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY2208 MATα chl1Δ::KanMX rkr1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 arg4-12 
KY2209 MATα rtf1Δ::KanMX rkr1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 [psi-] 
KY2210 MATa rtf1Δ::KanMX rkr1Δ::KanMX his3Δ200 leu2Δ1 trp1Δ63 [psi-] 
KY2212 MATa ade1-14 leu2Δ1 ura3-52 trp1Δ63 
KY2213 MATa rtf1Δ101::LEU2 ade1-14 leu2Δ1 ura3-52 trp1Δ63 
KY2214 MATα chl1Δ::KanMX ade1-14 leu2Δ1 ura3-52 trp1Δ63 
KY2215 MATα chl1Δ::KanMX rtf1Δ101::LEU2 ade1-14 leu2Δ1 ura3-52 trp1Δ63 
KY2236 MATα rkr1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KA137 MATα rpc17-DAmP::KanMX his3Δ1/200 leu2Δ0/1 lys2-128δ ura3Δ0/-52 trp1Δ63 
OKA248 MATa rtf1Δ101::LEU2 rpc17-DAmP::KanMX leu2Δ0/1 his4-912δ kys2-128δ 
OKA249 MATα rpc17-DAmP::KanMX leu2Δ0/1 his4-912δ kys2-128δ 
SHY13 MATa rkr1Δ::HIS3 his3Δ200 leu2Δ1 ura3-52 lys2-128δ 
KMKY174 MATα rkr1Δ::HIS3 rpc17-DAmP::KanMX his3Δ1/200 leu2Δ0/1 ura3Δ0/-52 
KMKY178 MATα rtf1Δ101::LEU2 rpc17-DAmP::KanMX his3Δ1/200 leu2Δ0/1 ura3Δ0/-52 lys2-128δ 
KMKY181 MATα rtf1Δ101::LEU2 his3Δ1/200 leu2Δ0/1 ura3Δ0/-52 lys2-128δ trp1Δ63 met15Δ0 
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3.0  THE PAF1 COMPLEX SUBUNIT RTF1 BUFFERS CELLS AGAINST THE 
TOXIC EFFECTS OF [PSI+] AND DEFECTS IN RKR1-DEPENDENT QUALITY 
CONTROL IN S. CEREVISIAE  
3.1 INTRODUCTION 
 
During transcription elongation, various proteins modify chromatin in coordination with RNA 
polymerase (RNA Pol II) to ensure accurate and efficient transcription of nucleosomal templates 
(LI et al. 2007a). Changes in chromatin include nucleosome remodeling, the exchange of histone 
variants for canonical histones, and histone modifications such as the methylation, 
ubiquitylation, and acetylation of lysine (K) residues. The conserved Paf1 complex (Paf1c), 
which consists of Paf1, Ctr9, Leo1, Cdc73, and Rtf1, associates with RNA Pol II on all actively 
transcribed genes (MAYER et al. 2010) and couples the modification of histones to transcription 
elongation (reviewed in (CRISUCCI and ARNDT 2011b; JAEHNING 2010)). Paf1c is required for 
multiple histone modifications associated with active genes including the monoubiquitylation of 
H2B K123, a modification for which the Rtf1 subunit of Paf1c plays a prominent role (NG et al. 
2003a; TOMSON et al. 2011; WARNER et al. 2007; WOOD et al. 2003b). Rad6 is the ubiquitin 
conjugating enzyme (E2) for H2B K123 ubiquitylation, while Bre1 is the ubiquitin-protein ligase 
(E3) (HWANG et al. 2003). This modification is a prerequisite for downstream histone H3 
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methylation (DOVER et al. 2002; NG et al. 2003a; SUN and ALLIS 2002; WOOD et al. 2003b). In 
yeast, loss of H2B K123 ubiquitylation broadly impacts gene expression and chromatin structure 
(BATTA et al. 2011; MUTIU et al. 2007).  In humans, errors in Paf1c-dependent histone 
modifications can lead to aberrant gene expression and tumorigenesis (reviewed in (CRISUCCI 
and ARNDT 2011b)). 
Paf1c has several functions in addition to promoting specific histone modifications, 
including directing the proper 3’-end formation of transcripts (MUELLER et al. 2004; NAGAIKE et 
al. 2011; NORDICK et al. 2008a; PENHEITER et al. 2005; SHELDON et al. 2005). Depletion of 
human Paf1c (hPaf1c) subunits impairs mRNA cleavage, polyadenylation, and export to the 
cytoplasm (NAGAIKE et al. 2011). Additionally, loss of hCdc73 results in aberrantly processed 
and polyadenylated histone mRNAs (FARBER et al. 2010). In yeast, deletion of Paf1c subunits 
leads to decreased poly(A) tail length and alternative poly(A) site usage (MUELLER et al. 2004; 
STRAWN et al. 2009). These observations indicate that Paf1c is essential for both the proper 
expression and processing of a subset of RNAs and that loss of Paf1c can result in aberrant 
transcripts, which are inefficiently exported or translated. In support of this idea, erroneous 
transcripts resulting from loss of Paf1c are substrates for mRNA quality control pathways, 
including nonsense mRNA decay (PENHEITER et al. 2005) (reviewed in (CRISUCCI and ARNDT 
2011b; JAEHNING 2010)).  
RKR1, which is required for viability in S. cerevisiae strains lacking the Paf1c subunit 
Rtf1, encodes a conserved RING finger-containing ubiquitin-protein ligase (BRAUN et al. 2007). 
Deletion of RKR1 also causes severe growth defects in strains lacking PAF1 or CTR9 (BRAUN et 
al. 2007). Given that rkr1Δ causes severe synthetic growth defects in strains with an htb1-K123R 
mutation, Rkr1 most likely functions in a pathway parallel to the histone modification functions 
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of Paf1c to promote an important cellular process (BRAUN et al. 2007). Interestingly, Rkr1 is 
required for the proper ubiquitylation and degradation of nonstop proteins in yeast and physically 
associates with ribosomes (BENGTSON and JOAZEIRO 2010; BRAUN et al. 2007; FLEISCHER et al. 
2006; WILSON et al. 2007). Nonstop proteins can result from mRNAs lacking stop codons 
(nonstop mRNAs), and both the mRNAs that encode these nonstop proteins and the resulting 
nonstop proteins themselves are targeted for degradation (BENGTSON and JOAZEIRO 2010; VAN 
HOOF et al. 2002; WILSON et al. 2007), thus implicating Rkr1 in a protein quality control 
pathway (BENGTSON and JOAZEIRO 2010). Importantly, mutations in RKR1 homologs in higher 
eukaryotes are associated with neurodegeneration and colon cancer (CHU et al. 2009; IVANOV et 
al. 2007). 
To investigate the relationship between the transcription factor Rtf1 and the protein 
quality control factor Rkr1, I performed a transposon-based mutagenesis screen to identify 
suppressors of rtf1Δ rkr1Δ synthetic lethality in S. cerevisiae. I found that mutations in the gene 
encoding the Hsp104 chaperone rescue lethality of an rtf1Δ rkr1Δ strain. Enhanced or depleted 
levels of Hsp104 alter [PSI+] prion propagation (CHERNOFF et al. 1995), suggesting a role for 
this prion in rtf1Δ rkr1Δ synthetic lethality. Consistent with this idea, I found that conditions for 
curing [PSI+] restore viability of rtf1Δ rkr1Δ strains and that transfer of [PSI+] to rtf1Δ rkr1Δ 
[psi-] cells causes lethality. Additionally, I found that the presence of [PSI+], presumably through 
increased nonstop proteins, negatively influences the fitness of rkr1Δ strains even in the presence 
of Rtf1. Unexpectedly, the absence of RTF1 in a rkr1Δ background causes a decrease in the 
levels of nonstop reporter proteins. My results suggest that Rtf1 and its H2B ubiquitylation 
function protect cells against the combined deleterious effects of [PSI+] and defects in Rkr1-
mediated protein quality control. 
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3.2 MATERIALS AND METHODS 
3.2.1 Yeast strains and standard growth conditions 
KY Saccharomyces cerevisiae strains are isogenic with FY2, a GAL2+ derivative of S288C 
(WINSTON et al. 1995). Yeast deletion mutants, crosses, and transformants were created using 
standard protocols (AUSUBEL 1988; ROSE 1991). Yeast were grown on rich (YPD), synthetic 
complete (SC), synthetic minimal (SD), 5-fluoro-orotic acid (5-FOA) or sporulation media as 
specified and prepared as previously described (ROSE 1991). Strains were typically cured of 
prions by streaking for single colonies onto YPD supplemented with 5 mM guanidine 
hydrochloride. For creating [prion-] strains from diploids, tetrad dissections were performed on 
YPD containing 2.5 mM guanidine hydrochloride. 
3.2.2 Plasmids 
The his3 nonstop plasmid, pAV240 (LEU2-marked), and protein A nonstop plasmid, pAV184 
(URA3-marked), were gifts from Dr. Ambro van Hoof (WILSON et al. 2007). The sup35NM-GFP 
(URA3- or LEU2-marked) and RNQ1-GFP plasmids were gifts from Dr. Susan Liebman (ZHOU 
et al. 2001). The URA3-marked plasmid carrying RTF1, pKA69, was used to maintain rtf1Δ 
rkr1Δ viability (STOLINSKI et al. 1997). HSP104 was driven by a GPD promoter on a 2µ pRS424 
(TRP1) plasmid (MUMBERG et al. 1995; RUBEL et al. 2008). This plasmid was used to derive 
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plasmids for overexpression of URE2, LSM4, LSM2, and RNQ1. The open reading frames and 3’ 
UTR sequences of URE2, LSM4, LSM2, and RNQ1 were amplified by PCR from a plasmid 
source and inserted in place of HSP104 using the SacI and BamHI sites (NAGALAKSHMI et al. 
2008). LSM4 and URE2 overexpression clones were made by Mark Sullivan. The ade1-14 and 
sup35-Y351C alleles (BRADLEY et al. 2003) were amplified from strains provided by Dr. Susan 
Liebman and cloned using XmaI and SacI sites into pRS306 for two-step gene replacement of the 
ADE1 or SUP35 gene, respectively (SCHERER and DAVIS 1979). 
3.2.3 Mutagenesis and confirmation of genetic suppressors 
Transposon (Tn) mutagenesis to identify suppressors of rtf1Δ rkr1Δ synthetic lethality was 
performed by transforming a LEU2-marked set of integrating plasmids (described in (KUMAR et 
al. 2000)) into an rtf1Δ rkr1Δ strain (KY1663) carrying an RTF1/URA3/CEN/ARS plasmid 
(pKA69) and selecting on SC-leucine (L) medium, as described in detail in section 2.2.4 of this 
thesis.  
3.2.4 High-copy-number suppressor screen 
To obtain high-copy-number suppressors of rtf1Δ rkr1Δ synthetic lethality, a 2-micron LEU2-
marked plasmid library of genomic fragments (RUBEL et al. 2008; YOSHIHISA and ANRAKU 
1989) was transformed into an rtf1Δ rkr1Δ strain (KY2205) carrying pKA69. Approximately 
13,500 Leu+ colonies were screened for the ability to grow on 5-FOA medium, indicating loss of 
pKA69. One hundred and thirty-one candidates were verified by testing on 5-FOA medium, and 
plasmids were isolated by standard extraction methods (HOFFMAN and WINSTON 1987). Plasmids 
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were then re-transformed into KY2205, and 48 exhibited the suppression phenotype.  Of these, 
21 contained either RTF1 or RKR1. Of the remaining candidates, six unique plasmids remained. 
One plasmid, which was isolated seven times, contained the gene LSM4. Another plasmid, which 
was isolated three times, contained multiple open reading frames, including URE2. A third 
plasmid, obtained twice, also contained multiple open reading frames, including HSP104. This 
screen was originally performed by Mary Braun.  
3.2.5 Yeast dilution growth assays 
Unless stated otherwise, yeast strains were grown to saturation at 30oC in rich or selective media, 
washed with sterile water, and diluted into 1x108 cells/ml stocks from which 10-fold dilutions 
were made. Two microliters of cell suspension were plated on appropriate control and selective 
media and plates were incubated at 30oC for the specified number of days. Media for testing 
rtf1Δ and rkr1Δ phenotypes contained 0.8 µg/ml cycloheximide, 50 µM cadmium chloride, 10% 
ethanol, or 15 mM caffeine in YPD or SC as indicated. 
3.2.6 Cytoduction 
An rtf1Δ rkr1Δ ade1-14 [psi-] strain (KY2286), created by dissection onto YPD containing 
GuHCl, was transformed with RTF1/URA3 (pKA69) and made ρ0 by growth in liquid culture 
with ethidium bromide. Using previously described methods (WICKNER et al. 2006), this 
recipient strain was used for cytoduction with two kar1 donor strains, L2261 ([PIN+] [psi-]) and 
L2265 ([PSI+] [pin-]) (MATHUR et al. 2009). Transfer of cytoplasm to the recipient strain was 
confirmed by growth on YP medium containing 3% glycerol (YPG) and transfer of the donor 
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prion was confirmed by live cell confocal microscopy of plasmid-encoded GFP-tagged prion 
domains.  The kar1 donor strains and GFP plasmids were gifts from Dr. Susan Liebman. 
3.2.7 Live cell confocal microscopy 
Strains were transformed with sup35NM-GFP plasmid (ZHOU et al. 2001) to test for the presence 
of [PSI+] or a RNQ1-GFP plasmid to test for the presence of [PIN+] and patched onto selective 
media containing 100 µM CuSO4. Plates were protected from light and incubated at 30oC for 
several days. Live cell imaging was performed on wet mounts using a Leica TCS SP5 Confocal 
Microscope (Leica Microsystems, Buffalo Grove, IL). 
3.2.8 Immunofluorescence 
A rkr1Δ strain (KY2289) was transformed with either an HA-RKR1 (pMB11) or untagged RKR1 
plasmid (pPC65) (BRAUN et al. 2007). These strains were grown to mid-log phase and prepared 
as previously described (AMBERG et al. 2006).  Briefly, cells were fixed with formaldehyde, 
treated with Zymolyase 20T, and adhered to a polylysine slide before overnight incubation with 
1:500 anti-HA (Roche) and 1 hour incubation with 1:250 Alexa 647 (Molecular Probes). Slides 
were mounted with ProLong GOLD Antifade DAPI reagent (Invitrogen) and imaged using a 
Leica TCS SP5 Confocal Microscope (Leica Microsystems, Buffalo Grove, IL). 
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3.2.9 Western analysis of nonstop protein levels 
Strains transformed with pAV184 (WILSON et al. 2007) were grown at 30oC in SC-uracil (U) 
liquid culture containing 2% galactose to an OD600 of 0.7 to 0.9. Cells were normalized to 10.8 
OD600 units and extracts were made using glass bead lysis in 20% trichloroacetic acid as 
previously described (COX et al. 1997; ZHENG et al. 2010). An equal amount of each extract (5 
µl) was run on a 15% SDS-polyacrylamide gel and transferred to nitrocellulose membrane for 
western analysis using standard methods (HARLOW and LANE 1988). The membrane was probed 
with Peroxidase-Anti-Peroxidase (1:2000 dilution; Sigma) to assay levels of Protein A and anti-
G6PDH antibody (1:50,000 dilution; Sigma) as a loading control. Immunoreactivity was 
measured using chemiluminescence (Perkin-Elmer) and a 440 CF digital imaging station 
(Kodak). 
3.3 RESULTS 
3.3.1 Genetic suppressors of rtf1∆ rkr1∆ synthetic lethality 
To investigate the basis for lethality of strains lacking Rtf1 and the ubiquitin-protein ligase Rkr1, 
I performed a transposon-based (Tn) mutagenesis screen for suppressors of the rtf1Δ rkr1Δ 
synthetic lethal interaction as described in Chapter 2 of this thesis. One candidate that met these 
criteria is described in further detail in this chapter, while two additional candidates are also 
described in Chapter 2.  
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Following the plasmid rescue of the transposon insertion (BURNS et al. 1994), DNA 
sequencing revealed a transposon insertion in the 3’ coding region of HSP104. Hsp104 encodes a 
heat shock protein that can disrupt aggregated proteins (PARSELL et al. 1994) and is involved in 
the maintenance and propagation of yeast prions (reviewed in (GRIMMINGER-MARQUARDT and 
LASHUEL 2010)). As described in Chapter 2, to confirm that the Tn mutation rescued rtf1∆ rkr1∆ 
synthetic lethality by disrupting Hsp104 function, I generated an hsp104Δ strain and crossed it to 
a rkr1Δ strain. Double mutants from these crosses were then mated with an rtf1Δ strain. The 
diploids, which are heterozygous for three genes (rtf1∆, rkr1∆, and hsp104∆), were subjected to 
tetrad analysis. Surprisingly, the rtf1∆ rkr1∆ double mutant segregants were alive and healthy, 
indicating dominant suppression by hsp104∆ (Figure 15A). In addition, the hsp104Δ rtf1Δ rkr1Δ 
triple mutants were viable, independently confirming the identification of an hsp104 mutation in 
my suppressor screen (Figure 15A).  
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Figure 15: Mutation of HSP104 suppresses rtf1Δ rkr1Δ synthetic lethality and cures [PSI+] 
This figure is a combination of results shown in Chapter 2. (A) Tetrad dissections of crosses between an rtf1Δ strain 
(KY958) and a rkr1Δ hsp104Δ strain. Dissections were done on YPD and incubated at 30oC for 3 days. Double 
mutant rtf1Δ rkr1Δ segregants are highlighted by boxes while triple mutants are highlighted by circles. Note 
suppression of rtf1Δ rkr1Δ synthetic lethality occurs with or without hsp104Δ co-segregation, indicating that 
hsp104Δ acts as a dominant suppressor in the diploid. (B) The strain originally used for transposon-mediated 
mutagenesis (KY1663) and the hsp104Tn::LEU2 mutant recovered from the transposon-based suppressor screen 
were transformed with a LEU2-marked or a URA3-marked pCUP1-SUP35NM-GFP plasmid. Strains were patched 
onto SC-L or SC-U plates containing 100 µM CuSO4 and incubated in the dark at 30oC before live cell imaging was 
performed by confocal microscopy. Observations were made of at least three transformants per strain and 100 cells 
per transformant. Representative images are shown. No variability was seen among cells with respect to the GFP 
pattern. 
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3.3.2 The transposon insertion in HSP104 cures cells of [PSI+] 
As described in Chapter 2, deletions in the C-terminal domain of Hsp104 have been shown to 
weaken its ATPase activity and ability to propagate prions, particularly [PSI+], an aggregate of 
the translation termination factor Sup35 (CHERNOFF et al. 1995; MACKAY et al. 2008). Because 
the transposon insertion disrupted the C-terminal domain of Hsp104, I investigated if the rtf1Δ 
rkr1Δ strain used in the suppressor screen was [PSI+] and whether the hsp104Tn::LEU2 
suppressor mutation cleared [PSI+] from this strain. A plasmid expressing the GFP-tagged prion 
domain of Sup35 was transformed into the original rtf1Δ rkr1Δ [RTF1, URA3, CEN/ARS] strain 
used in my transposon mutagenesis screen and transformants were visualized by live-cell 
imaging using a confocal microscope (ZHOU et al. 2001). Previous studies have shown that this 
GFP-tagged Sup35 protein appears as small fluorescent puncta in [PSI+] cells and as diffuse 
fluorescence in [psi-] cells (ZHOU et al. 2001). Using this method, I found that the original strain 
used in our screen was indeed [PSI+] and that a transposon insertion within HSP104 resulted in 
[psi-] conditions in all cells examined (Figure 15B). Given the importance of Hsp104 in prion 
propagation, I next investigated the role of prions in the genetic interaction between RTF1 and 
RKR1.  
3.3.3 RKR1 genetic interactions are rescued by curing strains of [PSI+] 
As noted above, HSP104 is required for the propagation of yeast prions (CHERNOFF et al. 1995; 
SHORTER and LINDQUIST 2006). Therefore, the loss of prions in an hsp104Δ/HSP104 
heterozygous diploid strain likely rescued lethality between rtf1Δ and rkr1Δ, independently of 
whether the hsp104∆ mutation actually segregated with the rtf1∆ and rkr1∆ mutations (Figure 
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15A). Growth on media containing guanidine hydrochloride has been shown to cure yeast of 
prions by inactivating the ATPase domain of Hsp104 (FERREIRA et al. 2001; JUNG and MASISON 
2001). To determine if clearing prions through this method could also rescue rtf1Δ rkr1Δ 
lethality, an rtf1Δ/RTF1 rkr1Δ/RKR1 heterozygous diploid was sporulated and tetrads were 
dissected onto YPD or YPD containing 2.5 mM guanidine hydrochloride (GuHCl). Strikingly, 
tetrad analysis revealed that rtf1Δ rkr1Δ double mutants grew as well as wild-type strains on 
YPD containing GuHCl but were inviable on YPD alone (Figure 16A). Therefore, inactivation of 
HSP104 by mutation or treatment with GuHCl rescues rtf1Δ rkr1Δ synthetic lethality.  
HSP104 is required for the propagation of several yeast prions, including [PSI+], [URE3], 
and [PIN+] (reviewed in (HASLBERGER et al. 2010)). Similar to a loss of HSP104 function, 
overexpression of HSP104 can also alleviate yeast of [PSI+], but it has not been shown to affect 
the propagation of other yeast prions (CHERNOFF et al. 1995; SHORTER and LINDQUIST 2006). 
Therefore, to investigate if rtf1Δ rkr1Δ lethality might be rescued by loss of [PSI+] or of yeast 
prions in general, I overexpressed HSP104 to test for rescue of synthetic lethality. An rtf1Δ 
rkr1Δ strain, which carried an RTF1 URA3-marked plasmid to allow growth, was transformed 
with a TRP1-marked HSP104 overexpression plasmid. Transformants were grown under 
selective conditions and replica plated to medium containing 5-FOA to select for loss of the 
RTF1 plasmid. Interestingly, the HSP104 high-copy plasmid allowed for growth of the rtf1Δ 
rkr1Δ double mutants (Figure 16B). Taken together, my results indicate that deletion, 
inactivation, or overexpression of HSP104 suppresses rtf1Δ rkr1Δ synthetic lethality by clearing 
[PSI+].  
A defect in H2B K123 ubiquitylation can phenocopy an rtf1Δ mutation with respect to 
rkr1Δ synthetic growth defects (BRAUN et al. 2007). I therefore investigated if the inactivation of 
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Hsp104 could also rescue the genetic interaction between rkr1Δ and htb1-K123R, a derivative of 
H2B that lacks the ubiquitylation site for Rad6-Bre1. To answer this question, I performed a 
plasmid shuffle experiment with RKR1 and rkr1Δ strains, which carried a URA3-marked HTA1-
HTB1 plasmid and a HIS3-marked HTA1-htb1K123R plasmid, and were deleted for the 
chromosomal H2A and H2B genes. Serial dilution analysis on 5-FOA medium selected for cells 
that had lost the URA3-marked wild-type HTA1-HTB1 plasmid and retained the HIS3-marked 
HTA1-htb1K123R plasmid. As previously shown, the rkr1Δ mutation causes a strong synthetic 
growth defect in combination with the H2B K123R substitution by this assay (Figure 16C) 
(BRAUN et al. 2007). However, if these strains were first cured of prions by passaging on 
medium containing 5 mM GuHCl prior to plating on 5-FOA medium, rkr1Δ htb1K123R strains 
were viable (Figure 16C). 
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Figure 16: Inactivation or overexpression of HSP104 rescues rkr1Δ synthetic genetic interactions 
(A) Heterozygous rtf1Δ/RTF1 rkr1Δ/RKR1 diploids (KY2202 mated by KY453) were dissected onto YPD or YPD 
containing 2.5 mM guanidine hydrochloride (GuHCl) and incubated at 30oC for 3 days. (B) An rtf1Δ rkr1Δ 
[RTF1/URA3] strain (KY1663) was transformed with either a 2µ TRP1-marked pGPD-HSP104 plasmid or a TRP1-
marked empty vector (pRS424), and transformants were purified on SC-W and replica plated to SC-W + 5-FOA. 
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Plates were incubated at 30oC for 3 days. (C) Wild type (KY2203) or rkr1Δ (KY2204) strains, lacking both 
endogenous histone H2A and H2B gene copies, were transformed with a URA3-marked wild type copy of HTA1-
HTB1 and a HIS3-marked HTA1-htb1 K123R plasmid. Strains were cured by streaking onto YPD + 5 mM GuHCl. 
Dilution growth assays were performed on SC-H or SC-H + 5-FOA, and cells were incubated at 30oC for 2 days. 
PRION+ indicates uncured cells; prion- indicates cells passaged on medium containing GuHCl. 
 
 
 
3.3.4 Overexpression of prion-coding genes URE2 and LSM4 rescues rtf1Δ rkr1Δ lethality 
Over twenty potential or verified prions have been identified in budding yeast, with [PSI+] being 
one of the best characterized (ALBERTI et al. 2009). Interactions between different prions can be 
both positive and negative. The de novo formation and propagation of some prions require the 
presence of other prions (DERKATCH et al. 2001), while the maintenance of some prions may be 
negatively impacted by the presence of other prions, possibly by affecting chaperone activity 
(reviewed in (CROW and LI 2011)). 
In a second, unbiased suppression screen (see Material and Methods), Mary Braun 
identified high-copy-number plasmids that rescued rtf1Δ rkr1Δ synthetic lethality. Confirming 
earlier results, one plasmid suppressor contained HSP104. Interestingly, several other suppressor 
plasmids contained URE2, which encodes the prion [URE3] (reviewed in (MASISON et al. 
2000)), or LSM4, which codes for a protein with a prion-forming domain (ALBERTI et al. 2009). 
The overexpression of [URE3] has been shown to antagonize the propagation of [PSI+] 
(SCHWIMMER and MASISON 2002). Therefore, to further test the hypothesis that the clearance of 
[PSI+] suppresses rtf1Δ rkr1Δ lethality, I transformed an rtf1Δ rkr1Δ double mutant strain 
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carrying an RTF1 URA3-marked plasmid with overexpression plasmids for the prions [URE3] or 
[LSM4] and assessed the growth of these strains on 5-FOA medium (ALBERTI et al. 2009; 
DERKATCH et al. 2001). HSP104 overexpression served as a positive control. As expected, the 
rtf1Δ rkr1Δ strain was unable to grow without a plasmid-source of RTF1. However, the 
overexpression of prion-encoding genes URE2 and LSM4 suppressed rtf1Δ rkr1Δ synthetic 
lethality to the same degree as overexpression of HSP104 (Figure 17A). I also investigated the 
effects of overexpressing the gene RNQ1, which encodes the prion [PIN+] (DERKATCH et al. 
2001), on rtf1Δ rkr1Δ synthetic lethality. Although some transformants revealed suppression of 
rtf1Δ rkr1Δ synthetic lethality by RNQ1 overexpression, others did not, possibly because [PSI+] 
and [PIN+] variants can differentially affect each other’s propagation (Figure 18) (BRADLEY and 
LIEBMAN 2003). 
Collectively, my results indicate that [PSI+] is negatively impacted by overexpression of 
[URE3] and [LSM4] prions, and that [PSI+] causes rtf1Δ rkr1Δ mutants to be inviable. To 
investigate if the aggregation propensity of [PSI+] is negatively affected under each of these 
conditions, I used live-cell confocal microscopy to image the presence of [PSI+] in strains 
overexpressing HSP104, URE2, or LSM4. As expected, rtf1Δ rkr1Δ [RTF1, URA3, CEN/ARS] 
cells expressing the Sup35NM-GFP 2-micron plasmid contained fluorescent puncta confirming 
the presence of [PSI+] (Figure 17B). In strains that overexpressed Sup35NM-GFP and also 
HSP104, URE2, or LSM4, I observed a large number of cells that exhibited diffuse fluorescence 
and were apparently cured of [PSI+] (Figure 17B and 17C).  
The recovery of URE2 and LSM4 from an independent genetic screen as suppressors of 
rtf1Δ rkr1Δ lethality further indicated the importance of [PSI+] to this genetic interaction. 
However, due to the known roles of Lsm4 in regulating RNA processing and degradation as part 
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of the Lsm complex (reviewed in (BEGGS 2005), I asked whether the suppression of rtf1Δ rkr1Δ 
lethality by LSM4 overexpression could be explained by a disruption of Lsm complex function. 
To this end, I constructed a plasmid to overexpress another member of the Lsm complex, Lsm2, 
which is not known to have a prion-forming domain. Unlike the case for LSM4, the LSM2 
overexpression plasmid did not rescue rtf1Δ rkr1Δ synthetic lethality (Figure 18). Collectively, 
my data indicate a positive correlation between overexpression of certain prions, clearance of 
[PSI+], and suppression of rtf1Δ rkr1Δ inviability. 
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Figure 17: Overexpression of HSP104, URE2 or LSM4 rescues rtf1Δ rkr1Δ lethality and clears [PSI+] 
(A) An rtf1Δ rkr1Δ strain (KY2205) carrying a URA3-marked RTF1 plasmid was transformed with 2µ TRP1-
marked pGPD-HSP104, pGPD-URE2, pGPD-LSM4, or empty vector. Dilution assays were performed on SC-W or 
SC-W + 5-FOA and plates were incubated at 30oC for 2 days. (B) Strains from (A) were transformed with LEU2-
marked pCUP1-SUP35NM-GFP. Transformants were patched onto SC-L-W containing 100 µM CuSO4 and 
incubated in the dark at 30oC before live cell imaging was performed using confocal microscopy. Two 
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representative images are shown for each strain. (C) This panel displays the percentage of [PSI+] and [psi-] cells 
from among 50-100 cells from three separate transformants.   
 
 
 
 
 
 
Figure 18: Effect of LSM2 or RNQ1 overexpression on rtf1Δ rkr1Δ synthetic lethality 
An rtf1Δ rkr1Δ strain (KY2205) carrying a URA3-marked RTF1 plasmid was transformed with 2µ TRP1-marked 
pGPD-LSM4, pGPD-LSM2, pGPD-RNQ1, or empty vector. Ten-fold serial dilution assays were performed on SC-
W or SC-W + 5-FOA media and plates were incubated at 30oC for 2 days. Overexpression of RNQ1 resulted in 9 out 
of 23 transformants that showed rescue of rtf1Δ rkr1Δ lethality (representative transformants depicted as A, B, or C). 
No variation in the lack of rescue of rtf1Δ rkr1Δ lethality by overexpression of LSM2 was observed in 25 
transformants (representative transformants depicted as A or B). 
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3.3.5 [PSI+] causes rtf1Δ rkr1Δ synthetic lethality 
To confirm that the combined loss of RTF1 and RKR1 causes synthetic lethality only in [PSI+] 
conditions, I performed cytoduction experiments using a viable, cured rtf1Δ rkr1Δ strain 
transformed with a URA3-marked RTF1 plasmid as a recipient strain and specific prion-
containing donor strains. The recipient also carried the ade1-14 nonsense allele to monitor the 
transfer of [PSI+], which causes translational read-through of ade1-14 and production of 
functional Ade1 protein (CHERNOFF et al. 1995). Cytoductions were performed with two donor 
strains (MATHUR et al. 2009), one carrying [PSI+] and the other carrying [PIN+]. Only 
cytoduction of [PSI+] resulted in the inability to lose the RTF1 plasmid, as indicated by growth 
on SD-Ade and death on 5-FOA media (Figure 19A). I confirmed transfer of [PSI+] or [PIN+] by 
live-cell confocal microscopy with GFP tagged-prion domains (Figure 19B). These results 
confirm that the prion [PSI+] causes rtf1Δ rkr1Δ lethality. 
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Figure 19: Cytoduction of [PSI+] into cured rtf1Δ rkr1Δ strains causes synthetic lethality 
A) An rtf1Δ rkr1Δ ade1-14 strain (KY2286) cured of prions by dissection on medium containing GuHCl was 
transformed with a URA3-marked RTF1 plasmid and made ρ0 by growth in ethidium bromide-containing medium. 
This strain served as a recipient for cytoduction with donor kar1 strains containing only [PSI+] (L2265) or [PIN+] 
(L2261). A dilution growth assay is shown with the recipient, cytoductants, and donors on YPD, YPGlycerol (YPG) 
to show successful cytoduction of recipients, SD-Ade to show transfer of [PSI+], and 5-FOA to score for loss of the 
RTF1/URA3 plasmid. Plates were incubated at 30oC for 2-6 days. (B) Cytoductants from (A) were transformed with 
a HIS3-marked pCUP1-SUP35NM-GFP or pCUP1-RNQ1-GFP plasmid, patched on selective plates containing 100 
µM CuSO4, and incubated in the dark at 30oC before live cell imaging was performed by confocal microscopy. 
Observations were made of at least three transformants per strain and 100 cells per transformant. Representative 
images are shown. No variability was seen among cells with respect to the GFP pattern. 
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3.3.6 Synthetic lethality is due in part to [PSI+]-mediated nonsense suppression 
To investigate if the lethal effect of [PSI+] on rtf1Δ rkr1Δ double mutants is due to the presence 
of a prion or to a reduction in Sup35 function, I introduced the sup35-Y351C mutation into our 
genetic background and asked whether this mutation could inhibit the growth of rtf1Δ rkr1Δ [psi] 
double mutants. The sup35-Y351C mutation was previously shown to increase read-through of 
stop codons (BRADLEY et al. 2003) and impair the growth of a rkr1Δ strain (BENGTSON and 
JOAZEIRO 2010). Interestingly, rtf1Δ rkr1Δ sup35-Y351C [psi-] strains grew more slowly than 
rtf1Δ rkr1Δ SUP35 [psi-] cells (Figure 20). The increased nonsense suppression due to sup35-
Y351C did not fully recapitulate the effects of [PSI+] in rtf1Δ rkr1Δ strains; however, this may be 
due to the effect of the sup35-Y351C mutation in our strain background, as [PSI+] and sup35 
alleles can cause different phenotypes in different strain backgrounds (TRUE et al. 2004). 
Additionally, my results may indicate that Sup35 aggregates or additional consequences of 
[PSI+], not duplicated by the sup35-Y351C allele, contribute to the rtf1Δ rkr1Δ genetic 
interaction. Regardless, the slow growth of rtf1Δ rkr1Δ sup35-Y351C cells suggests that an 
increase in nonsense suppression plays at least a partial role in rtf1Δ rkr1Δ [PSI+] lethality. 
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Figure 20: Nonsense suppression impairs growth of rtf1Δ rkr1Δ cells 
(A) Tetrad dissections of crosses between a [psi-] rkr1Δ sup35-Y351C strain (KY2292) and a [psi-] rtf1Δ rkr1Δ 
SUP35 strain (KY2286). Dissections were done on YPD and incubated at 30oC for 2 days. Double mutant rtf1Δ 
rkr1Δ SUP35 segregants are highlighted by boxes while rtf1Δ rkr1Δ sup35-Y351C triple mutants are highlighted by 
circles. (B) A tetrad from (A) was further analyzed by five-fold serial dilution analysis on YPD and incubated at 
30oC for 1 day. Growth differences are less apparent on YPD on later days. 
 
 
 
3.3.7 [PSI+] impacts rkr1Δ phenotypes 
My results demonstrate that the presence of [PSI+] greatly affects rkr1Δ genetic interactions. To 
further assess the physiological impact of [PSI+] on these strains, I assayed the growth of rtf1Δ 
and rkr1Δ strains in the presence or absence of prions under conditions of cell stress. Both rtf1Δ 
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and rkr1Δ strains are sensitive to caffeine and cadmium chloride (Figure 21A). Interestingly, the 
CdCl2-sensitivity of rkr1Δ strains was strongly alleviated by curing prions through GuHCl 
treatment (Figure 21A). In addition, a slight ethanol sensitivity of rkr1Δ strains was detected 
only in uncured conditions. Together, these results suggest that prions influence the fitness of 
strains lacking RKR1, particularly under conditions of cell stress. I verified that [PSI+] influenced 
rkr1Δ phenotypes by transforming a rkr1Δ strain with the HSP104, URE2, and LSM4 
overexpression plasmids and measuring cadmium chloride sensitivity. Overexpressing these 
genes suppressed the sensitivity of rkr1Δ cells to cadmium chloride, similar to the effects seen in 
a cured strain obtained by passage on GuHCl (Figure 21A and 21B). Additionally, I tested the 
effect of the sup35-Y351C mutation on the phenotype of a rkr1Δ [psi-] strain and found that it 
causes sensitivity to cadmium chloride, as seen for rkr1Δ [PSI+] cells (Figure 21A and 21C). 
This result demonstrates that [PSI+]-mediated nonsense suppression causes this rkr1Δ phenotype 
and affects the fitness of strains lacking RKR1. 
While the curing of prions did not suppress the caffeine sensitivity of rkr1Δ strains, it did 
partially suppress the caffeine sensitivity of an rtf1Δ strain (Figure 21A). Interestingly, double 
mutant rtf1Δ rkr1Δ strains obtained by dissection onto medium containing GuHCl were more 
sensitive to caffeine than either cured single mutant strain (Figure 21A). These data demonstrate 
that RTF1 and RKR1 are both required for cell viability under certain growth conditions even in 
the absence of prions. These results also correlate with our observation that a residual growth 
defect is apparent for GuHCl-treated rkr1Δ htb1-K123R double mutants compared to GuHCl-
treated RKR1 htb1-K123R strains (Figure 16C). 
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Figure 21: The presence of [PSI+] affects rkr1Δ phenotypes 
(A) Wild type (KY761), rtf1Δ (KY2211), and rkr1Δ (KY2236) strains, or these strains first passaged onto YPD + 5 
mM GuHCl, as well as an rtf1Δ rkr1Δ [psi-] strain (KY2209) were used for dilution growth assays on YPD or YPD 
containing 50 µM CdCl2, 10% EtOH, 15 mM caffeine, or 0.8 µg/ml cycloheximide and incubated at 30oC for 2 to 6 
days. PRION+ indicates uncured cells; prion- indicates cells passaged on medium containing GuHCl. (B) A rkr1Δ 
strain (KY2236) was transformed with 2µ TRP1-marked pGPD-HSP104, pGPD-URE2, pGPD-LSM4, or empty 
vector (pRS424). Five-fold serial dilution analysis of these transformants was performed on SC-W or SC-W 
containing 50 µM CdCl2 and incubated 30oC for 3 days. (C) rkr1Δ (KY2309) and rkr1Δ sup35-Y351C (KY2306) 
strains were used for ten-fold dilution analysis on YPD and YPD containing 50 µM CdCl2 and incubated at 30oC for 
3 days.  
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Figure 22: An H2B K123R mutant strain is sensitive to cycloheximide but does not exhibit increased 
expression of a nonstop reporter. 
(A) HTB1 (KY2043) and htb1-K123R (KY2044) strains were grown to saturation and diluted to 3 x 108 cells/ml. 
Ten-fold serial dilutions were performed on YPD or YPD containing 0.8 µg/ml cycloheximide (CHX) and incubated 
at 30oC for 2 or 6 days, respectively. (B) HTB1 (KY2043) and htb1-K123R (KY2044) strains were transformed with 
a LEU2-marked plasmid containing a his3 nonstop reporter. Strains were then grown to saturation and diluted to 1 x 
108 cells/ml. Ten-fold serial dilutions were performed on SC-L or SC-L-H and plates were incubated at 30oC for 3 
days. 
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3.3.8 rtf1Δ suppresses the elevated levels of nonstop proteins in rkr1Δ cells 
In my phenotypic analyses, I found that rkr1Δ mutants are sensitive to cycloheximide (CHX) 
(Figure 21A). Furthermore, the RKR1 genetic interactors, rtf1Δ and htb1-K123R, also confer 
sensitivity to CHX (Figure 21A and 22A), and this phenotype is not rescued by clearing cells of 
prions (Figure 21C). CHX inhibits ribosome translocation during protein synthesis (SCHNEIDER-
POETSCH et al. 2010) as well as the decay of nonsense and nonstop mRNA (reviewed 
in(WAGNER and LYKKE-ANDERSEN 2002)) (FRISCHMEYER et al. 2002). Therefore, the CHX-
sensitivity of cells lacking Rkr1 or Rtf1 may indicate a requirement for these proteins under 
conditions of impaired translation and/or mRNA quality control.  
In previous studies, cells lacking Rkr1 exhibited an increase in nonstop protein levels 
without affecting the levels of nonstop mRNA (BENGTSON and JOAZEIRO 2010; WILSON et al. 
2007). As the prion form of Sup35, [PSI+] results in suppression of nonsense codons in nonsense 
mRNAs as well as read-through of normal stop codons (PAUSHKIN et al. 1996; WILSON et al. 
2005). Rkr1 has been reported to interact with ribosomes and be localized in the cytoplasm, 
where it is then necessary for nonstop protein degradation (BENGTSON and JOAZEIRO 2010; 
FLEISCHER et al. 2006). Because our previous studies indicated nuclear localization of Rkr1 
(BRAUN et al. 2007), I decided to re-examine the localization of Rkr1 using different strains, an 
N-terminally tagged HA-Rkr1 construct, and better visualization using confocal microscopy. 
Here, I found that Rkr1 is predominantly, though not exclusively, cytoplasmic, thus supporting 
its role in nonstop protein degradation in our strains (Figure 23).  
Given the role of Rkr1 in degrading nonstop proteins and the role of [PSI+] in generating 
nonstop proteins, I hypothesized that the lethality of rtf1Δ rkr1Δ [PSI+] cells might be due to an 
overabundance of these proteins. To test this idea and examine if RTF1 plays a role in regulating 
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nonstop protein levels, I used a nonstop reporter plasmid containing the HIS3 gene without a stop 
codon (WILSON et al. 2007). Because wild type cells carrying the reporter efficiently degrade the 
his3 nonstop transcript and protein, they fail to grow on media lacking histidine (WILSON et al. 
2007). However, cells lacking RKR1 are unable to degrade the His3 nonstop protein, and 
therefore grow on media lacking histidine (Figure 24A) (WILSON et al. 2007). Cells lacking 
RTF1 alone did not exhibit a his3 nonstop phenotype in the presence or absence of prions (Figure 
24A). Interestingly, however, absence of the histone H2A variant Htz1, which was previously 
shown to increase nonstop transcript levels (WILSON et al. 2007), only exhibited a his3 nonstop 
phenotype in [PSI+] conditions (Figure 24A). This result indicates that Sup35 aggregation 
exacerbates the nonstop phenotype in some strains, though not detectably in rkr1Δ strains by this 
assay. As for rtf1Δ cells, I did not observe a his3 nonstop phenotype for H2B K123R strains, 
suggesting that loss of H2B ubiquitylation does not cause an increase in nonstop RNA or protein 
levels as measured by this reporter (Figure 22B).  
To test if deletion of RTF1 and RKR1 additively elevate nonstop protein levels, we 
measured expression of the his3 nonstop reporter in viable, cured rtf1Δ rkr1Δ strains. 
Surprisingly, deletion of RTF1 suppressed the his3 nonstop phenotype of a rkr1Δ mutant, as 
indicated by reduced growth on –His medium (Figure 24B). I confirmed this result using a 
second nonstop reporter in which the Protein A gene lacks a stop codon (WILSON et al. 2007). 
Total Protein A levels were measured by western analysis (Figure 24C). Using this assay, I 
observed that the curing of prions caused a decrease in nonstop Protein A levels in the rkr1Δ 
strain (Figure 24C). Also, in agreement with results obtained with the his3 nonstop reporter, 
rtf1Δ rkr1Δ double mutants had reduced nonstop Protein A levels compared to rkr1Δ cells 
 117 
(Figure 24C). These results argue against a simple model in which a combinatorial increase in 
nonstop protein levels causes rtf1Δ rkr1Δ synthetic growth defects. 
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Figure 23: Localization of HA-Rkr1 is predominantly cytoplasmic.  
(KY2289) was transformed with either an HA-RKR1 (pMB11) or untagged RKR1 (pPC65) plasmid and grown to 
mid log phase before fixation and incubation with anti-HA antibody primary (Roche) and Alexa Red 647 secondary 
(Molecular Probes). Cells were mounted with ProLong DAPI stain (Invitrogen) and visualized using confocal 
microscopy. 
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Figure 24: rtf1Δ rkr1Δ strains exhibit a decrease in nonstop reporter proteins 
(A and B) WT (KY1030), rtf1Δ (KY564), rkr1Δ (KY2202), rtf1Δ rkr1Δ (KY2210), and htz1Δ (KY1404) strains 
were transformed with a LEU2-marked plasmid containing a his3 nonstop reporter. Ten-fold serial dilutions were 
plated on SC-L or SC-L-H medium and incubated at 30oC for 2 or 3 days, respectively. prion- strains were generated 
prior to transformation by curing on medium containing 2.5 or 5 mM GuHCl. (C) WT (KY307), rtf1Δ (KY2211), 
rkr1Δ (KY2236), and rtf1Δ rkr1Δ (KY2209) were transformed with a URA3-marked plasmid containing a protein A 
nonstop reporter and grown to early log phase in SC-U containing 2% galactose.  prion- strains were generated as in 
(A). TCA extracts were analyzed by western blotting using antibodies against Protein A or G6PDH, which served as 
a loading control.  PRION+ indicates uncured cells; prion- indicates passage on medium containing GuHCl. 
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3.4 DISCUSSION 
I investigated the genetic relationship between the Paf1c subunit Rtf1 and the ubiquitin-protein 
ligase Rkr1 to better understand the interaction between their transcription and protein quality 
control functions. A transposon mutagenesis screen for genetic suppressors of rtf1Δ rkr1Δ 
synthetic lethality identified a mutation in the gene encoding Hsp104. Further investigation into 
the suppression mechanism of an hsp104 mutation showed that rtf1∆ rkr1∆ strains are inviable 
only in the presence of [PSI+]. The overexpression, deletion, or GuHCl-mediated inactivation of 
HSP104, as well as the overexpression of the prion-coding genes URE2 and LSM4, all rescue 
rtf1∆ rkr1∆ synthetic lethality and clear cells of [PSI+]. [PSI+], the prion aggregate of Sup35, a 
translation termination factor necessary for proper stop codon recognition, results in read through 
of normal stop codons (PAUSHKIN et al. 1996; WILSON et al. 2005). In turn, Rkr1 is required for 
the efficient ubiquitylation and degradation of nonstop proteins by recognition of a poly-lysine 
tract resulting from translation through the poly(A) tail (BENGTSON and JOAZEIRO 2010). I have 
shown that [PSI+] and resulting nonsense suppression conditions exacerbate rkr1∆ phenotypes, 
suggesting that the presence of [PSI+] and excess nonstop proteins is detrimental in the absence 
of RKR1. However, it is only in the absence of Rtf1 that this increased burden on protein quality 
control machinery causes inviability.    
Improper recognition of stop codons leads to read-through of both normal and premature 
stop codons, resulting in nonstop proteins and nonsense suppression, respectively, and explaining 
the multiple phenotypic effects of [PSI+] (TRUE et al. 2004; WILSON et al. 2005). In addition, 
because degradation of many aberrant mRNAs depends on proper translation termination, the 
presence of [PSI+] also affects the degradation of these transcripts (WILSON et al. 2005). 
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Therefore, in combination, the presence of [PSI+] and the absence of RKR1 likely results in 
increased levels of nonstop proteins that cannot be efficiently recognized and degraded, as well 
as an increased burden on mRNA quality control. Though I have shown that [PSI+] influences 
the phenotypic consequences of deleting RKR1 in yeast, added stress to protein or mRNA quality 
control systems could also impact the severity of rkr1 mutations in higher eukaryotes and 
contribute to the development of diseases, such as neurodegeneration (CHU et al. 2009). 
In addition to mechanisms that recognize and degrade aberrant proteins, such as that 
involving Rkr1, several mRNA surveillance pathways also prevent the translation of erroneous 
transcripts. Two such quality control pathways are nonsense-mediated decay, which recognizes 
transcripts with premature termination codons, and nonstop decay, which recognizes transcripts 
without stop codons (reviewed in (FASKEN and CORBETT 2005)). Cells deficient in Paf1c exhibit 
transcript-specific increases or decreases in mRNAs targeted for quality control, presumably due 
to errors in RNA processing (PENHEITER et al. 2005; STRAWN et al. 2009). For example, 
mutations in yeast PAF1 result in shortened poly(A) tails as well as altered poly(A) site 
utilization, which produce substrates for mRNA surveillance pathways (MUELLER et al. 2004; 
NORDICK et al. 2008a; PENHEITER et al. 2005), and defects in hPaf1c give rise to aberrant 
transcripts, which are inefficiently processed or exported (FARBER et al. 2010; NAGAIKE et al. 
2011). In agreement with these earlier observations, I have shown that deletion of RTF1 results 
in decreased protein product from two nonstop reporters (Figure 24), presumably because the 
absence of Rtf1-dependent histone modifications leads to transcriptional alterations and/or 
effects on RNA export, stability, or translation.  
The mechanism by which Rtf1 and H2B ubiquitylation protects cells against the 
combined lethal effects of [PSI+] and rkr1∆ is not clear. My initial hypothesis was that deletion 
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of RTF1 elevates nonstop protein synthesis or stability to levels that are intolerable in [PSI+] 
rkr1∆ strains; however my nonstop reporter assays detected decreased, not increased, nonstop 
protein levels in rtf1∆ strains. Therefore, the synthetic lethality between rtf1∆ and rkr1∆ is not 
easily explained by an elevation in nonstop protein levels. An alternative explanation, based on 
the importance of Paf1c in transcription and RNA processing (reviewed in (CRISUCCI and ARNDT 
2011b; JAEHNING 2010)), is that rtf1∆ leads to a spectrum of aberrant transcripts that may impose 
stress on the cell or impair the expression of specific genes whose products play a role in RNA 
surveillance or protein quality control. These products would be especially important in cells 
lacking Rkr1 and containing [PSI+]. My observation that rtf1∆ and rkr1∆ mutants have similar 
stress-related phenotypes (Figure 22) further supports a role for both proteins in preventing the 
accumulation of quality control substrates. To address this hypothesis, RNA-seq could be used to 
identify differences in mRNA in wild type compared to rtf1Δ cells.  Finally, my data do not 
preclude the possibility that Rkr1 possesses alternate activities, which remain to be identified, 
and it is the absence of these functions that elevates the need for Paf1c and its associated histone 
modifications. Regardless of the precise mechanism, my results reveal a previously unrecognized 
requirement for a functional Paf1c and its associated histone modifications in protecting cells 
from the adverse effects of [PSI+] in the context of impaired protein quality control.  
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Table 3: S. cerevisiae strains used in Chapter 3 
 
Strain Genotype 
KY307 MATα his3Δ200 ura3-52 trp1Δ63 lys2Δ202 
KY453 MATα rtf1Δ100::URA3 his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-173R2 
KY564 MATα rtf1Δ102::ARG4 his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-173R2 arg4-12 
KY607 MATα rtf1Δ101::LEU2 his3Δ200 leu2Δ1 ura3-52 lys2-128δ 
KY761 MATα his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY958 MATα rtf1Δ101:LEU2: his3Δ200 leu2Δ1 ura3Δ0 trp1Δ63 lys2-128δ 
KY1030 MATα his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY1404 MATα htz1Δ::KanMX his3Δ200 leu2Δ0 ura3Δ0 lys2Δ0 
KY1663 MATα rtf1Δ102::ARG4 rkr1Δ::KanMX leu2Δ1 ura3-52 arg4-12 [pKA69: RTF1/URA3/C/A] 
KY2043 MATa hta2-htb2Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY2044 MATa HTA1-htb1K123R hta2-htb2Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY2202 MATa rkr1Δ::HIS3 his3Δ200 leu2Δ1 ura3-52 
KY2203 MATa hta1-htb1Δ::LEU2 hta2-htb2Δ::TRP1 his3Δ200 leu2Δ1 ura3-52 trp1Δ63 [URA3/HTA1-HTB1/C/A] 
[HIS3/HTA1-FLAG-htb1-K123R/C/A] 
KY2204 MATa hta1-htb1Δ::LEU2 hta2-htb2Δ::TRP1 rkr1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
[URA3/HTA1-HTB1/C/A] [HIS3/HTA1-FLAG-htb1-K123R/C/A] 
KY2205 MATa rtf1Δ102::ARG4 rkr1Δ::KanMX leu2Δ1 ura3-52 arg4-12 trp1Δ63 [pKA69: RTF1/URA3/C/A] 
KY2209 MATα rtf1Δ::KanMX rkr1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 [psi-] 
KY2210 MATa rtf1Δ::KanMX rkr1Δ::KanMX his3Δ200 leu2Δ1 trp1Δ63 [psi-] 
KY2211 MATα rtf1Δ::KanMX his3Δ200 leu2Δ1 ura3Δ0 trp1Δ63 
KY2236 MATα rkr1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY2286 MATα rtf1Δ101::LEU2  rkr1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 ade1-14  [psi-] 
KY2289 MATa rkr1Δ::HIS3 his3Δ200 leu2Δ1 trp1Δ63 lys2-128δ 
KY2292 MATa  rkr1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 ade1-14 [psi-] 
KY2306 MATa rkr1Δ::KanMX sup35-Y351C his3Δ200 leu2Δ1 ura3-52 trp1Δ63 ade1-14 [psi-] 
KY2309 MATa rkr1Δ::KanMX  his3Δ200 leu2Δ1 ura3-52 ade1-14 [psi-] 
L2261 MATa kar1 ura2 leu2 his [PIN+]  
L2265 MATa kar1 ura2 leu2 his [PSI+] 
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4.0  INVESTIGATIONS INTO RKR1 SUBSTRATES AND INTERACTIONS 
4.1 INTRODUCTION 
Numerous proteins are targeted for ubiquitylation in the cell, often as a prerequisite to 
degradation, but also as a part of a signaling event. The conserved 76 amino acid ubiquitin 
protein is conjugated to lysine resides on its target protein by a chain of ubiquitylation 
components. In yeast, this pathway consists of one essential E1 ubiquitin activating enzyme, 
Uba1, which links to ubiquitin through a high-energy bond. Ubiquitin is then transferred to one 
of 11 E2s, or ubiquitin conjugating enzymes. An E2 then catalyzes ubiquitylation of a substrate 
with the assistance of one of hundreds of E3s, or ubiquitin ligases, which aid in substrate 
specificity (reviewed in (HOCHSTRASSER et al. 1999)). When targeted for degradation by this 
pathway, a chain of ubiquitin is added to the substrate one at a time in a rapid and repeated 
sequence of events that makes these interactions difficult to capture, after which the protein is 
then degraded by the 26S proteasome (reviewed in (DESHAIES and JOAZEIRO 2009; 
HOCHSTRASSER et al. 1999)).  
  Global analysis studies have been conducted in several organisms to uncover protein-
protein interactions in the ubiquitin pathway (KAISER and HUANG 2005). However, given the 
transient nature of interactions necessary to degrade a substrate, these high-throughput studies 
are difficult. To identify E2-E3 interactions in humans, one group used a yeast-two hybrid screen 
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with the catalytic domains of over 30 human E2s and 250 E3 domains, confirming several 
known interactions and finding over 300 potential interactions (VAN WIJK et al. 2009). Another 
proteomic study isolated all ubiquitylated proteins in yeast and subjected them to mass 
spectrometry, identifying more than 1000 different proteins that are ubiquitylated at any given 
time (PENG et al. 2003). Deciphering the factors that are involved in the ubiquitylation of each of 
these proteins is a more arduous task.  A similar method of ubiquitin profiling isolated all 
ubiquitylated proteins in wild type yeast and in yeast cells lacking the proteasomal ubiquitin 
receptor Rpn10 to identify substrates dependent on Rpn10 for degradation (MAYOR et al. 2005). 
Another study involving yeast used a screened of 188 purified potential substrates for 
ubiquitylation by the E3 Rsp5 using a novel luminescent assay in vitro (KUS et al. 2005). The 
same group used commercially available protein microarrays to screen for additional Rsp5 
candidate substrates (GUPTA et al. 2007). However, this assay relied on the ability to optimize 
conditions using a known Rsp5 substrate, a piece of data which is not known for many of the 
hundreds of ubiquitin ligases in the cell. In addition, while these global analyses are helpful in 
identifying potential interactions, the next challenge is to verify these substrates, many of which 
are targeted for degradation, with in vivo and in vitro assays (BLOOM and PAGANO 2005).  
  RKR1 was originally identified in a screen for mutations that were synthetically lethal in 
the absence of Rtf1 of the Paf1 complex in yeast (BRAUN et al. 2007). RKR1 encodes a protein 
with a conserved N-terminal region and a RING-finger domain, which possesses in vitro 
ubiquitin ligase activity (BRAUN et al. 2007). The isolated mutation that conferred lethality in the 
context of rtf1Δ contained an early stop codon that truncated the protein before this RING 
domain. RING  (Really Interesting New Gene) domain proteins represent a class of ubiquitin 
ligases of which there are hundreds in yeast and humans (reviewed in (DESHAIES and JOAZEIRO 
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2009)). In addition, structural analyses of E2-E3 complexes have shown that this RING domain 
is an important component of ubiquitin ligase-ubiquitin conjugase binding and activation, 
indicating its essential nature in this function (DOMINGUEZ et al. 2004; ZHENG et al. 2000). 
RING E3s thus direct transfer of ubiquitin from an E2 to the substrate, an activity that is 
mechanistically different from that of HECT domain E3s, which are able to form an intermediate 
with ubiquitin to directly transfer it to its substrate (reviewed in (DESHAIES and JOAZEIRO 2009)). 
Therefore while the conserved RING domain of Rkr1 is most likely important for its E2 
interaction, the conserved N-terminal region of Rkr1 may be involved with substrate specificity.  
Rkr1 is predominantly cytoplasmic, localizes with ribosomes, and has been implicated in 
protein quality control of nonstop proteins (BENGTSON and JOAZEIRO 2010; WILSON et al. 2007). 
At the start of this project, none of this information was known and possible substrates and 
interacting partners for Rkr1 were of high interest to furthering our understanding of this protein 
and its requirement in the absence of RTF1. In this chapter, I will discuss how I used a wide 
range of techniques to find factors that interact with Rkr1 or require Rkr1 for ubiquitylation in 
yeast, including phenotypic studies, genetics, cross-linking and immunoprecipitation of Rkr1, as 
well as targeted studies of potential substrates. 
4.2 MATERIALS AND METHODS 
4.2.1 Yeast strains and growth conditions 
KY Saccharomyces cerevisiae yeast strains are isogenic with FY2, a GAL2+ derivative of S288C 
(WINSTON et al. 1995). Yeast deletion mutants, crosses, and transformants were created using 
 127 
standard protocols (AUSUBEL 1988; ROSE 1991). Yeast were grown on rich (YPD), synthetic 
complete (SC) or synthetic minimal (SD) as specified and prepared as previously described 
(ROSE 1991). Media to test growth phenotypes were was prepared as described in the figure 
legends and used for 10-fold dilution analysis with the indicated number of cells.  
4.2.2 His-Ubiquitin Assays 
This assay was performed as previously described (MURATANI et al. 2005). Briefly, strains were 
transformed with plasmids expressing potential substrates (described in figure legend) and HIS-
tagged or untagged ubiquitin expressed from a copper-inducible promoter. Strains were induced 
during early log phase for four hours with 500 µM CuSO4, collected, and lysed in a denaturing 
6M guanidine-hydrochloride buffer. An equal amount of lysate (2-5 mg) was incubated with Ni-
NTA beads (Qiagen) and rotated 2 hours at RT before washing and eluting by boiling in 2X 
Sample buffer + 0.2 M imidazole and running on a 7-20% gradient gel, transferred with 
nitrocellulose, and analyzed by western analysis with anti-HIS for efficiency of 
immunoprecipitation and antibody against the tagged substrate to detect it in the 
immunoprecipitated sample.  
4.2.3 Proteasome inhibition and detection of ubiquitylation 
Strains were grown in the presence of SC+0.1% proline overnight and diluted to an OD600 of 0.5 
in fresh SC+ 0.1% proline + 0.003% SDS to allow transient permeabilization of the cell 
membrane as previously described (LIU et al. 2007). Cells were grown at 30oC for 3 hours before 
addition of MG132 (75 µM final; Sigma) or equivalent microliters of DMSO (Sigma) and grown 
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for another 30 minutes. Cells were collected and lysates were made using traditional bead 
beating methods with Buffer Ub (40 mM HEPES-NaOH pH7.5, 350 mM NaCl, 0.1% Tween-20, 
10% glycerol, 20mM NEM, 1X Protease inhibitors). Immunoprecipitations were done with 3 mg 
of protein added to anti-FLAG M2 resin (Kodak) and rotated for 2 hours at 4oC before loading 
on a 7-20% gradient gel, transferred to PVDF, and analyzed by western analysis.  
4.2.4 Cross-linking and immunoprecipitation  
Strains were grown to early log phase in SC-Trp media to select for plasmids that express RKR1 
(pPC65) or modTAP-RKR1 (pMB67), which harbors a modified TAP tag containing a FLAG-
protein A sequence. Cross-linking was performed using 1% formaldehyde for the indicated 
length of time before being quenched with a G/T buffer (3M Glycine, 20 mM Tris). Extracts 
were made using traditional bead beating methods in 1 mL SUME buffer (10 mM MOPS pH6.8, 
1% SDS, 10 mM EDTA, 1X Protease Inhibitors). For immunoprecipitation, total lysate was 
incubated with 100 µl IgG agarose (Sigma) for 2 hours and washed (50 mM NaCl, 10 mM Tris) 
and resuspended in 80 µl SUME + 0.005% Bromophenol Blue. After boiling at 100oC for 3’, 
samples were loaded onto two 8% SDS POLYACRYLAMIDE gels. One (5 µl) was used for 
western analysis to confirm immunoprecipitation. The remainder was run 1 cm into the running 
gel and the gel slices were excised, destained, and sent for sequencing in collaboration with Dr. 
Richard Gardner at the University of Washington.  
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4.2.5 Western analysis 
Western analysis was performed by standard methods using nitrocellulose membranes unless 
otherwise described. Blots probed with anti-ubiquitin antibody were first boiled in water for 5’ 
prior to blocking with 5% milk. Antibodies used include Anti-ubiquitin (1:50 Santa; Cruz). anti-
FLAG M2 (1:1000; Sigma), anti-His (1:1000; GE Healthcare), and anti-G6PDH (1:50,000; 
Sigma). Immunoreactivity was measured using chemiluminescence (Perkin-Elmer) and a 440 CF 
digital imaging station (Kodak). 
 
4.3 RESULTS 
4.3.1 The RING domain of Rkr1 is required for resistance to cycloheximide 
To better understand the function of Rkr1 in yeast, I performed a screen for phenotypes affected 
by the deletion or overexpression of RKR1. These phenotypes covered a wide range of processes, 
including cell division and signaling as well as undefined phenotypes. In yeast, these data can 
help to classify and categorize a gene, which can functionally connect it to other genes. Prior to 
this screen, Mary Braun demonstrated that rkr1Δ strains are sensitive to media lacking inositol, a 
phenotype generally connected to errors in transcription which is also seen in strains lacking 
members of the Paf1 complex (BRAUN et al. 2007). 
 Interestingly, from my extensive screen only one new phenotype for Rkr1 emerged. 
rkr1Δ strains are sensitive to media containing low levels of cycloheximide (Figure 25). I was 
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unable to complement this phenotype with a plasmid containing RKR1, which could indicate a 
secondary mutation is the cause of this phenotype or that a precise level of Rkr1 is necessary for 
cycloheximide resistance. However, I did observe this phenotype in multiple rkr1Δ strains 
(Figure 25 and data not shown). I also performed tetrad analysis of a rkr1Δ/RKR1 heterozygous 
diploid and showed that this phenotype sorted 2:2 with the absence of RKR1 (Data not shown). 
The original rkr1 isolate that is synthetically lethal with rtf1 strains contains a premature 
termination codon before the RING domain (Δ RING; Figure 25). The Rkr1 protein from this 
strain is expressed at levels similar to wild type (Mary Braun, unpublished data). This mutation 
also causes cycloheximide sensitivity, indicating that cycloheximide resistance is dependent on 
the RING domain of Rkr1 (Figure 25).  
Though the reason for this phenotype is not entirely clear, there is a connection between 
cycloheximide and aberrant mRNAs that is described in Chapter 3 of this thesis. Alternatively, 
cycloheximide sensitivity could indicate ubiquitin depletion in rkr1Δ strains (HANNA et al. 
2003). However, I have not observed a decrease in total ubiquitin in any experiment with rkr1Δ 
cellular lysates (data not shown).  Interestingly, I have also shown in Chapter 3 that deletion of 
RTF1 and substitution of the H2B ubiquitylation site results in cycloheximide sensitivity, 
indicating that this phenotype is paralleled in rkr1Δ genetic interactors. However, deletion of 
SAN1, a RING finger ubiquitin ligase involved in quality control (GARDNER et al. 2005), does 
not exhibit this phenotype (data not shown). This suggests that this cycloheximide phenotype is 
not a general property of strains lacking quality control ubiquitin ligases. Although this 
phenotype does not define a function for Rkr1, I reasoned it could still help me identify other 
proteins that worked with Rkr1 (See Appendix for additional experiments). Therefore, using the 
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cycloheximide and inositol phenotypes as well as others, I next sought to identify additional 
players in a pathway with Rkr1. 
 
 
 
 
Figure 25: The RING domain of Rkr1 is required for cycloheximide (CHX) resistance. 
Wild type (KY1198), rkr1Δ::KanMX (MBY29), rkr1Δ::HIS3 (MBY6B), and rkr1Δ RING (SHY17) strains were 
grown to saturation and used in a 10-fold serial dilution analysis starting with 2x108 cells/ml on SC Complete or SC 
complete containing 0.8 µg/ml CHX. Plates were incubated 2 (left) or 6 days (right) at 30oC.  Both MBY29 and 
MBY6B contain clean deletions of RKR1 replaced by either a KanMX or HIS3 cassette. SHY17 was originally 
identified as the SL505 mutation, uncovered by Patrick Costa’s screen for strains that were synthetically lethal with 
rtf1Δ.  
 
 
4.3.2 Phenotypes and genetics of rkr1Δ interactions 
I hypothesized that the loss of genes that encode proteins which physically interact with Rkr1 or 
are required for its function, such as a ubiquitin conjugase (E2), would exhibit a similar 
genotypic and phenotypic profile to the loss of RKR1. Therefore, using the known phenotypes 
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and genetics of Rkr1 described above and in Chapter 3, I first screened mutations in E2 genes for 
a similar pattern of phenotypes (Figure 26 and 27). To this end, I used several E2 mutations that I 
made or obtained in our strain background, as well as several from the yeast deletion collection 
(Table 4). There are 11 E2s in S. cerevisiae, two of which are essential for viability. Anthony 
Piro introduced a temperature sensitive cdc34-2 allele in our background which I was able to use 
for these experiments. UBC1 is the second essential E2. However, at the time of these studies, 
there was no conditional allele of UBC1 to test for rkr1Δ -associated phenotypes and therefore it 
is not represented in my experiments.  
I screened these E2 mutant strains using serial dilution analysis for their ability to grow 
on medium containing cycloheximide, cadmium chloride, or caffeine, or on medium lacking 
inositol (Figure 26 and 27). All but 3 E2 mutations tested were sensitive to medium containing 
caffeine, suggesting this is a more general phenotype of these gene mutations and may not be 
useful in identifying an E2 partner for Rkr1. Because the loss of RKR1 results in accumulation in 
his3 nonstop protein from a plasmid reporter, I also transformed these strains and assayed for a 
his3 nonstop phenotype (Table 4 and Chapters 2, 3) (WILSON et al. 2007). While none of the 
mutations tested caused a his3 nonstop phenotype, several E2 mutations did reveal other 
similarities to loss of RKR1 (Summarized in Table 4). For example, a rad6Δ mutation paralleled 
a rkr1Δ strain in all other phenotypes (Figures 26 and 27, Table 4). However, because Rad6 is 
required for H2B-K123 ubiquitylation that is dependent on Rtf1, these phenotypes may also be 
mirroring this pathway (HWANG et al. 2003). In addition to rad6Δ strains, the cdc34-2 and ubc4Δ 
strains also showed similar, though not identical, phenotypes to loss of RKR1 or RTF1 (Figures 
26 and 27, Table 4). It is also important to note that loss of Rkr1 causes cadmium chloride 
sensitivity in our yeast background, but not of a rkr1Δ strain from the deletion collection (Figure 
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27). This may be due to a simple difference in yeast strain background. However, I showed in 
Chapter 3 that rkr1Δ strain are sensitive to medium containing cadmium chloride only in the 
presence of the prion [PSI+]. Therefore, this result may also indicate that the deletion collection 
strains do not contain a high level of this prion, and therefore this phenotype may not be useful 
with these strains.  
Because rtf1Δ rkr1Δ strains are inviable, I next hypothesized that loss of a different factor 
in the same pathway as Rkr1 would display the same genetics. To this end, an E2 mutation 
combined with loss of RTF1 should also be lethal. Similarly, because they are in the same 
pathway, the combination of this E2 mutation and loss of RKR1 would most likely not have a 
genetic interaction (Figure 4). To address this hypothesis, I performed tetrad analysis between 
rkr1Δ or rtf1Δ strains with rad6Δ, cdc34-2, ubc4Δ, or ubc5Δ strains. However, no genetic 
interactions were observed in any of these crosses (Summarized in Table 4).  
A study of human E2 and RING E3 interactions using a yeast two-hybrid screen 
identified hundreds of potential interactions between E2-E3 partners. Interestingly, this study 
found that human Ubc4 and Ubc5 physically interacted with the RING domain of human Rkr1 
(VAN WIJK et al. 2009). Ubc4 and Ubc5 are considered at least partially redundant E2s within 
yeast, and the double mutation of these genes is either very sick or lethal (SEUFERT and JENTSCH 
1990; STOLL et al. 2011). While loss of UBC4 exhibited some phenotypes similar to loss of 
RKR1, the deletion of UBC5 was not identical in phenotypes to the deletion of UBC4, suggesting 
these two genes have some non-overlapping roles in yeast (Figure 26, 27 and Table 4).  Because 
both strains initially used in my analysis were obtained from the yeast deletion collection and 
hence are different strain background which may have different phenotypic consequences, I next 
introduced a ubc4Δ mutation in our strain background to perform additional studies. Again, I 
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expected the loss of the E2 partner for Rkr1 to genetically mimic the loss of RKR1. However, I 
did not find that deletion of ubc4Δ caused sickness in the absence of RTF1 (data not shown). 
Therefore, while a physical interaction may still exist between Ubc4 and Rkr1, or even between 
Rkr1 and Ubc5, Rad6, or Cdc34, my data on E2-Rkr1 interactions in yeast would suggest that 
Rkr1 may have multiple partners in the cell necessary for its function.  
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Figure 26: Some E2 mutants display inositol or cycloheximide sensitivity phenotypes. 
Strains obtained from the yeast deletion collection are denoted as (D). (A) Wild type (OY8), rad6∆ (KY931), rkr1∆ 
(MBY36), bre1∆ (KY961), rtf1∆ (ECY1), cdc34-2 (KY1363), ubc4∆ (OKA196), ubc5∆ (OKA197), ubc6∆ 
(KY1606), ubc7∆ (OKA201), ubc8∆ (OKA198), ubc10∆ (OKA125), ubc11∆ (OKA199), and ubc13∆ (OKA200) 
strains were grown to saturation and used in a 10-fold dilution analysis starting with 1x108 cell/ml on SD or SD – 
inositol. Plates were incubated 2 or 3 days at 30oC.   (B) Wild type (OY8), rad6∆ (KY931), rkr1∆ (MBY168), 
cdc34-2 (KY1363), ubc4∆ (OKA196), ubc5∆ (OKA197), ubc6∆ (KY1606), ubc7∆ (OKA201), ubc8∆ (OKA198), 
ubc10∆ (OKA125), ubc11∆ (OKA199), and ubc13∆ (OKA200) strains were grown to saturation and used in a 10-
fold dilution analysis starting with 3x108 cell/ml on YPD or YPD containing 0.8 µg/ml CHX. Plates were incubated 
2 or 6 days at 30oC.   
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Figure 27: Some E2 mutants are unable to grow on media containing Cadmium Chloride or 
Caffeine. 
The top panel of this figure represents strains from the deletion collection denoted as (D). All other strains are from 
the KY background. Wild type (D) (OY8), ubc4∆ (D) (OKA124), ubc5∆ (D) (OKA197), ubc7∆ (D) (OKA201), 
ubc8∆ (D) (OKA198), ubc10∆ (D) (OKA125), ubc11∆ (D) (OKA199), ubc13∆ (D) (OKA200), rkr1∆ (D) (in 
collection), wild type (KY665) rkr1∆ (SHY17), rad6∆ (BT132), cdc34-2 (KY1363), and ubc6∆ (KY1607) strains 
were grown to saturation and used in a 10-fold dilution analysis starting with 1x108 cell/ml on YPD or YPD 
containing 50 µM CdCl2 or 15 mM Caffeine. Plates were incubated 2 or 3 days at 30oC.   
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4.3.3 In vivo cross-linking and immunoprecipitation of Rkr1 to identify potential 
substrates and interactions 
My genetic studies did not identify any one single E2 functionally interacting with Rkr1 in yeast, 
suggesting that Rkr1 could interact with multiple E2s within the cell. Due to its role in quality 
control, Rkr1 could also be involved in the degradation of specific proteins or a class of proteins, 
and could interact with multiple ubiquitin or proteasome components to accomplish this 
function. Any or all of these interactions may also be transient. Therefore, to identify possible 
substrates, partners, or interactors, and to give further insight into the function of Rkr1, I tried 
multiple methods of immunoprecipitation for Rkr1 to identify these interactions. This included a 
traditional TAP purification, as well as cross-linking and immunoprecipitation of HA-Rkr1 (data 
not shown). However, none of these methods revealed any detectable interactions for Rkr1 by 
silver-staining. 
Dr. Richard Gardner (University of Washington) developed a method for identifying 
protein-protein interactions using cross-linking of cells with formaldehyde followed by 
quantitative mass-spectrometry of the total immunoprecipitated sample, rather than identification 
of proteins by visible bands on a silver-stained gel. This method was successfully used to 
confirm a substrate for the quality control ubiquitin ligase San1 (ROSENBAUM et al. 2011). 
Partnering with Dr. Gardner, I performed similar cross-linking using formaldehyde and a strain 
expressing either a FLAG-Protein-A-Rkr1 (modTAP-Rkr1) or untagged Rkr1 construct and 
followed with an immunoprecipitation of Rkr1 using IgG agarose. I first verified that Rkr1 could 
be detectably cross-linked to some cellular proteins following treatment with formaldehyde for 
varying amounts of time. This was indicated by a supershift in the size of Rkr1 using western 
analysis (Figure 28A). Next, I performed multiple cross-linking and immunoprecpitations of 
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modTAP- or untagged-Rkr1. Of these samples, a portion was checked for western analysis to 
verify the immunoprecipitation (Figure 28B). The remaining sample was run 1 cm into a 7.5% 
SDS POLYACRYLAMIDE gel in duplicate technical replicates of tagged or untagged lysate. I 
excised the gel slices containing protein and sent to Dr. Gardner them for further analysis by 
quantitative mass-spectrometry. This experiment was performed to this step in duplicate. A table 
of the top hits from one of these experiments is shown in Table 5. 
As expected, of the proteins detected by mass-spectrometry, Rkr1 was the most abundant 
when comparing tagged with untagged samples. Dr. Gardner cross-referenced these results with 
results obtained from his experiments with San1 and Ubp10 (examples indicated in gray in Table 
5) to identify proteins that had specific interactions with Rkr1 (indicated in white) with over 2-
fold ratio of peptides identified from tagged vs. untagged Rkr1 samples. However, there was no 
consistency in top hits between the two duplicate experiments. Interestingly, many of the 
proteins obtained were ribosomal proteins. Rkr1 has been shown to purify with ribosomes in 
yeast, which would explain our results (BENGTSON and JOAZEIRO 2010). Although these 
experiments did not indicate any specific targets or interacting partners for Rkr1, the non-
reproducible results do reinforce an important piece of information about Rkr1, in that Rkr1 is 
involved in quality control and therefore may not be expected to associate specifically and 
reproducibly with proteins.  
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Figure 28: Cross-linking and immunoprecipitation of modTAP-Rkr1. 
 (A) rkr1Δ strains (MBY36) transformed with RKR1/TRP1 (pPC65) or modTAP-RKR1/TRP1 (pMB67) plasmids 
were grown to early log phase and fixed with 1% formaldehyde for the indicated amount of time before quenching. 
Extracts were made in SUME buffer and run on an 8% SDS POLYACRYLAMIDE gel before transfer to 
nitrocellulose. Western analysis to detect super-shifted and cross-linked Rkr1 was done with anti-FLAG antibody. 
(B) Extracts prepared as in (A) but cross-linked for 8 minutes before quenching were subjected to 
immunoprecipitation using IgG beads. A portion of this sample was analyzed by western analysis with anti-FLAG 
as in (A) to confirm immunoprecipitation, while the remainder of the sample was run on an 8% SDS 
POLYACRYLAMIDE gel 1 cm into the stacking and excised for quantitative mass-spectrometry. 
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4.3.4 Rkr1 is required for Htz1 ubiquitylation, but only when HTZ1 is FLAG-tagged and 
overexpressed 
In this chapter, I have so far described several approaches I have used to find partners and 
substrates for Rkr1.  In addition to these methods, I have also used a targeted approach to 
investigate potential Rkr1 substrates as indicated by genetic interactions. The substrate that I 
investigated to the greatest degree was the histone H2A variant, Htz1.  
In collaboration with Dr. Nevan Krogan at UCSF, we performed an Epistatic Miniarray 
Analysis (E-MAP) of a rkr1Δ strain (COLLINS et al. 2007). E-MAP analyzes the genetic 
interaction profiles of many genes to identify functional groups. This provided a genetic 
“profile” for rkr1∆, which could then be compared to other known genetic profiles. Often, 
similar genetic profiles indicate genes that work in similar pathways, such as an enzyme and its 
substrate. Interestingly, rkr1∆  had a similar genetic profile to loss of HTZ1, which encodes a 
histone variant of H2A, as well as members of the Swr1 complex which catalyze the ATP-
dependent exchange of Htz1 for canonical H2A (MIZUGUCHI et al. 2004). These results 
prompted experiments by Elia Crisucci and Mary Braun in our lab, who found that Rkr1 was 
required for the full ubiquitylation of FLAG-Htz1 when FLAG-Htz1 was overexpressed from a 
plasmid, suggesting that it may be a substrate for Rkr1 ubiquitin ligase activity. To test the 
specificity of Rkr1 for this ubiquitylation event, I asked if FLAG-Htz1 ubiquitylation required 
Bre1, another RING finger ubiquitin ligase with connections to chromatin (HWANG et al. 2003). 
Bre1 mediates H2B K123 ubiquitylation with the ubiquitin conjugase Rad6, a process which is 
dependent on Rtf1 of the Paf1 complex (WARNER et al. 2007; WOOD et al. 2003a; WOOD et al. 
2003b).  
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   FLAG-Htz1 was overexpressed in wild type, rkr1Δ and bre1Δ strains with a copper-
inducible HIS-tagged or untagged ubiquitin plasmid. Proteins that were modified by HIS-Ub 
were immunoprecipitated from lysates made in denaturing conditions and the 
immunoprecipitated material was analyzed by western blotting for the presence of FLAG-Htz1. 
As expected from previous studies in the lab (Mary Braun and Elia Crisucci, unpublished data), 
rkr1Δ strains had decreased levels of FLAG-Htz1 in the ubiquitylated fraction of the cell lysate 
compared to wild type cells. However, loss of BRE1 did not affect these levels of FLAG-Htz1 
ubiquitylation (Figure 29). Although multiple ubiquitin ligases could be involved in targeting 
Htz1 for ubiquitylation when overexpressed, this result indicates that there is specificity to this 
assay and that not all RING finger ubiquitin ligases functionally or genetically linked to 
transcription are required for the quality control of Htz1.  
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Figure 29: Rkr1 is specifically required for wild type levels of FLAG-Htz1 ubiquitylation when 
FLAG-HTZ1 is overexpressed. 
Wild type (KY306), rkr1Δ (MBY168), or bre1Δ (KY969) strains were transformed with a 2µ plasmid expressing 
FLAG-Htz1 (pMB82, LEU2) or empty vector (pRS425, LEU2) and either a 2µ plasmid containing HIS-Ubiquitin 
(pUB221, URA3/TRP1) or untagged ubiquitin (pUB175, URA3/TRP1) on a copper-inducible promoter. Strains 
were grown to early log phase in SC-Leu-Trp and were induced for 4 hours with 500 µM CuSO4. Extracts were 
made using a denaturing buffer. Immunoprecipitation of all HIS-tagged ubiquitylated proteins was done using Ni-
NTA agarose and these samples were run on a 7-20% gradient gel for western analysis with anti-FLAG M2 to detect 
Htz1 or anti-HIS to assess the efficiency of the immunoprecipitation.  
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4.3.5 Endogenous FLAG-Htz1 is not detectably ubiquitylated 
We have shown that Rkr1 is required for the ubiquitylation of overexpressed FLAG-Htz1. 
Unlike monoubiquitylation, which is often associated with signaling, polyubiquitylation of Htz1 
most likely indicates targeting for degradation and quality control (reviewed in (WEISSMAN 
2001).  Interestingly, the overexpression of HTZ1 has been documented in breast cancer cells 
(HUA et al. 2008). However, the loss of another Paf1 complex member, PAF1, does not increase 
levels of HTZ1 by microarray analysis (Elia Crisucci, unpublished results). Therefore, rtf1Δ 
rkr1Δ synthetic lethality is not easily explained by an aberrant increase in this histone variant. 
 It remained possible that an excess of Htz1 in the absence of RTF1 could have lethal 
transcriptional consequences, so I next wanted to investigate if Rkr1 was important to the 
ubiquitylation of Htz1 when expressed at endogenous levels. To answer this question, HTZ1-
FLAG was expressed from the endogenous locus in wild type and rkr1Δ cells.  Strains were 
grown in the presence of the proteasome inhibitor MG132 to prevent protein degradation, and 
lysates were made in buffers containing a deubiquitinase inhibitor and protease inhibitors (LIU et 
al. 2007). A wild type strain expressing FLAG-HTB1 (FLAG-H2B) was used as a positive 
control for ubiquitylation. Though we know H2B is monoubiquitylated at K123 as a signal for 
downstream histone methylation events, polyubiquitylation of this protein can be detected under 
some conditions (GENG and TANSEY 2008). I then performed an immunoprecipitation using 
FLAG-M2 agarose and western analysis for the ubiquitin on Htz1-FLAG or FLAG-H2B. As 
expected, my control FLAG-H2B was polyubiquitylated, and this could be detected both in the 
presence and absence of MG132 (Figure 30B; lanes FLAG-H2B, D and M). However, I was 
unable to detect any ubiquitylation signal of Htz1 in wild type or rkr1Δ lysates when expressed 
from the endogenous locus (Figure 30B; lanes HTZ1-FLAG, M).   
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Figure 30: Endogenously expressed FLAG-Htz1 is not detectably ubiquitylated. 
(A) Wild type or rkr1Δ strains expressing FLAG (KY1483, KY1488) or untagged Htz1 (KY306, MBY37) or 
FLAG-H2B (KY1044) were grown to early log phase in SC + Proline + 0/003% SDS to allow treatment with 
MG132 (M) or DMSO (D) for 30 minutes. Lysates were made with Buffer Ub (See Material and Methods) and 
analyzed by western analysis with anti-FLAG to check histone expression or anti-G6PDH as a loading control. (B) 
Lysates made as in (A) were subject to immunoprecipitation with anti-FLAG M2 agarose before detection by 
western analysis with anti-ubiquitin or anti-FLAG M2. 
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4.3.6 Overexpressed HA-Htz1 is not ubiquitylated in  a Rkr1-dependent manner 
The result that endogenous Htz1 is not detectably ubiquitylated led me to question whether Htz1 
was a real target of Rkr1 under normal conditions, or an artifact of the overexpression system. 
When overexpressed, FLAG-Htz1 has been shown to immunoprecipitate with Rkr1, yet I was 
unable to detect a specific physical interaction between endogenously expressed Htz1 and Rkr1 
in our strains ((MIZUGUCHI et al. 2004) and data not shown). Therefore, Rkr1 may only target 
Htz1 when Htz1 is at high levels. Conversely, because Rkr1 is involved in general quality 
control of proteins, my results so far may have indicated that Htz1 is not a specific target of 
Rkr1.  
To date, nonstop proteins are the only targets of Rkr1 that have been established 
(BENGTSON and JOAZEIRO 2010; WILSON et al. 2007). Notably, Rkr1 most likely recognizes the 
poly-lysine tail of a nonstop protein which is a result of translational read-through into the 
poly(A) tail (BENGTSON and JOAZEIRO 2010). Histones are naturally lysine rich, as these residues 
are often targets of modifications such as methylation and ubiquitylation. In addition to the fact 
that Htz1 contains multiple lysines, there was a concern that the FLAG tag of Htz1, which 
contains 6 lysines per 3XFLAG sequence, could mimic a poly-lysine tail of a nonstop protein. 
FLAG tags can also be non-specific targets of ubiquitylation (Dr. Richard Gardner, personal 
communication).  Therefore, to assess if Rkr1 was targeting Htz1 specifically, or through the 
FLAG tag, Dr. Margaret Shirra created an HA-tagged 2µ construct for overexpressing Htz1. 
Using this plasmid, I used the HIS-ubiquitin immunoprecipitation assay as above to investigate 
the levels of ubiquitylation of HA-Htz1 in wild type and rkr1Δ cells. Interestingly, I found that 
while HA-Htz1 is targeted for polyubiquitylation, this event is not dependent on the presence of 
Rkr1 in yeast (Figure 31). 
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Figure 31: RKR1 is not required for HA-Htz1 ubiquitylation when HA-HTZ1 is overexpressed. 
Wild type (KY665) and rkr1Δ (SHY11) strains were transformed with HA-HTZ1 (LEU2) plasmid or empty vector 
(pRS425, LEU2) and HIS-tagged (pUB221-URA3, TRP1) or untagged ubiquitin (pUB175-URA3, TRP1) plasmids 
with a copper-inducible promoter. Strains were grown to log phase in SC-Leu-Trp and induced with 500 µM CuSO4 
for four hours. Lysates were made under denaturing conditions. Immunoprecipitations were performed against all 
ubiquitylated proteins using Ni-NTA agarose and western analysis was performed with anti-HIS to assess efficiency 
of ubiquitin immunoprecipitation or anti-HA to assess levels of ubiquitylated Htz1 in immunoprecipitation. 
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4.4 DISCUSSION 
The holy grail of investigating an E3 is identifying its interactions and targets and understanding 
its cellular role. To this end, I discussed in this chapter multiple methods I have used to detect 
substrates and partners for Rkr1-mediated ubiquitylation which have included both directed and 
global methods of analysis. Though at the time of these experiments, we were not aware of the 
role of Rkr1 in nonstop protein quality control, it is possible and likely that other Rkr1 
interactions still remain to be found. 
Using phenotypic analysis, I was able to assign new phenotypes to rkr1 mutant strains 
and use these data to explore potential interactions with Rkr1. In a genetic search for the 
ubiquitin conjugase partner or E2 for Rkr1, I found similar cycloheximide, inositol, cadmium 
chloride, and caffeine sensitivities for strains mutated in RKR1, CDC34, RAD6, and UBC4. 
Therefore, these genes may encode the most likely candidates for a Rkr1 E2 partner. In 
agreement with this conclusion, all of these E2s are found in the cytoplasm where Rkr1 is also 
predominantly localized (BENGTSON and JOAZEIRO 2010). Because Rad6 is required for 
ubiquitylation of H2B at K123, which is an Rtf1-dependent event (HWANG et al. 2003; NG et al. 
2003a; WOOD et al. 2003b), the phenotypic similarities between rad6Δ and rkr1Δ are most likely 
due to its role in a pathway parallel to Rkr1 (BRAUN et al. 2007), especially considering that loss 
of RTF1 confers the same phenotypes. While a mutation in CDC34 confers phenotypes more 
similar to loss of RKR1, Ubc4/Ubc5 have been identified as physical interactors with the human 
RING domain of Rkr1, and therefore are also very plausible candidates (VAN WIJK et al. 2009). I  
may not be able to observe rkr1Δ-related phenotypes in a ubc4Δ or ubc5Δ strain due to the partial 
redundancy of Ubc4 and Ubc5 in yeast (SEUFERT and JENTSCH 1990; STOLL et al. 2011). 
However, a strain containing mutations in both of these genes is inviable or extremely sick, and 
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therefore cannot be used for these studies. In addition, because I was unable to include it in my 
analysis, I cannot discount that the essential E2 Ubc1 is also involved in a Rkr1 interaction. The 
absence of a nonstop phenotype for any of the E2 mutants tested suggests that either none of 
these E2s interact with Rkr1, or that Rkr1 has multiple partners with which it functions.  
In addition to phenotypic analyses, I have also tried other unbiased methods to identify 
novel Rkr1 interactions and potential substrates. These methods include purification of Rkr1 and 
potential interacting proteins under cross-linking conditions. Although these methods were 
successful in identifying Rkr1 and a range of interactions, which included ribosomal proteins, 
this method did not reveal any specific or reproducible interactions that may have suggested 
specific substrates for Rkr1-dependent degradation. In fact, the results would indicate Rkr1 is 
involved broadly in quality control and does not specifically target a subset of proteins, but rather 
a class of proteins which may occur under conditions of stress such as in the absence of RTF1. 
The recent findings that Rkr1 is involved in nonstop protein quality control, as well as my results 
in earlier chapters, further support this hypothesis (BENGTSON and JOAZEIRO 2010). For future 
experiments involving this cross-linking method, I have created two additional modTAP 
constructs of Rkr1, which include a deletion of the conserved N-terminal region or RING 
domain. I have not yet used these constructs in this experiment, but they may provide additional 
clues into Rkr1 function by capturing interactions without allowing ubiquitylation and/or 
degradation of a substrate. In addition, performing these experiments in the absence of RTF1 
may provide the stress needed to enhance Rkr1-specific interactions. However, it is very likely 
that as a quality control ubiquitin ligase, if in fact Rrk1 targets a group of substrates rather than 
individual and normal proteins, then this method may only identify transient interactions 
necessary to degrade these proteins such as E2, proteasome, or ribosomal subunits and partners.  
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Additional methods of investigating a pathway for Rkr1 function included a collaboration 
with Dr. Nevan Krogan to obtain an epistatic miniarray profile (E-MAP) for rkr1Δ strains. Often, 
substrates and enzymes in these studies will exhibit a similar genetic profile. We found that 
rkr1∆ strains have a similar genetic profile to strains deleted of HTZ1 or members of the SWR1 
complex, which led us to hypothesize that Htz1 is a possible substrate for Rkr1. Htz1 as a 
potential target for Rkr1 ubiquitylation was first analyzed by Mary Braun and Elia Crisucci. 
However, I showed in this chapter that, although another RING finger ubiquitin ligase, Bre1, is 
not required for FLAG-Htz1 ubiquitylation when HTZ1 is overexpressed, Rkr1 is only required 
for targeting this protein when this protein is FLAG-tagged. This may be an artifact, resulting 
from Rkr1 recognizing the lysines in the FLAG tag as being similar to a poly-lysine tail of a 
nonstop protein (BENGTSON and JOAZEIRO 2010). Additionally, I showed that endogenous Htz1 
is not detectably ubiquitylated under conditions of proteasome inhibition.  
Our E-MAP analysis functionally clustered Rkr1 with Htz1 and the Swr1 complex. 
Interestingly, we have since learned that Htz1 also plays a modest role in regulating nonstop 
protein levels (Chapter 3 and (WILSON et al. 2007)). In the E-MAP studies, the second complex 
that displayed a genetic profile similar to that of Rkr1 was the elongator (ELP) complex, which 
has been implicated both in transcription elongation and in tRNA modification (reviewed in 
(SVEJSTRUP 2007). Although this connection could also indicate that the ELP proteins are targets 
for Rkr1 ubiquitylation, the elongator complex is also required for proper translational fidelity 
and recognition of stop codons through its role in tRNA modification (HUANG et al. 2005). 
Therefore, the E-MAP results may have been indicating the role of Rkr1 in protein quality 
control, rather than potential substrates.  
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Finding partners and substrates for a ubiquitin ligase, whose role is to degrade proteins, is 
an arduous task. To find physical interactions for Rkr1, I have used both directed and unbiased 
methods and a variety of innovative techniques and genetic approaches. However, as an E3 
involved in the degradation of aberrant proteins, Rkr1 most likely interacts transiently with a 
wide array of proteins in the cell and these interactions can be difficult to detect. Although the 
data presented here did not identify new interactions for this ubiquitin ligase, the results all show 
in an overwhelming support for Rkr1 in quality control, where new interactions most likely 
depend on the ever-changing stress conditions of the cell.  
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Table 4: Summary of E2 phenotypes and genetics 
(Strain) KY indicates strains from the Arndt lab collection. D indicates strains from the deletion collection. 
(Localization) N = Nucleus, C = Cytoplasm, ER = Endoplasmic Reticulum, P = Peroxisome. N/D = Not done. N/A 
= Not applicable. (+) indicates degree of growth while (-) indicates no growth at all. The light gray shading denotes 
reference strains for phenotypes, while the pink shading indicates E2 mutations. Studies with the essential gene 
UBC1 were not performed. 
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Table 5: Mass-Spec results from Rkr1 Cross-linking and IP 
Number of peptides displayed (Tagged or Untagged) is a summary of peptides identified from three individual 
immunoprecipitations within one experiment for either the tagged or untagged Rkr1 construct. The results were 
ranked by Tagged vs Untagged peptides and the top 20 identified proteins are shown here. Gray shading indicates 
proteins also purified with San1 and Ubp10 (considered background). Rkr1 is highlighted in teal.  
 
Protein 
TAG-
GED 
UNTAG-
GED TAG/UNTAG 
RKR1 52 0 #DIV/0! 
RPL5 8 0 #DIV/0! 
RPS23A 6 0 #DIV/0! 
TDH2 10 1 10 
IDS2 8 1 8 
TKL1 11 2 5.5 
FAS1 20 4 5 
GCD11 5 1 5 
URB1 5 1 5 
VMA1 5 1 5 
ARF1 8 2 4 
RPL10 8 2 4 
RPS2 8 2 4 
RPP0 22 6 3.6 
RPS22A 7 2 3.5 
TEF4 25 8 3.1 
ENO1 12 4 3 
GPB1 12 4 3 
RPL14B 6 2 3 
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Table 6: S. cerevisiae strains used in Chapter 4 
 
Strain Genotype 
SHY11 MAT α rkr1Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 trp1Δ63 his4-9128δ ura3-52 
SHY17 MAT a rkr1Δ::HIS3 his3Δ200 leu2Δ1 trp1Δ63 
BTY132 MAT a rad6Δ::KanMX his3Δ200 leu2Δ1 ura3Δ0  
ECY1 MAT a rtf1Δ::KanMX 
MBY6B 
MBY29 
MBY36 
MAT a rkr1-SL505 leu2Δ1 trp1Δ63 ade2 ade3 
MAT a rkr1Δ::KanMX his3Δ200 leu2Δ1 trp1Δ63 
MAT α rkr1Δ::KanMX his3Δ200 trp1Δ63 
MBY37 MAT α rkr1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
MBY168 MAT a rkr1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY306 MAT α lys2-173R2 ura3-52 leu2Δ1 trp1Δ63 
KY665 MAT α rkr1Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 trp1Δ63 his4-9128δ ura3-52 
KY931 MAT a rad6Δ::URA3 his4-912δ leu2Δ1 ura3-52 
KY969 MAT α bre1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY1044 MAT a hta1-htb1Δ::LEU2 hta2-htb2Δ::TRP1 his3Δ200 leu2Δ1 ura3-52 trp1Δ63 [pJH23= 
HIS3/HTA1-FLAG-HTB1/C/A] 
KY961 MAT α bre1Δ::KanMX his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY1483 MAT α HTZ1-FAG::KanMX lys2-173δ leu2Δ1 ura3-52 
KY1488 MAT a HTZ1-FLAG::KanMX rkr1Δ::KanMX lys2-173δ leu2Δ1 ura3-52 trp1Δ63 
KY1198 MAT α his3Δ200 leu2Δ1 trp1Δ63 
KY1363 MAT α cdc34-2 his3Δ200 leu2Δ1 ura3-52 
KY1606 MAT α ubc6Δ::KanMX his3Δ200 leu2Δ1 ura3-52 lys2-128δ trp1Δ63 ade8Δ 
KY1607 MAT a his3Δ200 leu2Δ1 ura3-52 lys2-128δ  
OY8 MAT a his3Δ1 leu2Δ0 ura3Δ met15Δ0 
OKA125 MAT a ubc10Δ::KanMX his3Δ1 leu2Δ0 ura3Δ met15Δ0 
OKA196 MAT a ubc4Δ::KanMX his3Δ1 leu2Δ0 ura3Δ met15Δ0 
OKA197 MAT a ubc5Δ::KanMX his3Δ1 leu2Δ0 ura3Δ met15Δ0 
OKA198 MAT a ubc8Δ::KanMX his3Δ1 leu2Δ0 ura3Δ met15Δ0 
OKA199 MAT a ubc11Δ::KanMX his3Δ1 leu2Δ0 ura3Δ met15Δ0 
OKA200 MAT a ubc13Δ::KanMX his3Δ1 leu2Δ0 ura3Δ met15Δ0 
OKA201 MAT a ubc7Δ::KanMX his3Δ1 leu2Δ0 ura3Δ met15Δ0 
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5.0  CONCLUSIONS AND FUTURE DIRECTIONS 
Rkr1 is a ubiquitin ligase required for the ubiquitylation and degradation of nonstop proteins, 
which arise from translational read-through of normal stop codons or from translation of nonstop 
mRNAs that lack stop codons (BENGTSON and JOAZEIRO 2010; WILSON et al. 2007). Both these 
mRNAs and the resulting proteins are normally targets of quality control. Rkr1 was first 
identified and characterized following a genetic screen for genes that were essential in the 
absence of the transcription elongation factor, Rtf1 (BRAUN et al. 2007). As a member of the 
Paf1 complex, Rtf1 accompanies RNA Pol II across actively transcribed open reading frames 
(MAYER et al. 2010). Rtf1 is also required for H2B ubiquitylation on K123, a conserved 
modification whose correct patterning is important to both the activation and repression of 
several genes (NG et al. 2003a; TOMSON et al. 2011; WARNER et al. 2007; WOOD et al. 2003b). 
Interestingly, Rkr1 is required in the absence of this specific Rtf1 function, connecting the 
pathways of histone modification to protein quality control (BRAUN et al. 2007). 
5.1 MUTATIONS THAT SUPPRESS SYNTHETIC LETHALITY BETWEEN 
DELETIONS OF RTF1 AND RKR1 
To better understand the requirement for Rkr1 in the absence of Rtf1-mediated H2B 
ubiquitylation, I performed a screen to identify suppressors of rtf1Δ rkr1Δ synthetic lethality 
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using a LEU2-marked transposon mutagenesis library (KUMAR et al. 2000). Suppressors of rtf1Δ 
rkr1Δ synthetic lethality could function in several ways. For example, synthetic lethality in rtf1Δ 
rkr1Δ strains could be due to a buildup in one Rkr1 substrate. In this case, mutation of the gene 
encoding this substrate could rescue lethality in these strains by decreasing substrate levels. 
Alternatively, mutations identified by this screen could result in suppression of a rtf1Δ or rkr1Δ-
specific defect in these cells. I screened over 15,000 transformants, originally identifying over 50 
candidates that were further analyzed for their ability to rescue lethality as a result of a single 
transposon insertion. This resulted in 15 candidates that were used in a backcross to verify that 
no additional mutation was present that could suppress rtf1Δ rkr1Δ synthetic lethality 
independent of the LEU2-marked transposon. Three transformants all passed this criteria, and the 
transposon insertions were mapped using plasmid rescue and sequencing (BURNS et al. 1994). In 
this thesis, I further characterize and describe these mutations in HSP104, CHL1, and RPC17.  
5.1.1 HSP104 
A transposon insertion in the 3’ coding region of HSP104 was able to rescue rtf1Δ rkr1Δ 
lethality. Hsp104 is required for the proper disaggregation of misfolded proteins following heat 
shock, as well as the propagation of yeast prions (reviewed in (GRIMMINGER-MARQUARDT and 
LASHUEL 2010)). Prions are insoluble and infectious protein aggregates that are inherited by 
daughter cells but can also appear de novo. Hsp104 breaks prion aggregates into smaller 
infectious particles which seed and recruit soluble protein in order to propagate the prion 
(reviewed in (GRIMMINGER-MARQUARDT and LASHUEL 2010)). It has been shown that mutations 
that disrupt the ATPase domain of Hsp104, which lies in the C-terminal region of the protein, 
impair the ability of Hsp104 to propagate prions and results in their clearance from yeast cells 
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(CHERNOFF et al. 1995; MACKAY et al. 2008). Accordingly, I have shown that the transposon 
insertion I identified from my genetic screen is able to clear cells of the prion [PSI+], an 
aggregate of the essential translation termination factor Sup35.  
Yeast have several identified and potential prions (reviewed in (CROW and LI 2011)). Of 
these prions, I confirmed that it was the presence of [PSI+] specifically that led to synthetic 
lethality between rtf1Δ and rkr1Δ using several mechanisms. Although Hsp104 is required for 
general yeast prion propagation, it has been shown that the overexpression of HSP104 can 
uniquely clear cells of [PSI+] (CHERNOFF et al. 1995). In accordance with this, I found that both 
the deletion and overexpression of HSP104 rescued rtf1Δ rkr1Δ synthetic lethality. In addition, I 
showed that inactivating Hsp104 by growing yeast in the presence of guanidine hydrochloride 
(FERREIRA et al. 2001; JUNG and MASISON 2001)  also rescued synthetic lethality. I also verified 
results from a previous genetic screen by Mary Braun to identify genes that suppressed rtf1Δ 
rkr1Δ lethality when overexpressed. In this screen, Mary Braun isolated several plasmids that 
contained multiple open reading frames. Interestingly, three genes contained on these plasmids 
were HSP104, URE2 and LSM4, which encode the yeast prions [URE3] and [LSM4], 
respectively. Prions can have both positive and negative interactions (reviewed in (DERKATCH 
and LIEBMAN 2007)), and I showed that overexpression of these prion-encoding genes caused 
clearance of [PSI+] and rescue of rtf1Δ rkr1Δ lethality. Lastly, I proved that this prion caused 
lethality between rtf1Δ and rkr1Δ by transferring [PSI+] -containing cytoplasm to viable [psi-] 
rtf1Δ rkr1Δ cells, which resulted in cell death.  
As a Sup35 aggregate, [PSI+] causes multiple phenotypes in yeast. [PSI+] cells are unable 
to efficiently recognize stop codons, resulting in translational-read through of normal stop 
codons as well as nonsense stop codons (WILSON et al. 2005). This results in proteins that are 
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now targets of quality control pathways. In addition, efficient translation termination is necessary 
to recruit degradation machinery specific for aberrant mRNAs, such as nonsense and nonstop 
mRNAs. Therefore, without sufficient soluble Sup35, there is an increase in these defective 
transcripts, presenting an additional problem in quality control for the cell (TRUE et al. 2004; 
WILSON et al. 2005). One of the consequences of [PSI+], nonstop proteins, are targets of Rkr1-
mediated ubiquitylation and degradation (BENGTSON and JOAZEIRO 2010). I showed that the 
presence of [PSI+] negatively influences rkr1Δ phenotypes and genetic interactions. In addition, 
using a sup35-Y351C mutation that mimics the nonsense suppression phenotype of [PSI+], I 
showed that it was the inability to recognize stop codons that led to the rkr1Δ phenotype of 
cadmium chloride sensitivity.  
Interestingly, however, I also observed that although the sup35-Y351C allele caused 
slight sickness in [psi-] rtf1Δ rkr1Δ cells, it did not cause synthetic lethality.  There are several 
explanations for this result. First, the mutation may not completely recapitulate nonsense 
suppression to the levels of [PSI+] in our strains. Second, there may be additional phenotypes of 
[PSI+] not mimicked by this allele, such as mRNA quality control problems, that also contribute 
to synthetic lethality. In the future, as the requirement for RTF1 in [PSI+] rkr1Δ cells is better 
understood, this explanation  may become clearer. For example, the absence of RTF1 may lead 
to additional mRNA quality control problems such as an increase in improperly processed 
transcripts. Alternatively, the loss of RTF1 may cause a decrease in transcript levels for proteins 
that are necessary to combat the excess problems in quality control in [PSI+] rkr1Δ strains. 
Lastly, the presence of cellular protein aggregates such as [PSI+] may present a physical quality 
control problem to these cells. However, because the presence of other prions, such as [PIN+], 
does not induce rtf1Δ rkr1Δ synthetic lethality, this is a less likely scenario.   
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Given my results, it may also be beneficial to isolate and characterize the remaining 12 
transposon insertion mutations I originally identified from my screen. I initially put these 
mutations aside, because I saw spontaneous growth of rtf1Δ rkr1Δ spores without linkage to the 
transposon insertion in the final genetic cross. However, in the process of confirming the role of 
the non-Mendelian genetic element [PSI+] in rtf1Δ rkr1Δ synthetic lethality, I have observed 
several instances of rtf1Δ rkr1Δ viability, particularly during tetrad analysis. I have not correlated 
this viability with the presence or absence of [PSI+], but I find this result varies with the strains 
used for the genetic cross. Levels of [PSI+] within strains can vary in strength, and therefore it is 
very possible that loss of [PSI+] in a spore during meiosis could result in viability when rtf1Δ and 
rkr1Δ co-segregate. In addition, I have shown that diploids heterozygous for hsp104Δ are able to 
rescue rtf1Δ rkr1Δ synthetic lethality, even without co-segregation of hsp104Δ with rtf1Δ rkr1Δ, 
suggesting that hsp104Δ is a dominant suppressor. For these reasons, the 12 transposon 
insertions that I did not further investigate could prove to have valid suppressors as well. 
5.1.2 CHL1 
Another genetic suppressor of rtf1Δ rkr1Δ synthetic lethality that I describe in this thesis is 
mutation in the sister chromatid cohesion gene CHL1. Chl1 in yeast is a putative DNA helicase 
required for proper sister chromatid cohesion during S phase and proper chromosome 
segregation during meiosis II (MAYER et al. 2004; PETRONCZKI et al. 2004; S 2000). Deletion of 
CHL1 suppresses a maml1Δ defect in kinetochore attachment by compromising sister chromatid 
cohesion and allowing successful meiotic division (PETRONCZKI et al. 2004). Chl1 has also been 
implicated in telomeric silencing and rDNA recombination (DAS and SINHA 2005). Loss of 
CHL1 causes DNA damage and replication phenotypes (LAHA et al. 2011; LAHA et al. 2006).  
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At this time, it is unclear why a chl1 mutation rescues rtf1Δ rkr1Δ synthetic lethality. I 
have shown that this is not due to the clearance of [PSI+], and therefore this suppression 
mechanism is different than that of an hsp104 mutation. When I was further exploring the effect 
of rtf1Δ on nonstop protein synthesis in cells, I found that it decreased the levels of these 
proteins. Although the mechanism of this is not currently known, I did show that deletion of 
CHL1 opposed this rtf1Δ defect. In addition, the loss of RTF1 causes a decrease in the levels of 
expression from the nonsense allele ade1-14 (STRAWN et al. 2009). I show in my studies that a 
chl1 mutation opposes this defect as well, partially suppressing this phenotype and causing an 
increase in Ade1 protein. These results provide an avenue for further study of this newly 
identified connection between Rtf1 and Chl1.  
Given that chl1Δ, a suppressor of rtf1Δ rkr1Δ synthetic lethality, opposes rtf1Δ-specific 
phenotypes, I hypothesize that it rescues lethality by suppressing an rtf1Δ defect rather than a 
defect in rkr1Δ. The loss of RTF1 is most likely affecting levels of nonsense and nonstop 
reporter proteins at the level of transcription or processing, which could have negative 
consequences on export, stability, or translatability of the transcript. I have used the Protein A 
nonstop reporter to measure levels of nonstop mRNA in multiple strains using northern analysis, 
but this reporter is on a high-copy number plasmid and the levels of expression vary widely even 
in wild type strains. Therefore, it still remains to be identified whether rtf1Δ affects nonstop 
transcript levels.  Interestingly, it has been shown that Ctr9 of Paf1c is required for proper 
poly(A) site usage of the ade1-14 transcript (STRAWN et al. 2009). In the future, it would be 
interesting to validate this result in rtf1Δ strains, and to see if the absence of CHL1 suppresses 
this result by correcting the poly(A) site. It is possible that by choosing an earlier or later poly(A) 
site for cleavage, the loss of RTF1 could actually create new nonstop or nonsense targets that 
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cannot be appreciated by the reporters I’ve used thus far. These aberrant mRNAs could lead to 
quality control problems that would be detrimental in [PSI+] rkr1Δ cells. The most effective way 
to analyze this problem would be a genome-wide or targeted analysis of poly(A) sites in rtf1Δ 
cells, possibly by enriching for nonsense and nonstop transcripts using a upf1Δ or ski7Δ 
background, respectively. Candidate genes affected in this manner by loss of RTF1 could then be 
tested for suppression by loss of CHL1. Rkr1 is required in the absence of Rtf1, Xrn1, and Spt10 
(This thesis) (BRAUN et al. 2007). Therefore, the types of transcripts that are improperly 
processed or mis-regulated by loss of RTF1 may be further clarified or identified by comparing 
microarray data from wild type, rtf1Δ, xrn1Δ, and spt10Δ cells.  
Chl1 is required for proper sister chromatid cohesion (SCC) (MAYER et al. 2004). 
Interestingly, Rtf1-mediated H2B ubiquitylation is required for methylation of the kinetochore 
protein Dam1 by the H3 K4 methyltransferase Set1 (LATHAM et al. 2011; ZHANG et al. 2005b), a 
process which could also affect sister chromatid cohesion. Dam1 methylation inhibits Dam1 
phosphorylation by Aurora B/Ipl1 (ZHANG et al. 2005b). Lower levels of Dam1 phosphorylation 
cause defects in chromosome segregation (CHEESEMAN et al. 2002). Interestingly, loss of SCC 
causes an increase in Dam1 phosphorylation. Although the effects of this extended 
phosphorylation are not clear, it may be important to kinetochore detachment (KEATING et al. 
2009). Therefore, it would also be interesting to analyze the role of Rtf1 in Chl1-related defects, 
such as SCC.  The specific role for Chl1 in SCC is not currently known. However, one 
hypothesis might be that it is required to recognize an event downstream from H2B 
ubiquitylation necessary for SCC. In the absence of RTF1, H2B K123 ubiquitylation and Dam1 
methylation does not occur (LATHAM et al. 2011; ZHANG et al. 2005b). The loss of CHL1 might 
bypass this requirement for Dam1 methylation, leading to suppression of these rtf1Δ-specific 
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defects. Alternatively, a chl1Δ mutation may suppress the rtf1Δ-defect and restore Dam1 
methylation. To test these hypothesizes, I would assess levels of Dam1 methylation in rtf1Δ 
chl1Δ strains compared to rtf1Δ single mutants, which lack Dam1 methylation. In addition, I 
would also test a possible role for Rtf1 in SCC. Lastly, to gather more information about the 
connection between these genes, I would test rtf1Δ chl1Δ strains for suppression of multiple 
chl1Δ or rtf1Δ phenotypes by dilution analysis. These phenotypes would include HU and MMS 
sensitivity (indications of DNA replication and damage defects), caffeine, cycloheximide, and 
caffeine (general stress), as well as benomyl (mitotic defects).  
5.1.3 RPC17 
The third genetic suppressor of rtf1Δ rkr1Δ synthetic lethality that I identified was a mutation 
within the 3’ UTR of RPC17. Like the mutation in CHL1, an rpc17 strain does not clear cells of 
[PSI+]. RPC17 is an essential gene that encodes a subunit of RNA Pol III (FERRI et al. 2000). I 
confirmed this genetic suppressor using an rpc17-DAmP allele that I obtained from Open 
Biosystems (BRESLOW et al. 2008). This allele also contains an insertion within the 3’ UTR, 
which has been shown to lower transcript levels, likely by targeting them for degradation 
(BRESLOW et al. 2008). Therefore, it is reasonable to hypothesize that lower levels of RPC17 
transcript, and hence lower levels of Rpc17 protein, result from a 3’ UTR mutation. However, 
this has yet to be confirmed. In addition, I hypothesize that the lower levels of this transcript 
cause a decrease in RNA Pol III function, possibly resulting in a decrease in tRNA levels and a 
decrease in translation efficiency.  
I have tested the ability of the rpc17 mutation to suppress multiple rtf1Δ or rkr1Δ 
phenotypes or genetics. Thus far, the only phenotype slightly suppressed by an rpc17-DAmP 
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allele is 6AU sensitivity in rtf1Δ cells (SQUAZZO et al. 2002). 6AU depletes the cellular pool of 
nucleotides, which has been argued to cause RNA Pol II stalling and transcription elongation 
defects (EXINGER and LACROUTE 1992). This suggests that loss of RNA Pol III activity might in 
some way affect RNA Pol II elongation. One possible explanation for this may be that decreased 
Pol III transcription means less use of the free nucleotide pool, and therefore more available for 
use by Pol II.  
By affecting levels of tRNAs, lower levels of RPC17 transcripts may indirectly affect 
translation. Translation may be slowed, or it may not efficiently recognize certain codons. It is 
unclear how this could rescue rtf1Δ rkr1Δ lethality. However, if rtf1Δ rkr1Δ synthetic lethality is 
caused by an increase in aberrant mRNA that creates an increase in aberrant protein that is 
unable to be degraded in the absence of RKR1, then decreased translation may ease this burden. 
To test this idea, I would first investigate if the rpc17-DAmP allele causes a decrease in tRNA 
levels. I would follow this with experiments to identify the effect of this allele on translation 
efficiency. 
Lastly, several other connections to translation have been identified in our lab. In the 
genetic screen performed by Mary Braun that identified high-copy suppressors of rtf1Δ rkr1Δ 
lethality, which led to my experiments on LSM4 and URE2, there were also multiple translation-
related genes contained on these plasmids. These included THS1, which encodes a threonyl-
tRNA synthetase, and two separate plasmids that contained tRNA(Ala) genes. These genes must 
be individually cloned into overexpression vectors to determine if they rescue rtf1Δ rkr1Δ 
synthetic lethality. In addition, in the E-MAP studies performed in collaboration with Dr. Nevan 
Krogan on rkr1Δ strains, it was determined that loss of RKR1 has a similar genetic profile to 
strains lacking Elongator subunits (Elp1-6; unpublished data). Elongator has been associated 
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with transcription elongation in yeast and human cells, and is also necessary for maintaining 
levels of the chaperone Hsp70 in mammalian cells (SUAUD et al. 2011) (reviewed in (SVEJSTRUP 
2007)). In addition, it has an established role in tRNA modification and translational fidelity 
(reviewed in (SVEJSTRUP 2007)). Given these results and the connections between Rkr1 and 
nonstop proteins, as well as prions and chaperones, it is possible that rtf1Δ or rkr1Δ strains, or 
both, are greatly influenced by changes in translation and chaperones.  
5.2 TARGETS AND PHYSICAL INTERACTIONS OF RKR1 
When Rkr1 was first characterized by our lab, it was identified by its genetic interaction with a 
transcription elongation factor (BRAUN et al. 2007). In subsequent years, it has been described by 
its role in nonstop protein quality control (BENGTSON and JOAZEIRO 2010; WILSON et al. 2007). 
During my thesis work, I sought to better understand this ubiquitin ligase and its requirement in 
the absence of RTF1 by first identifying interacting partners or substrates. By nature of its role as 
a ubiquitin ligase, most of these physical connections are most likely transient. Therefore, I tried 
immunoprecipitation of Rkr1 both in uncross-linked and cross-linked conditions to capture these 
transient interactions. However, I was unable to consistently identify any proteins from these 
methods. In light of the discovery that Rkr1 is a quality control ubiquitin ligase, this result may 
not be surprising. Not only would substrates be transiently interacting with a quality control E3 
prior to degradation, the substrates likely vary among growth conditions and are not expected to 
be enriched for a particular protein.  
In addition, I also used phenotypic and genetic analyses to identify E2 partners for Rkr1, 
but this method revealed that more than one E2 is most likely involved. Based on my results, 
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Rad6, Cdc34, and Ubc4 have the most similar phenotypic profile to Rkr1, indicating that they 
likely fall in a similar pathway. However, loss of RKR1 causes an increase in nonstop protein 
levels of a reporter construct while no E2 mutant exhibited the same phenotype. This indicates 
that there is most likely redundancy in a Rkr1-E2 partnership. I was also unable to test the 
essential E2 Ubc1, and so this protein is still a viable candidate for this interaction. Interestingly, 
a large-scale screen using human RING domains and human E2s in a yeast two-hybrid assay 
identified an interaction between human Rkr1 and Ubc4/5 (VAN WIJK et al. 2009). Although this 
result was not confirmed with purified proteins, it may be validated as additional studies are 
performed to expand the network of E2-E3 interactions in other organisms. 
 Lastly, I investigated Htz1 as a substrate for Rkr1 ubiquitylation. Collaboration with Dr. 
Nevan Krogan produced an E-MAP analysis of rkr1Δ cells, which identifies mutations with 
similar genetic profiles that most likely function in similar pathways. Strains deleted of RKR1 
exhibit a genetic profile similar that of strains lacking the histone variant Htz1 or members of the 
Swr1 complex, which functions to exchange Htz1 for canonical H2A in nucleosomes (KROGAN 
et al. 2004; KROGAN et al. 2003a; MIZUGUCHI et al. 2004).  Preliminary studies by Mary Braun 
and Elia Crisucci found that Htz1 was a target for Rkr1-mediated ubiquitylation when HTZ1 was 
overexpressed. I expanded on these studies, showing that endogenous Htz1 is not targeted for 
ubiquitylation. This suggested that Htz1 was ubiquitylated only when overexpressed and 
therefore was a substrate of quality control. Further, I showed that an HA-tagged Htz1 was not a 
substrate for Rkr1 when overexpressed, unlike the FLAG-tagged Htz1 construct. Rkr1 may 
therefore be targeting this FLAG tag, which contains multiple lysine residues similar to the poly-
lysine chain on nonstop proteins.  However, in order to further clarify this result, it would be 
interesting to test other overexpressed FLAG-tagged substrates for Rkr1-mediated ubiquitylation.  
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To date, Rkr1 has not been shown to ubiquitylate proteins other than nonstop substrates. My 
results from this thesis support the role for Rkr1 in protein quality control, and it is not unlikely 
that Rkr1 also recognizes as yet unidentified targets outside of nonstop.  
5.3 FINAL CONCLUSIONS 
My thesis work has aimed to understand the connection between Rtf1 and Rkr1, as well as to 
identify additional roles for these proteins. In my studies, I have found support for the role of 
Rkr1 in quality control of aberrant proteins. Importantly, I have also shown that the prion [PSI+] 
negatively influences the loss of RKR1 and adds to a burden in quality control (Figure 32). I have 
shown that this is lethal in the absence of RTF1, although the mechanism behind this synthetic 
lethality is still unclear and remains an avenue for future studies. Loss of RTF1 and H2B 
ubiquitylation may increase problems in quality control by affecting mRNA processing and 
creating additional mRNA substrates, resulting in a lethal stress to [PSI+] rkr1Δ cells. In an 
alternative hypothesis, loss of RTF1 could cause a change in products needed to protect cells 
from quality control in [PSI+] rkr1Δ conditions. Future studies into the effect of rtf1Δ on 
transcript levels and processing may clarify these ideas.  
In addition, my genetic suppressor results leave two interesting paths for further study of 
Rtf1 and Rkr1. Through Chl1 and Rpc17, I have potentially connected these factors to sister 
chromatid cohesion and translation in previously unappreciated roles. Therefore, future studies in 
these areas may reveal exciting new roles for Rtf1 and Rkr1, and, in addition, for Chl1 and 
Rpc17 (Figure 32).  
 166 
        
         
Figure 32: Final conclusions on suppression mechanisms of rtf1Δ rkr1Δ synthetic lethality 
Through a transposon mutagenesis screen, I identified mutations in the genes encoding Hsp104, Chl1, and Rpc17 
that rescue rtf1Δ rkr1Δ synthetic lethality. Hsp104 inactivation or overexpression clears yeast of the prion [PSI+], 
which increases quality control problems in yeast, both in protein and aberrant mRNA. Therefore, it may be that 
Rtf1, as a transcription factor, is needed to protect yeast in the face of this increased burden. The suppression 
mechanism of a chl1Δ mutation is unclear, but loss of CHL1 opposes rtf1Δ -specific defects in nonsense and nonstop 
products. Depletion of Rtf1 may therefore cause changes in RNA processing that lead to an additional accumulation 
in aberrant mRNAs and deletion of Chl1 may suppress these errors. It remains to be investigated if the role of Chl1 
in sister chromatid cohesion is important in this suppression mechanism, or if Chl1 also plays a role in transcription. 
Finally, I’ve shown that a mutation in the essential gene RPC17 is also a genetic suppressor of rtf1Δ rkr1Δ synthetic 
lethality. One hypothesis to explain this suppression is that this mutation affects RNA Pol III function and tRNA 
levels, with downstream effects on translation efficiency and the accumulation of quality control products. 
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6.0  APPENDIX 
ADDITIONAL STUDIES INTO THE FUNCTIONS OF RKR1 AND THE PAF1 
COMPLEX 
6.1 PAF1C-DEPENDENT HISTONE MODIFICATIONS ARE NOT 
SIGNIFICANTLY AFFECTED IN HISTONE ACETYLTRANSFERASE OR HISTONE 
DEMETHYLASE MUTANT STRAINS 
Transcription occurs within the controlled context of chromatin, which may is altered by various 
mechanisms in order to accommodate elongating RNA polymerase II (Pol II) and transcribe the 
DNA template (LI et al. 2007a). Chromatin alterations include ATP-dependent chromatin 
remodeling, the exchange of histone variants, and histone modifications such as methylation, 
ubiquitylation, and acetylation. Histone modifications are patterned specifically to allow the 
transcription or repression of genes (LI et al. 2007a).  
Several factors are required to establish the correct pattern of histone modifications 
necessary for proper transcription. One such set of factors is the Paf1 complex (Paf1c).  Rtf1 of 
Paf1c is necessary for the mono-ubiquitylation of K123 on H2B, which is a prerequisite for 
downstream methylation of H3 K4 and K79 by Set1 and Dot1, respectively (DOVER et al. 2002; 
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SUN and ALLIS 2002).  These specific ubiquitylation and methylation marks are regulated most 
strongly by Rtf1 of the Paf1 complex, and are associated with active transcription.  
 Besides these marks, numerous other histone modifications have been characterized. 
These include methylation of H3 K36 by the methyltransferase Set2 (STRAHL et al. 2002) as well 
as histone acetylation by HATs, which is typically a mark of active transcription (POKHOLOK et 
al. 2005). Interestingly, these two modifications are mechanistically coupled, as H3 K36 di-
methylation recruits the Rpd3s HDAC, which deacetylates histones and represses cryptic 
initiation within genes (CARROZZA et al. 2005; KEOGH et al. 2005; LI et al. 2009). In addition to 
HDACs, cells also contain histone demethylases (DMTs), which have been shown to 
demethylate methylated histones (reviewed in (MOSAMMAPARAST and SHI 2010)). This suggests 
evidence for an extremely dynamic chromatin environment, with multiple players involved in the 
establishment and erasure of correct histone modifications.  
 In a study to investigate if Paf1c played a role in histone modification pathways other 
than the H2B K123 ubiquitylation pathway, western analysis and chromatin 
immunoprecipitation (ChIP) was used to examine the effect of deleting members of Paf1c on H3 
K36 tri-methylation. Deletion of PAF1 or CTR9  specifically abolishes H3 K36 tri-methylation 
and deletion of CDC73 reduces this mark, while loss of RTF1 or LEO has little effect (CHU et al. 
2007). This result was specific to this methylation state, as loss of these subunits had little to no 
effect on di-methylation of H3 K36. Set2 recruitment to active genes is decreased in paf1Δ 
strains, but more severely at the 3’ ends than the 5’ ends. Interestingly, deletion of PAF1 also 
causes an increase in H3 and H4 acetylation at the 5’ end of genes (CHU et al. 2007). These 
results suggested that in the absence of Paf1, an increase in acetylation may modulate a 
corresponding decrease in H3 K36 tri-methylation.  
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To test this hypothesis, I investigated HATs that might be responsible the for increased 
histone acetylation observed in a paf1Δ strain, as well as DMTs which may be hyperactive at the 
5’ end of genes in the absence of Paf1 and cause a decrease in H3 K36 tri-methylation. To this 
end, I first continued genetic analysis started by Rajna Simic to investigate genetic interactions 
between paf1Δ and loss of several yeast HATs or DMTs. A genetic interaction may indicate that 
these two factors are required for similar processes. I found no genetic interaction between paf1Δ  
and mutations in any of five proposed DMTs (ECM5, GIS1, YJR119C, RPH1, and JHD1) 
(KWON and AHN 2011) (Table 7). However, I found that deletion of PAF1 caused sickness or 
lethality in combination with loss of the HATs or HAT subunits GCN5, VID21, RTT109, or SAS2 
(Table 8, Figure 33) (LEE and WORKMAN 2007).  
Next, I performed western analysis of single HAT or DMT mutant strains, as well as 
double mutants with paf1Δ to identify for strains that exhibited a decrease in histone acetylation 
or an increase in H3 K36 tri-methylation back to wild type levels. To perform these experiments, 
I used multiple antibodies against histone methylation and histone acetylation available in the 
lab, in order to observe any additional or unexpected changes in any histone modification states 
in the mutant strains.  However, I did not detect reversal of H3 K36 tri-methylation or histone 
acetylation back to wild type levels in any double mutant strain with paf1Δ and HATΔ or DMTΔ 
(Subset of data shown in Figure 33). These results may indicate that multiple pathways are 
redundantly at work in regulating histone acetylation and H3 K36 tri-methylation with Paf1 (See 
also Table 7 and 8). For example, both Jhd1 and Rph1 are DMTs for H3 K36 methylation, which 
is decreased in the absence of PAF1 (CHU et al. 2007; KIM and BURATOWSKI 2007; KWON and 
AHN 2011). Therefore, I also created a jhd1Δ rph1Δ paf1Δ strain but found that it also did not 
significantly enhance H3 K36 tri-methylation levels (Figure 34).   
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Loss of PAF1 results in a loss of H3 K36 tri-methylation and corresponding increase in 
acetylation of histone H3 and H4 at the 5’ ends of genes (CHU et al. 2007). Here, I have 
described experiments that sought a DMT or HAT that may be recruited in the absence of Paf1. 
However, these preliminary investigations did not identify potential factor(s).  This may be due 
to the nature of western analysis, which reveals the global state of histone modification and may 
not detect subtle changes observable by ChIP. Redundancy in these histone modification 
pathways may also have made these experiments difficult to interpret. Lastly, these results may 
suggest that additional factors are involved in this process. For example, instead of a HAT being 
recruited to increase histone acetylation at the 5’ end of genes in paf1Δ cells, there may be a 
deficiency in HDAC recruitment resulting in the inability to deacetylate histones. The HDAC 
Set3 has been shown to deacetylates histone at the 5’ ends of genes in response to H3 K4 di-
methylation (KIM and BURATOWSKI 2009). Similarly, rather than the recruitment of a DMT to 
 demethylate H3 K36 tri-methylation in paf1Δ cells, the catalytic activity of Set2 may be 
impaired, blocking progression of H3 K36 di-methylation to tri-methylation. Interestingly, it has 
recently been shown that improper phosphorylation of the RNA Pol II C-terminal domain results 
in global loss of H3 K36 tri-methylation, although this also correlates with a decrease in Set2 
levels (FUCHS et al. 2012). Future studies will likely illuminate how these factors and others 
contribute to such a complex set of histone modifications necessary for proper transcription.  
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Figure 33: Genetic interactions between paf1Δ and histone acetyltransferase mutants. 
Tetrad dissections of diploids that were heterozygous for paf1Δ and a deletion of a histone acetyltransferase protein 
(Crosses performed by Rajna Simjic and scored by Kristin Klucevsek). Shown is one representative tetrad from the 
dissection plate. 
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Figure 34: Western analysis of histone modifications in strains lacking the HAT Gcn5 or various 
DMTs. 
(A). Wild type (KY311), set1Δ (KY941), set2Δ (KY914), dot1Δ (KY935), paf1Δ (KY686), gcn5Δ (KY1343), or 
gcn5Δ paf1Δ (KY1347) extracts were made using RIPA buffer and assayed for histone modifications using western 
analysis and standard techniques. Antibodies used were against H3 acetylation (AcH3, 1:2000; Upstate), H4 
acetylation (AcH4, 1:40,000; Upstate), Sec61 (1:1000; Gift from Dr. Jeff Brodsky), total H3 (1:2000, Abcam), and 
H3 K36me3 (1:3000, Abcam). (B). Wild type (KY311), set2Δ (KY914), paf1Δ (KY686), paf1Δ rph1Δ (KY1339), 
paf1Δ jhd1Δ (KY1334), paf1Δ jhd1Δ rph1Δ (KY1393), jhd1Δ rph1Δ (KY1396), rph1Δ (KY1337), or jhd1Δ 
(KY1333) extracts were made and analyzed as in (A) with antibodies against H3 K36 tri-methylation or total H3 
levels as a control. 
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Table 7: HAT or HAT complex mutations used in Appendix 
(*) Indicates subunit of HAT complex that is not known to possess HAT activity but is an important part of the 
complex.  Red indicates acetylation recognized by AcH3 or AcH4 antibodies.  
 
 
 
 
 
Table 8: DMT proteins studied in Appendix 
   
DMT Histone Substrate 
Jhd1 H3K36me2 
Jhd2 H3K4me2,3 
Rph1 H3K36me2,3 
Gis1 Predicted to have no catalytic activity 
Ecm5 Predicted to have no catalytic activity 
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6.2 A SCREEN TO IDENTIFY HISTONE H3 OR H4 RESIDUES THAT 
GENETICALLY OR FUNCTIONALLY INTERACT WITH LOSS OF RKR1 
Rkr1 was initially identified as a protein that is required in the absence of the transcription factor 
Rtf1 for cell viability, as well the Rtf1-mediated histone modification, H2B K123 
monoubiquitylation (BRAUN et al. 2007; NG et al. 2003a). This is a mark generally associated 
with active transcription, indicating that Rkr1 might also play a role parallel to this process 
(XIAO et al. 2005). Importantly, H2B ubiquitylation is required for downstream methylation of 
histone H3 on lysines 4 and 36, which is also a mark of active transcription (DOVER et al. 2002; 
SUN and ALLIS 2002; WOOD et al. 2003b). Therefore, it was hypothesized that Rkr1 might also 
have an important role in transcription.  
To better understand the function of Rkr1, I performed a synthetic genetic array (SGA) 
analysis to identify additional histone residues that when mutated caused synthetic lethality in 
the rkr1Δ strains. The Boeke lab has generated a set of integrated histone H3 and H4 point 
mutations representing 486 alleles where each residue has been systematically changed to an 
alanine, and each alanine to a serine (DAI et al. 2008). Additional amino acid substitutions 
designed to mimic modification states, such as mutation of all lysine residues to arginine and 
glutamine to mimic deacetylation or acetylation, respectively (DAI et al. 2008). Deletions of 
different sizes were also made of the histone tails (DAI et al. 2008). The collection exists in a 96-
well plate format, allowing for easy SGA analysis by performing a cross between these strains 
and a rkr1Δ strain (KMKY81) to identify genetic interactions. Both strains used in this query had 
only one copy of the histone H3 and H4 genes, with the other endogenous copy deleted. 
A genetic screen using these mutants, performed in duplicate, identified 8 mutations that 
were synthetically lethal or sick in the absence of RKR1.  They included the following: H3E73A, 
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H4H18A, H4K16Q, H4K16A, H4Δ13-20, H4Δ17-20, H4Δ9-16, and H4Δ15-18. In order to 
confirm these interactions, I performed individual crosses with these strains. However, I found 
that upon using standard techniques to do these crosses, each of these strains actually had 
difficulties mating with my rkr1Δ strain or the resulting diploid had difficulties sporulating. 
None of these residues had any discernible genetic interactions when tetrad dissections were able 
to be performed. Therefore, each of the genetic interactions from the original screen were most 
likely artifacts of the mutant histone strains’ inabilities to properly mate or sporulate, which 
could indicate an important function for these histone residues, but not a function relevant to 
Rkr1.  
Although RKR1 did not appear to interact genetically with any histone H3 or H4 
mutations, I next decided to screen this library for sensitivity to cycloheximide. Strains lacking 
RKR1, as well as strains defective in the H2B ubiquitylation pathway, including strains lacking 
RTF1, BRE1, RAD6, or containing a H2B K123 substitution, are all sensitive to media 
cycloheximide.  These results indicate that cycloheximide sensitivity might be useful for 
identifying genes or residues important for a similar process, such as transcription. Therefore, I 
used a large-scale analysis to first identify histone H3 and H4 mutant strains that appeared to 
have slow growth on cycloheximide-containing medium. Next, I struck these strains out in 
duplicate to confirm their poor growth compared to wild type and rkr1Δ control cells. 
Interestingly, I found a specific set of residues that are important for cycloheximide resistance 
with many of them having established roles in active transcription (DU and BRIGGS 2010; 
HAINER and MARTENS 2011; POKHOLOK et al. 2005; PSATHAS et al. 2009) (Table 9). In addition, 
these residues lie mostly in regions of histone H3 or H4 that are in contact with DNA, indicating 
that they could be disrupting DNA-histone interactions (Figure 35). Therefore, although I did not 
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identify any histone H3 or H4 residues that are synthetically lethal in the context of a rkr1Δ 
strain, I did identify histone amino acid substitutions that share an important phenotype with 
rkr1Δ and H2B K123R, further suggesting that this phenotype may be indicative of an important 
cellular process connected to transcription.  
 
 
 
 
Figure 35: Residues that are required for cycloheximide resistance. 
Histone H3 (red) and Histone H4 (blue) residues identified in a screen for mutants sensitive to cycloheximide (See 
table 9). The positions of the amino acids are shown on the structure of  histone H3 and H4, as well as their contact 
with DNA (LUGER et al. 1997). 
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Table 9: Residues that are required for cycloheximide resistance 
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6.3 THE EFFECT OF RKR1 ON CELL CYCLE PROGRESSION 
A screen was performed to identify mutations that were synthetically lethal in the absence of the 
Paflc member, Rtf1 (COSTA and ARNDT 2000). Nine genes were found in this screen, which 
represented a range of cellular functions, with 8 of the 9 having either direct or indirect 
connections to transcription (Table 10) (Costa and Arndt, unpublished data and (COSTA and 
ARNDT 2000)). There was one gene, which was later named RKR1, which coded for an 
uncharacterized open reading frame that has since been identified as a ubiquitin ligase involved 
in nonstop protein degradation (BENGTSON and JOAZEIRO 2010; BRAUN et al. 2007; WILSON et 
al. 2007). Because most of the genes recovered from the synthetic lethality screen with rtf1Δ 
were involved in transcription, we hypothesized that Rkr1 might also have connections to the 
cellular processes represented by these results.  
To help in uncovering the function of Rkr1, a phenotypic screen was performed to 
identify conditions which required Rkr1 function (See Chapter 4). The most notable phenotype 
that resulted from this screen was a sensitivity to cycloheximide. Although the cause of this 
uncharacterized phenotype is not clear, cycloheximide interrupts translation and has been linked 
to increases in aberrant mRNA  low levels of ubiquitin or cell cycle disruptions (FRISCHMEYER et 
al. 2002; HANNA et al. 2003; MCCUSKER and HABER 1988; WAGNER and LYKKE-ANDERSEN 
2002). Interestingly, two other genes encoding mutations that are synthetically lethal with rtf1Δ 
are SWI4 and SWI6, which are transcriptional activators needed for proper cell cycle regulation 
(NASMYTH and DIRICK 1991). The cause of their synthetic lethality with rtf1Δ is currently 
unknown. However, I also wanted to know if Rkr1 was involved in proper regulation of the cell 
cycle. To investigate this, I performed a cell cycle arrest of wild type or rkr1Δ cells. As a control, 
swi4Δ cells were used. Briefly, mating type a cells were grown to an OD600 of 0.2, treated with 5 
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µg/ml α-factor, and incubated at 30oC for 2.5 hours or until cell cycle arrest in G1 phase was 
observed. Cells were transferred to a new sterile tube and released from α-factor by washing and 
resuspending in fresh YPD. Cultures were then allowed to continue growing while samples were 
taken at the indicated time points. These samples were sonicated to separate individual cells. The 
number of unbudded, small budded, and large budded cells were counted. This experiment was 
performed in duplicate using blind analysis, without knowing which samples represented which 
strain. 
As expected, the loss of SWI4 resulted in an S to G2 cell cycle delay compared to wild 
type cells (Figure 36). However, the loss of RKR1 had no discernible effect on the cell cycle in 
any phase (Figure 36). Therefore, Rkr1 is not required for proper cell cycle progression and its 
genetic interaction with rtf1Δ or its cycloheximide phenotype is not likely due to a cell cycle 
defect.  
 
 
Table 10: Genes uncovered from rtf1Δ synthetic lethality screen 
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Figure 36: rkr1∆ strains do not have a cell cycle delay 
Wild type (KY669), rkr1∆ (MBY168), or swi4∆ (KK10) strains were grown in YPD to log phase and arrested with 
α-factor. Cells were released by washing in YPD and allowed to grow at 30oC. The number of cells unbudded (G1 to 
S phase), with small buds (G2 phase), or large buds (M phase), were counted at the indicated time points. Shown are 
the percent of small budded cells, which represents cells transitioning from S into G2. No differences were seen in 
the numbers of unbudded or large budded cells compared between any of the strains (data not shown). The 
Experiment was performed in duplicate, with one representative experiment shown.  
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Table 11: S. cerevisiae strains used in Appendix 
 
Strain Genotype 
KKY10 MAT a swi4Δ::HIS3 lyst-128δ leu2Δ1 ura3-52 trp1Δ1 
MBY39 MAT a rkr1Δ::KanMX4 his3Δ200 lys2-128δ leu2Δ1 trp1Δ63  
KMKY81 MAT α rkr1Δ::KanMX ht1-hhf1::NatMX4 CAN1::MFA1pr-HIS3 his3Δ200 leu2Δ1/0 ura3-52/0 
trp1Δ63 lys2Δ0 
KY311 MAT α his3Δ200 leu2Δ1 ura3-52 
KY686 MAT a paf1Δ::URA3 ura3-52 lys2-128δ 
KY669 MAT a his3Δ200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 
KY914 MAT α set2Δ::HIS3 his3Δ200 lys2-173R2 leu2Δ1 ura3-52 
KY935 MAT a dot1Δ::HIS3 his3Δ200 ura3-52 
KY941 MAT α set1Δ::HIS3 his3Δ200 ura3-52 
KY1333 MAT a jhd1Δ::KanMX his3Δ200 leu2Δ1 ura3-52  lys2-173R2 
KY1334 MAT α jhd1Δ::KanMX paf1Δ::URA3 his3Δ200 leu2Δ1 ura3-52   
KY1337 MAT a rph1 his3Δ200 ura3-52  trp1Δ63 
KY1339 MAT a rph1Δ::KanMX paf1Δ::URA3 his3Δ200 ura3-52  trp1Δ63 
KY1343 MAT α gcn5Δ::HIS3 his3Δ200 leu2Δ1 ura3-52 trp1Δ63 
KY1347 MAT a gcn5Δ::HIS3 paf1Δ::URA3 his3Δ200 leu2Δ1 ura3-52  
KY1393 MAT a jhd1Δ::KanMX paf1Δ::URA3 rph1Δ::KanMX his3Δ200 ura3-52   
KY1396 MAT α jhd1Δ::KanMX rph1Δ::KanMX his3Δ200 ura3-52  arg4-12 
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